<!DOCTYPE html><html lang="en" class="scroll-smooth"><head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Pharmacology Test - Brain And Scalpel</title>
    <link rel="preload" href="assets/background.jpg" as="image">
    <script src="https://cdn.tailwindcss.com"></script>
    <!-- HLS.js for M3U8 support -->
    <script src="https://cdn.jsdelivr.net/npm/hls.js@latest"></script>
    <style>
        
/* Liquid Glass Morphism Universal Theme - Enhanced & Mobile-First */
:root {
  --glass-bg: rgba(0, 0, 0, 0.6);
  --glass-bg-light: rgba(255, 255, 255, 0.1);
  --glass-bg-medium: rgba(255, 255, 255, 0.15);
  --glass-bg-heavy: rgba(255, 255, 255, 0.2);
  --glass-border: rgba(255, 255, 255, 0.2);
  --glass-border-light: rgba(255, 255, 255, 0.1);
  --text-primary: rgba(255, 255, 255, 0.95);
  --text-secondary: rgba(255, 255, 255, 0.7);
  --text-tertiary: rgba(255, 255, 255, 0.5);
  --accent-blue: #60a5fa;
  --accent-purple: #a855f7;
  --accent-green: #34d399;
  --accent-orange: #fb923c;
  --accent-red: #f87171;
  --accent-yellow: #fbbf24;
}

* {
  margin: 0;
  padding: 0;
  box-sizing: border-box;
}

html {
  scroll-behavior: smooth;
}

body {
  margin: 0;
  min-height: 100vh;
  font-family: system-ui, -apple-system, BlinkMacSystemFont, 'Segoe UI', sans-serif;
  position: relative;
  overflow-x: hidden;
  color: var(--text-primary);
  background-color: #000;
}

/* iOS Background Fix */
body::before {
  content: '';
  position: fixed;
  top: 0;
  left: 0;
  height: 100vh;
  width: 100vw;
  z-index: -2;
  background: url("assets/background.jpg") center center / cover no-repeat;
}

body::after {
  content: "";
  position: fixed;
  inset: 0;
  background: rgba(0, 0, 0, 0.4);
  backdrop-filter: blur(10px);
  -webkit-backdrop-filter: blur(10px);
  z-index: -1;
}

/* Glass morphism components */
.glass {
  background: var(--glass-bg);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-light {
  background: var(--glass-bg-light);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid var(--glass-border-light);
  border-radius: 12px;
}

.glass-medium {
  background: var(--glass-bg-medium);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-heavy {
  background: var(--glass-bg-heavy);
  backdrop-filter: blur(25px);
  -webkit-backdrop-filter: blur(25px);
  border: 1px solid var(--glass-border);
  border-radius: 20px;
}

.glass-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.glass-card:hover {
  transform: translateY(-8px);
  background: rgba(255, 255, 255, 0.12);
  border-color: rgba(255, 255, 255, 0.25);
  box-shadow: 0 20px 60px rgba(0, 0, 0, 0.4);
}

.glass-button {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.8), rgba(168, 85, 247, 0.8));
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: white;
  font-weight: 600;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 4px 20px rgba(96, 165, 250, 0.3);
  cursor: pointer;
  border: none;
}

.glass-button:hover {
  transform: translateY(-2px);
  box-shadow: 0 8px 30px rgba(96, 165, 250, 0.4);
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.9), rgba(168, 85, 247, 0.9));
}

.glass-button:disabled {
  opacity: 0.5;
  cursor: not-allowed;
  transform: none;
}

.glass-input {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: var(--text-primary);
  transition: all 0.3s ease;
}

.glass-input:focus {
  outline: none;
  border-color: var(--accent-blue);
  background: rgba(255, 255, 255, 0.12);
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.3);
}

.glass-input::placeholder {
  color: var(--text-tertiary);
}

/* Performance analysis styles */
.performance-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.score-circle {
  position: relative;
  width: 150px;
  height: 150px;
  margin: 0 auto;
}

.score-circle svg {
  transform: rotate(-90deg);
}

.score-circle .circle-bg {
  fill: none;
  stroke: rgba(255, 255, 255, 0.1);
  stroke-width: 8;
}

.score-circle .circle-progress {
  fill: none;
  stroke-width: 8;
  stroke-linecap: round;
  transition: stroke-dasharray 2s cubic-bezier(0.4, 0, 0.2, 1);
}

.score-text {
  position: absolute;
  top: 50%;
  left: 50%;
  transform: translate(-50%, -50%);
  text-align: center;
}

/* Review question styles */
.review-question {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.1);
  border-radius: 16px;
  padding: 20px;
  margin-bottom: 20px;
}

.review-question.correct {
  border-left: 4px solid #22c55e;
}

.review-question.incorrect {
  border-left: 4px solid #ef4444;
}

.review-question.not-attempted {
  border-left: 4px solid #6b7280;
}

/* Gradient backgrounds for accents */
.gradient-blue {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
}

.gradient-purple {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
}

.gradient-green {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
}

.gradient-orange {
  background: linear-gradient(135deg, var(--accent-orange), #f97316);
}

.gradient-red {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
}

.gradient-yellow {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
}

/* Navigation button styles */
.nav-btn-not-attempted {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  color: rgba(255, 255, 255, 0.7);
}

.nav-btn-current {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.4);
}

.nav-btn-correct {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-incorrect {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-bookmarked {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-marked-review {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-answered {
  background: linear-gradient(135deg, #6b7280, #4b5563);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

/* Option button styles - REVISED FOR INLINE FEEDBACK */
.option-button {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.15);
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  position: relative;
  overflow: hidden;
  width: 100%;
  text-align: left;
  padding: 1rem;
  border-radius: 12px;
  color: var(--text-primary);
  cursor: pointer;
  display: flex;
  align-items: center;
  gap: 1rem;
  font-size: 1rem;
}

.option-button:hover {
  background: rgba(255, 255, 255, 0.1);
  border-color: rgba(96, 165, 250, 0.5);
  transform: translateX(8px);
}

.option-button.selected {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.3), rgba(59, 130, 246, 0.3));
  border-color: var(--accent-blue);
  transform: translateX(8px);
}

#optionsContainer.answered .option-button:hover {
    transform: translateX(0); /* Disable hover effect after answering */
}

#optionsContainer.answered .option-button {
    cursor: not-allowed;
    pointer-events: none;
}

#optionsContainer.answered .option-button:not(.correct):not(.incorrect) {
    opacity: 0.5;
}

.option-button.correct {
    background: linear-gradient(135deg, #22c55e, #16a34a);
    border-color: #22c55e;
    color: white;
    transform: translateX(0);
}

.option-button.incorrect {
    background: linear-gradient(135deg, #ef4444, #dc2626);
    border-color: #ef4444;
    color: white;
    transform: translateX(0);
}

.option-letter {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  transition: all 0.3s ease;
  width: 2.5rem;
  height: 2.5rem;
  border-radius: 50%;
  display: flex;
  align-items: center;
  justify-content: center;
  font-weight: bold;
  color: var(--text-primary);
  flex-shrink: 0;
}

.option-button.selected .option-letter {
  background: var(--accent-blue);
  border-color: var(--accent-blue);
  color: white;
}

.option-button.correct .option-letter, .option-button.incorrect .option-letter {
    background: rgba(255, 255, 255, 0.2);
    border-color: rgba(255, 255, 255, 0.3);
}

.option-text {
  flex: 1;
  font-size: 1rem;
  line-height: 1.5;
}

/* Stats bar responsive grid */
.stats-grid {
  display: grid;
  grid-template-columns: repeat(5, 1fr);
  gap: 1rem;
  align-items: center;
  justify-items: center;
}

@media (max-width: 768px) {
  .stats-grid {
    grid-template-columns: repeat(3, 1fr);
    gap: 0.5rem;
  }
 
  .stats-grid > div:nth-child(4),
  .stats-grid > div:nth-child(5) {
    grid-column: span 1;
  }
}

@media (max-width: 480px) {
  .stats-grid {
    grid-template-columns: repeat(2, 1fr);
  }
 
  .stats-grid > div:last-child {
    grid-column: span 2;
    justify-self: center;
  }
}

/* Animations */
@keyframes float {
  0%, 100% { transform: translateY(0px); }
  50% { transform: translateY(-20px); }
}

@keyframes pulse-glow {
  0%, 100% { box-shadow: 0 0 20px rgba(96, 165, 250, 0.3); }
  50% { box-shadow: 0 0 40px rgba(96, 165, 250, 0.6); }
}

@keyframes checkmark {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(180deg); }
  100% { transform: scale(1) rotate(360deg); }
}

@keyframes cross {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(90deg); }
  100% { transform: scale(1) rotate(180deg); }
}

.animate-float {
  animation: float 6s ease-in-out infinite;
}

.animate-pulse-glow {
  animation: pulse-glow 2s ease-in-out infinite;
}

.animate-checkmark {
  animation: checkmark 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

.animate-cross {
  animation: cross 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

/* Custom scrollbar */
::-webkit-scrollbar {
  width: 8px;
}

::-webkit-scrollbar-track {
  background: rgba(255, 255, 255, 0.05);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb {
  background: rgba(255, 255, 255, 0.2);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb:hover {
  background: rgba(255, 255, 255, 0.3);
}

/* --- MOBILE RESPONSIVE STYLES --- */
.quiz-container {
    display: flex;
    flex-direction: column;
    gap: 1.5rem;
}

#mobile-nav-toggle {
    display: none; /* Hidden on desktop */
}

@media (min-width: 1024px) {
    .quiz-container {
        flex-direction: row;
        gap: 2rem;
    }
}

@media (max-width: 1023px) {
    .quiz-sidebar {
        position: fixed;
        top: 0;
        left: 0;
        width: 300px;
        height: 100%;
        z-index: 100;
        transform: translateX(-100%);
        transition: transform 0.3s ease-in-out;
        box-shadow: 10px 0px 30px rgba(0,0,0,0.5);
    }
    .quiz-sidebar.open {
        transform: translateX(0);
    }
    #mobile-nav-toggle {
        display: flex;
        position: fixed;
        bottom: 20px;
        left: 20px;
        z-index: 50;
    }
    .quiz-main-content {
        width: 100%;
    }
}

@media (max-width: 768px) {
    .glass-card, .glass {
        border-radius: 16px;
    }
    h1 { font-size: 2.5rem; }
    #questionText { font-size: 1.125rem; }
    .controls-container {
        flex-direction: column;
        gap: 1rem;
    }
    .controls-container button {
        width: 100%;
    }
}

    </style>
</head>
<body>
    <!-- Mode Selection Modal -->
    <div id="modeModal" class="fixed inset-0 bg-black bg-opacity-70 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-md w-full mx-4 shadow-2xl">
            <h2 class="text-2xl font-bold text-white mb-6 text-center">Choose Study Mode</h2>
            
            <div class="space-y-4">
                <button onclick="selectMode('study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Study Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Interactive learning with immediate feedback</p>
                        </div>
                        <div class="gradient-blue w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 12l2 2 4-4m6 2a9 9 0 11-18 0 9 9 0 0118 0z"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('test')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Test Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Practice test with performance analysis at end</p>
                        </div>
                        <div class="gradient-purple w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 2a1 1 0 000 2h2a1 1 0 100-2H9z"></path>
                                <path fill-rule="evenodd" d="M4 5a2 2 0 012-2v1a1 1 0 001 1h6a1 1 0 001-1V3a2 2 0 012 2v6a2 2 0 01-2 2H6a2 2 0 01-2-2V5zm3 4a1 1 0 000 2h.01a1 1 0 100-2H7zm3 0a1 1 0 000 2h3a1 1 0 100-2h-3z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Study</h3>
                            <p class="text-sm text-white text-opacity-70">Study with time pressure and immediate feedback</p>
                        </div>
                        <div class="gradient-green w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M10 18a8 8 0 100-16 8 8 0 000 16zm1-12a1 1 0 10-2 0v4a1 1 0 00.293.707l2.828 2.829a1 1 0 101.415-1.415L11 9.586V6z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_exam')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Exam</h3>
                            <p class="text-sm text-white text-opacity-70">Real exam simulation with strict timing</p>
                        </div>
                        <div class="gradient-red w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M12.395 2.553a1 1 0 00-1.45-.385c-.345.23-.614.558-.822.88-.214.33-.403.713-.57 1.116-.334.804-.614 1.768-.84 2.734a31.365 31.365 0 00-.613 3.58 2.64 2.64 0 01-.945-1.067c-.328-.68-.398-1.534-.398-2.654A1 1 0 005.05 6.05 6.981 6.981 0 003 11a7 7 0 1011.95-4.95c-.592-.591-.98-.985-1.348-1.467-.363-.476-.724-1.063-1.207-2.03z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
            </div>
        </div>
    </div>

    <!-- Performance Analysis Modal -->
    <div id="performanceModal" class="hidden fixed inset-0 bg-black bg-opacity-80 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-4xl w-full mx-4 shadow-2xl max-h-[90vh] overflow-y-auto">
            <div class="flex items-center justify-between mb-8">
                <h2 class="text-3xl font-bold text-white">Performance Analysis</h2>
                <button onclick="closePerformanceModal()" class="glass-light p-2 rounded-lg text-white hover:bg-white hover:bg-opacity-20">
                    <svg class="w-6 h-6" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M4.293 4.293a1 1 0 011.414 0L10 8.586l4.293-4.293a1 1 0 111.414 1.414L11.414 10l4.293 4.293a1 1 0 01-1.414 1.414L10 11.414l-4.293 4.293a1 1 0 01-1.414-1.414L8.586 10 4.293 5.707a1 1 0 010-1.414z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
            
            <!-- Score Overview -->
            <div class="grid grid-cols-1 md:grid-cols-3 gap-6 mb-8">
                <div class="performance-card p-6 text-center">
                    <div class="score-circle mb-4">
                        <svg width="150" height="150" class="mx-auto">
                            <circle class="circle-bg" cx="75" cy="75" r="65"></circle>
                            <circle id="scoreCircle" class="circle-progress" cx="75" cy="75" r="65" stroke="#22c55e" stroke-dasharray="0 408"></circle>
                        </svg>
                        <div class="score-text">
                            <div class="text-3xl font-bold text-white" id="accuracyScore">0%</div>
                            <div class="text-sm text-white text-opacity-70">Accuracy</div>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Results Summary</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Questions:</span>
                            <span class="text-white font-semibold" id="totalQuestionsResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-green-400">Correct:</span>
                            <span class="text-green-400 font-semibold" id="correctResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-red-400">Incorrect:</span>
                            <span class="text-red-400 font-semibold" id="incorrectResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-gray-400">Not Attempted:</span>
                            <span class="text-gray-400 font-semibold" id="notAttemptedResult">0</span>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Time Analysis</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Time:</span>
                            <span class="text-white font-semibold" id="totalTimeResult">0:00</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Avg per Question:</span>
                            <span class="text-white font-semibold" id="avgTimeResult">0:00</span>
                        </div>
                    </div>
                </div>
            </div>
            
            <!-- Action Buttons -->
            <div class="flex justify-center space-x-4 mb-8">
                <button onclick="reviewQuestions()" class="glass-button px-8 py-3 text-lg">
                    Review All Questions
                </button>
                <button onclick="retakeQuiz()" class="glass-light px-8 py-3 text-lg text-white hover:bg-white hover:bg-opacity-20">
                    Retake Quiz
                </button>
            </div>
            
            <!-- Question Review Section -->
            <div id="questionReviewSection" class="hidden">
                <h3 class="text-2xl font-bold text-white mb-6">Question Review</h3>
                <div id="reviewQuestionsContainer">
                    <!-- Review questions will be populated here -->
                </div>
            </div>
        </div>
    </div>

    <!-- Header -->
    <header class="glass sticky top-0 z-40 mb-6">
        <div class="container mx-auto px-6 py-4">
            <div class="flex items-center justify-between">
                <div class="flex items-center space-x-4">
                    <button onclick="goBack()" class="glass-light px-4 py-2 text-white hover:bg-white hover:bg-opacity-20 transition-all duration-300 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M9.707 16.707a1 1 0 01-1.414 0l-6-6a1 1 0 010-1.414l6-6a1 1 0 011.414 1.414L5.414 9H17a1 1 0 110 2H5.414l4.293 4.293a1 1 0 010 1.414z" clip-rule="evenodd"></path>
                        </svg>
                        Back
                    </button>
                    <div id="quizHierarchy" class="text-sm text-white text-opacity-60">
                        Marrow / NEET PG Test Series Subject Wise / Year 2023 - 24
                    </div>
                </div>
                
                <div class="flex items-center space-x-4">
                    <div class="glass-light px-3 py-1 text-sm text-white">
                        Question <span id="currentQuestion">1</span> of <span id="totalQuestions">50</span>
                    </div>
                    
                    <!-- Timer -->
                    <div id="timerContainer" class="hidden gradient-red px-3 py-1 text-sm text-white font-bold animate-pulse-glow">
                        <span id="timeDisplay">2:00</span>
                    </div>
                </div>
            </div>
        </div>
    </header>

    <!-- Progress Bar -->
    <div class="w-full h-1 bg-black bg-opacity-30 mb-6">
        <div id="progressBar" class="h-1 gradient-blue transition-all duration-500 ease-out" style="width: 0%"></div>
    </div>

    <!-- Stats Bar - Show only in study modes -->
    <div id="statsBar" class="glass-light mb-8">
        <div class="container mx-auto px-6 py-4">
            <div class="stats-grid">
                <div class="text-center">
                    <div class="text-lg font-bold text-green-400" id="correctCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Correct</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-red-400" id="incorrectCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Incorrect</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-blue-400" id="totalAttempted">0</div>
                    <div class="text-xs text-white text-opacity-60">Attempted</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-purple-400" id="accuracy">0%</div>
                    <div class="text-xs text-white text-opacity-60">Accuracy</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-orange-400" id="timeSpent">0:00</div>
                    <div class="text-xs text-white text-opacity-60">Time</div>
                </div>
            </div>
        </div>
    </div>

    <div class="quiz-container container mx-auto px-6">
        <!-- Question Navigation Sidebar -->
        <div id="quizSidebar" class="quiz-sidebar glass p-6 h-fit lg:sticky top-24">
            <h3 class="text-lg font-bold text-white mb-4">Question Navigator</h3>
            <div id="questionNav" class="grid grid-cols-5 gap-2 mb-6">
                <!-- Question numbers will be populated here -->
            </div>
            
            <div class="space-y-3 text-xs">
                <h4 class="text-sm font-medium text-white text-opacity-80 mb-3">Legend</h4>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-not-attempted rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Not Attempted</span>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-current rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Current</span>
                </div>
                <div id="studyModeLegend" class="space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-correct rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Correct</span>
                    </div>
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-incorrect rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Incorrect</span>
                    </div>
                </div>
                <div id="testModeLegend" class="hidden space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-answered rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Answered</span>
                    </div>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-bookmarked rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Bookmarked</span>
                </div>
                <div id="testModeReviewLegend" class="hidden items-center">
                    <div class="w-6 h-6 nav-btn-marked-review rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Marked for Review</span>
                </div>
            </div>
            
            <!-- Submit Quiz Button for test modes -->
            <div id="submitSection" class="hidden mt-6">
                <button onclick="submitQuiz()" class="glass-button w-full py-3 text-lg font-bold">
                    Submit Quiz
                </button>
            </div>
        </div>

        <!-- Main Quiz Interface -->
        <div class="quiz-main-content flex-1 max-w-4xl">
            <div class="glass-card p-4 md:p-8 lg:p-12 mb-8 relative">
                <!-- Question Text -->
                <div id="questionText" class="text-xl lg:text-2xl leading-relaxed text-white mb-8">
                    Loading question...
                </div>

                <!-- Question Media -->
                <div id="questionMedia" class="mb-8"></div>

                <!-- Options -->
                <div id="optionsContainer" class="space-y-3 mb-8">
                    <!-- Options will be inserted here -->
                </div>

                <!-- Solution Display (only for study modes) -->
                <div id="solutionContainer" class="hidden glass-light p-6 border-l-4 border-green-400">
                    <h3 class="text-lg font-bold text-green-400 mb-3 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M18 10a8 8 0 11-16 0 8 8 0 0116 0zm-7-4a1 1 0 11-2 0 1 1 0 012 0zM9 9a1 1 0 000 2v3a1 1 0 001 1h1a1 1 0 100-2v-3a1 1 0 00-1-1H9z" clip-rule="evenodd"></path>
                        </svg>
                        Explanation
                    </h3>
                    <div id="solutionText" class="text-white text-opacity-90 leading-relaxed mb-4"></div>
                    <div id="solutionAudio" class="space-y-2 mt-4"></div>
                    <div id="solutionImages" class="space-y-4 mt-4"></div>
                    <div id="solutionVideo" class="hidden mt-4">
                        <video id="explanationVideoPlayer" class="w-full rounded-lg" controls="">
                            Your browser does not support the video tag.
                        </video>
                    </div>
                </div>
            </div>

            <!-- Controls -->
            <div class="controls-container flex justify-between items-center mb-8">
                <button onclick="previousQuestion()" id="prevBtn" class="glass-button px-6 py-3 flex items-center justify-center disabled:opacity-50 disabled:cursor-not-allowed">
                    <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M12.707 5.293a1 1 0 010 1.414L9.414 10l3.293 3.293a1 1 0 01-1.414 1.414l-4-4a1 1 0 010-1.414l4-4a1 1 0 011.414 0z" clip-rule="evenodd"></path>
                    </svg>
                    Previous
                </button>
                
                <div class="flex justify-center flex-grow">
                    <button onclick="toggleBookmark()" id="bookmarkBtn" class="glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" id="bookmarkIcon" fill="currentColor" viewBox="0 0 20 20">
                            <path d="M5 4a2 2 0 012-2h6a2 2 0 012 2v14l-5-2.5L5 18V4z"></path>
                        </svg>
                        <span id="bookmarkText">Bookmark</span>
                    </button>
                    
                    <button onclick="toggleMarkForReview()" id="markReviewBtn" class="hidden glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                           <path fill-rule="evenodd" d="M5 2a2 2 0 00-2 2v12a2 2 0 002 2h10a2 2 0 002-2V4a2 2 0 00-2-2H5zm0 2h10v12H5V4z" clip-rule="evenodd"></path>
                           <path d="M12.586 6.586a2 2 0 10-2.828 2.828l-3 3a2 2 0 102.828-2.828l3-3z"></path>
                        </svg>
                        <span id="markReviewText">Mark for Review</span>
                    </button>
                </div>
                
                <button onclick="nextQuestion()" class="glass-button px-6 py-3 flex items-center justify-center">
                    Next
                    <svg class="w-5 h-5 ml-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M7.293 14.707a1 1 0 010-1.414L10.586 10 7.293 6.707a1 1 0 011.414-1.414l4 4a1 1 0 010 1.414l-4 4a1 1 0 01-1.414 0z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
        </div>
    </div>

     <!-- Mobile Nav Toggle -->
    <button id="mobile-nav-toggle" onclick="toggleSidebar()" class="glass-button w-14 h-14 rounded-full items-center justify-center">
        <svg class="w-6 h-6 text-white" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M4 6h16M4 12h16M4 18h16"></path></svg>
    </button>


    <script>const _0x4ea08a=_0x161a;(function(_0x1c0c5b,_0x9773e2){const _0x55d1e0=_0x161a,_0x5bee6a=_0x1c0c5b();while(!![]){try{const _0x2bca31=-parseInt(_0x55d1e0(0x1b2))/0x1+-parseInt(_0x55d1e0(0x3ae))/0x2+parseInt(_0x55d1e0(0x234))/0x3+-parseInt(_0x55d1e0(0x3e2))/0x4*(parseInt(_0x55d1e0(0x432))/0x5)+-parseInt(_0x55d1e0(0x35e))/0x6+-parseInt(_0x55d1e0(0x305))/0x7*(parseInt(_0x55d1e0(0x20b))/0x8)+-parseInt(_0x55d1e0(0x376))/0x9*(-parseInt(_0x55d1e0(0x238))/0xa);if(_0x2bca31===_0x9773e2)break;else _0x5bee6a['push'](_0x5bee6a['shift']());}catch(_0x417828){_0x5bee6a['push'](_0x5bee6a['shift']());}}}(_0x213a,0x1e627));const _0x4450ba=(function(){const _0x47a653=_0x161a,_0x178c33={'HgaAy':function(_0x186b52){return _0x186b52();},'mfEIa':function(_0x3f98ed,_0x55ba78){return _0x3f98ed!==_0x55ba78;},'XpCGr':_0x47a653(0x2a6),'msggH':_0x47a653(0x23d),'MXuNT':_0x47a653(0x3fa)};let _0x1bfcdf=!![];return function(_0x52e93a,_0xca1c7b){const _0x4a86a2=_0x47a653;if(_0x178c33[_0x4a86a2(0x2dc)](_0x4a86a2(0x3fa),_0x178c33['MXuNT']))_0x10c475[_0x4a86a2(0x408)]+=_0x4a86a2(0x371)+_0x47ee93[_0x4a86a2(0x3b7)]+_0x4a86a2(0x1e8);else{const _0x137a94=_0x1bfcdf?function(){const _0x1ce909=_0x4a86a2,_0x5aedda={'NtZIv':function(_0x439b50){const _0x247a84=_0x161a;return _0x178c33[_0x247a84(0x3a5)](_0x439b50);}};if(_0x178c33[_0x1ce909(0x2dc)](_0x178c33[_0x1ce909(0x187)],_0x178c33[_0x1ce909(0x3a4)])){if(_0xca1c7b){const _0x39b8fd=_0xca1c7b[_0x1ce909(0x256)](_0x52e93a,arguments);return _0xca1c7b=null,_0x39b8fd;}}else _0x5aedda['NtZIv'](_0xe10fe);}:function(){};return _0x1bfcdf=![],_0x137a94;}};}()),_0x1c6660=_0x4450ba(this,function(){const _0x3f978f=_0x161a,_0x45d262={'IMYSV':'(((.+)+)+)+$'};return _0x1c6660[_0x3f978f(0x44f)]()['search'](_0x45d262[_0x3f978f(0x195)])[_0x3f978f(0x44f)]()[_0x3f978f(0x2cc)](_0x1c6660)[_0x3f978f(0x308)](_0x45d262[_0x3f978f(0x195)]);});_0x1c6660();const _0x20ed5d=(function(){let _0x360016=!![];return function(_0x3df206,_0x432dba){const _0x5c86cb=_0x360016?function(){const _0x345a12=_0x161a;if(_0x432dba){const _0x17d3d8=_0x432dba[_0x345a12(0x256)](_0x3df206,arguments);return _0x432dba=null,_0x17d3d8;}}:function(){};return _0x360016=![],_0x5c86cb;};}()),_0x2d09d9=_0x20ed5d(this,function(){const _0x25273a=_0x161a,_0x420fe1={'sRduA':'correct','zxaOB':_0x25273a(0x435),'XrgjS':_0x25273a(0x465),'dzPoQ':function(_0x2c2984,_0x71cf1a){return _0x2c2984(_0x71cf1a);},'FdZpt':function(_0x1c3f66,_0x5c6918){return _0x1c3f66+_0x5c6918;},'pWXlL':function(_0x575b28,_0x6a9197){return _0x575b28+_0x6a9197;},'feACS':'{}.constructor(\x22return\x20this\x22)(\x20)','DlrXI':function(_0x3f3add,_0x434268){return _0x3f3add!==_0x434268;},'dPWNT':_0x25273a(0x36a),'FyrvD':function(_0x1364c4){return _0x1364c4();},'laAww':_0x25273a(0x455),'xUBYh':'info','fjfzL':'error','iMxPa':_0x25273a(0x1ff),'iQTLt':function(_0x2870f4,_0x4f3ebe){return _0x2870f4<_0x4f3ebe;},'pLFDK':function(_0x36ab7b,_0x2b01d4){return _0x36ab7b===_0x2b01d4;},'Femcu':_0x25273a(0x3ca)},_0xbf3325=function(){const _0x16ca4c=_0x25273a;let _0x5e8fcd;try{_0x5e8fcd=_0x420fe1[_0x16ca4c(0x2ce)](Function,_0x420fe1[_0x16ca4c(0x2e7)](_0x420fe1[_0x16ca4c(0x36e)](_0x16ca4c(0x12e),_0x420fe1[_0x16ca4c(0x229)]),');'))();}catch(_0x5aeac8){if(_0x420fe1[_0x16ca4c(0x29a)](_0x16ca4c(0x36c),_0x16ca4c(0x36c))){const _0xaabd=_0x511855['choices'][_0x603085[_0x16ca4c(0x400)]];_0xaabd['id']===_0x2f0505?(_0x4e00a3=_0x420fe1[_0x16ca4c(0x422)],_0x206215=_0x420fe1[_0x16ca4c(0x392)]):(_0x2266ef=_0x420fe1[_0x16ca4c(0x438)],_0x1327b6='Incorrect');}else _0x5e8fcd=window;}return _0x5e8fcd;},_0x3049f7=_0x420fe1[_0x25273a(0x12a)](_0xbf3325),_0x2c2b3c=_0x3049f7['console']=_0x3049f7['console']||{},_0x2f8c26=[_0x25273a(0x252),_0x420fe1[_0x25273a(0x441)],_0x420fe1['xUBYh'],_0x420fe1[_0x25273a(0x184)],_0x25273a(0x3c3),_0x25273a(0x36b),_0x420fe1[_0x25273a(0x282)]];for(let _0x18bb36=0x0;_0x420fe1[_0x25273a(0x260)](_0x18bb36,_0x2f8c26[_0x25273a(0x3b4)]);_0x18bb36++){if(_0x420fe1[_0x25273a(0x1a8)](_0x420fe1[_0x25273a(0x2ad)],_0x420fe1[_0x25273a(0x2ad)])){const _0x41e6a4=_0x20ed5d['constructor'][_0x25273a(0x2c4)][_0x25273a(0x221)](_0x20ed5d),_0x4d6a90=_0x2f8c26[_0x18bb36],_0x1df560=_0x2c2b3c[_0x4d6a90]||_0x41e6a4;_0x41e6a4[_0x25273a(0x23a)]=_0x20ed5d[_0x25273a(0x221)](_0x20ed5d),_0x41e6a4[_0x25273a(0x44f)]=_0x1df560['toString']['bind'](_0x1df560),_0x2c2b3c[_0x4d6a90]=_0x41e6a4;}else _0xcbb09d['location'][_0x25273a(0x442)][_0x25273a(0x159)](_0x420fe1[_0x25273a(0x298)])&&_0x163a59[_0x25273a(0x3ad)](_0x25273a(0x2e1)),_0x420fe1['FyrvD'](_0x28e338),_0x3c3a67[_0x25273a(0x30d)]();}});_0x2d09d9();let questionsData=[{'text':_0x4ea08a(0x361),'choices':[{'id':0x1,'text':_0x4ea08a(0x417)},{'id':0x2,'text':_0x4ea08a(0x2a8)},{'id':0x3,'text':_0x4ea08a(0x28a)},{'id':0x4,'text':_0x4ea08a(0x3d1)}],'correct_choice_id':0x2,'solution':_0x4ea08a(0x2d3),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':'A\x20middle-aged\x20woman\x20with\x20schizoaffective\x20disorder\x20was\x20recently\x20prescribed\x20a\x20different\x20antipsychotic\x20drug\x20instead\x20of\x20the\x20one\x20she\x20was\x20usually\x20taking.\x20She\x20is\x20also\x20on\x20sertraline.\x20She\x20presented\x20a\x20month\x20later,\x20complaining\x20of\x20breast\x20engorgement,\x20galactorrhea,\x20and\x20amenorrhea.\x20Investigations\x20revealed\x20highly\x20elevated\x20prolactin\x20levels.\x20The\x20drug\x20most\x20likely\x20prescribed\x20was?','choices':[{'id':0x1,'text':_0x4ea08a(0x207)},{'id':0x2,'text':'Risperidone'},{'id':0x3,'text':_0x4ea08a(0x2a0)},{'id':0x4,'text':_0x4ea08a(0x27d)}],'correct_choice_id':0x2,'solution':'<p>The\x20above\x20clinical\x20scenario\x20is\x20suggestive\x20of<strong>\x20hyperprolactinemia</strong>\x20secondary\x20to\x20the\x20use\x20of\x20<strong>risperidone</strong>,&nbsp;an<strong>&nbsp;atypical\x20antipsychotic\x20</strong>that\x20can\x20be\x20used\x20in\x20schizoaffective\x20disorder.</p>\x0a<p>The\x20clinical\x20symptoms\x20are\x20indicative\x20of\x20<strong>hyperprolactinemia</strong>,\x20most\x20likely\x20caused\x20by\x20the\x20<strong>dopamine\x20antagonist</strong>\x20<strong>action</strong>\x20of\x20risperidone.\x20Normally,\x20prolactin\x20secretion\x20is\x20inhibited\x20by\x20dopamine.\x20Therefore,\x20drugs\x20that\x20act\x20as\x20dopamine\x20antagonists\x20lead\x20to\x20loss\x20of\x20this\x20inhibitory\x20action\x20and\x20cause\x20hyperprolactinemia.\x20This\x20results\x20in\x20symptoms\x20like\x20<strong>breast\x20engorgement,\x20galactorrhea,\x20amenorrhea</strong>\x20in\x20women,\x20and\x20infertility\x20in\x20men.&nbsp;</p>\x0a<p>Risperidone&nbsp;is\x20an\x20<strong>atypical\x20antipsychotic</strong>\x20indicated\x20in\x20the\x20management\x20of\x20schizophrenia,\x20acute\x20mania\x20or\x20mixed\x20with\x20bipolar\x20disorder,\x20aggressive\x20episodes\x20in\x20autism\x20spectrum\x20disorder,\x20etc.\x20It&nbsp;is\x20an\x20<strong>antagonist</strong>\x20of\x20the\x20<strong>serotonin\x205-HT2A</strong>,\x20<strong>dopamine\x20D2</strong>,\x20a1-adrenergic,&nbsp;a2-adrenergic,\x20and<strong>\x20histamine\x20H1\x20receptors</strong>.</p>\x0a<p>In&nbsp;<strong><span\x20class=\x22s1\x22>schizoaffective\x20disorder</span></strong><span\x20class=\x22s1\x22>,&nbsp;symptoms\x20of\x20</span><span\x20class=\x22s1\x22><strong>mania</strong>\x20or\x20<strong>depression</strong>\x20develop\x20concurrently\x20with\x20the\x20major\x20symptoms\x20of<strong>\x20schizophrenia.</strong>\x20Thus,\x20they\x20are\x20treated\x20with\x20mood\x20stabilizers\x20for\x20manic\x20episodes\x20(like\x20carbamazepine)\x20or\x20s</span>elective\x20serotonin\x20reuptake\x20inhibitors\x20(like\x20sertraline)\x20for\x20depressive\x20episodes.\x20Antipsychotics\x20are\x20prescribed\x20for\x20psychotic\x20symptoms.</p>\x0a<p>In\x20this\x20patient,\x20sertraline\x20was\x20administered\x20along\x20with\x20risperidone.\x20The\x20combined\x20use\x20of\x20<strong>risperidone</strong>\x20and\x20<strong>selective\x20serotonin\x20reuptake\x20inhibitors</strong>\x20(as\x20in\x20this\x20patient)\x20can\x20result\x20in\x20a\x20significant\x20elevation\x20of\x20prolactin\x20levels.\x20This\x20is\x20due\x20to\x20the\x20CYP2D6\x20enzyme\x20inhibitory\x20actions\x20of\x20SSRIs,\x20thereby\x20inhibiting\x20the\x20metabolism\x20of\x20other\x20CYP2D6\x20substrates.&nbsp;</p>\x0a<p>This\x20hyperprolactinemia\x20can\x20be\x20rapidly\x20reversed\x20by\x20discontinuing\x20the\x20drug\x20or\x20switching\x20to\x20other\x20low\x20potency/\x20prolactin\x20sparing\x20(eg.\x20quetiapine)\x20atypical\x20antipsychotics.\x20In\x20case,\x20risperidone\x20needs\x20to\x20be\x20continued,\x20administering\x20<strong>bromocriptine</strong>\x20can\x20alleviate\x20the\x20symptoms.&nbsp;</p>\x0a<p>Other\x20options:</p>\x0a<p><strong>Brexpiprazole,\x20clozapine,\x20and\x20aripiprazole\x20</strong>are\x20atypical\x20antipsychotics.\x20they\x20do\x20not\x20have\x20any\x20effect\x20on\x20prolactin\x20secretion.</p>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x4ea08a(0x125),'choices':[{'id':0x1,'text':'Ergotamine'},{'id':0x2,'text':_0x4ea08a(0x43c)},{'id':0x3,'text':_0x4ea08a(0x409)},{'id':0x4,'text':_0x4ea08a(0x185)}],'correct_choice_id':0x1,'solution':_0x4ea08a(0x1a7),'explanation_video':'','question_images':[_0x4ea08a(0x203)],'explanation_images':[]},{'text':_0x4ea08a(0x347),'choices':[{'id':0x1,'text':_0x4ea08a(0x1fd)},{'id':0x2,'text':_0x4ea08a(0x450)},{'id':0x3,'text':_0x4ea08a(0x152)},{'id':0x4,'text':_0x4ea08a(0x295)}],'correct_choice_id':0x2,'solution':_0x4ea08a(0x226),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x4ea08a(0x3e3),'choices':[{'id':0x1,'text':_0x4ea08a(0x1e4)},{'id':0x2,'text':_0x4ea08a(0x2f4)},{'id':0x3,'text':_0x4ea08a(0x156)},{'id':0x4,'text':_0x4ea08a(0x403)}],'correct_choice_id':0x2,'solution':_0x4ea08a(0x16b),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x4ea08a(0x369),'choices':[{'id':0x1,'text':_0x4ea08a(0x38a)},{'id':0x2,'text':_0x4ea08a(0x385)},{'id':0x3,'text':'Amlodipine'},{'id':0x4,'text':_0x4ea08a(0x3ec)}],'correct_choice_id':0x3,'solution':_0x4ea08a(0x165),'explanation_video':'','question_images':[_0x4ea08a(0x3bb)],'explanation_images':[]},{'text':_0x4ea08a(0x186),'choices':[{'id':0x1,'text':'They\x20act\x20by\x20inhibiting\x20the\x20cell\x20wall\x20synthesis.'},{'id':0x2,'text':_0x4ea08a(0x164)},{'id':0x3,'text':_0x4ea08a(0x380)},{'id':0x4,'text':_0x4ea08a(0x337)}],'correct_choice_id':0x3,'solution':_0x4ea08a(0x1a2),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':'Which\x20of\x20the\x20following\x20drugs\x20act\x20via\x20the\x20mechanism\x20depicted\x20in\x20the\x20illustration\x20shown\x20below?','choices':[{'id':0x1,'text':_0x4ea08a(0x1d0)},{'id':0x2,'text':_0x4ea08a(0x16a)},{'id':0x3,'text':_0x4ea08a(0x427)},{'id':0x4,'text':'2\x20and\x204\x20only'}],'correct_choice_id':0x3,'solution':_0x4ea08a(0x33d),'explanation_video':'','question_images':[_0x4ea08a(0x126)],'explanation_images':[_0x4ea08a(0x232)]},{'text':_0x4ea08a(0x231),'choices':[{'id':0x1,'text':_0x4ea08a(0x28c)},{'id':0x2,'text':_0x4ea08a(0x333)},{'id':0x3,'text':_0x4ea08a(0x1c9)},{'id':0x4,'text':_0x4ea08a(0x1d2)}],'correct_choice_id':0x2,'solution':_0x4ea08a(0x2b1),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':'What\x20percentage\x20of\x20drug\x20given\x20will\x20be\x20left\x20in\x20the\x20body\x20after\x203\x20half-lives,\x20if\x20the\x20drug\x20is\x20eliminated\x20by\x20first\x20order\x20kinetics?','choices':[{'id':0x1,'text':'15'},{'id':0x2,'text':'12.5'},{'id':0x3,'text':'25'},{'id':0x4,'text':_0x4ea08a(0x3a3)}],'correct_choice_id':0x2,'solution':'<p>The\x20percentage\x20of\x20drug\x20given\x20will\x20be\x20left\x20in\x20the\x20body\x20if\x20the\x20drug\x20eliminates\x20by\x20first-order\x20kinetics\x20after\x203\x20half-lives\x20is\x2012.5%.</p>\x0a<p>In\x20first-order\x20kinetics,\x20the\x20rate\x20of\x20elimination\x20of\x20the\x20drug\x20is\x20directly\x20proportional\x20to\x20the\x20drug\x20concentration.</p>\x0a<p>The\x20rate\x20of\x20clearance\x20remains\x20constant.</p>\x0a<table\x20style=\x22height:\x20178px;\x20width:\x20469px;\x22>\x0a<tbody>\x0a<tr>\x0a<td\x20style=\x22width:\x20107px;\x22><strong>Half-life</strong></td>\x0a<td\x20style=\x22width:\x20134.8px;\x22><strong>Elimination\x20(%)</strong></td>\x0a<td\x20style=\x22width:\x20207.2px;\x22><strong>Drug\x20left\x20in\x20the\x20body</strong><strong>(%)</strong></td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x20107px;\x22>First</td>\x0a<td\x20style=\x22width:\x20134.8px;\x22>50</td>\x0a<td\x20style=\x22width:\x20207.2px;\x22>\u00a050</td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x20107px;\x22>Second</td>\x0a<td\x20style=\x22width:\x20134.8px;\x22>75</td>\x0a<td\x20style=\x22width:\x20207.2px;\x22>\u00a025</td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x20107px;\x22><strong>Third</strong></td>\x0a<td\x20style=\x22width:\x20134.8px;\x22><strong>87.5</strong></td>\x0a<td\x20style=\x22width:\x20207.2px;\x22><strong>\u00a012.5</strong></td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x20107px;\x22>Fourth</td>\x0a<td\x20style=\x22width:\x20134.8px;\x22>93.75</td>\x0a<td\x20style=\x22width:\x20207.2px;\x22>\u00a06.25</td>\x0a</tr>\x0a</tbody>\x0a</table>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x4ea08a(0x244),'choices':[{'id':0x1,'text':_0x4ea08a(0x28b)},{'id':0x2,'text':_0x4ea08a(0x146)},{'id':0x3,'text':_0x4ea08a(0x11a)},{'id':0x4,'text':_0x4ea08a(0x363)}],'correct_choice_id':0x2,'solution':_0x4ea08a(0x188),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':'Drug\x20of\x20choice\x20for\x20ethylene\x20glycol\x20poisoning\x20is','choices':[{'id':0x1,'text':_0x4ea08a(0x36d)},{'id':0x2,'text':'Fomepizole'},{'id':0x3,'text':_0x4ea08a(0x169)},{'id':0x4,'text':'Disulfiram'}],'correct_choice_id':0x2,'solution':_0x4ea08a(0x396),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x4ea08a(0x1eb),'choices':[{'id':0x1,'text':_0x4ea08a(0x16f)},{'id':0x2,'text':'1,\x202,\x203,\x204'},{'id':0x3,'text':_0x4ea08a(0x345)},{'id':0x4,'text':_0x4ea08a(0x350)}],'correct_choice_id':0x4,'solution':_0x4ea08a(0x43f),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':'In\x20which\x20of\x20the\x20following\x20drug\x20toxicities\x20is\x20alkalinization\x20of\x20urine\x20done?','choices':[{'id':0x1,'text':_0x4ea08a(0x38f)},{'id':0x2,'text':'Amphetamine'},{'id':0x3,'text':_0x4ea08a(0x384)},{'id':0x4,'text':_0x4ea08a(0x122)}],'correct_choice_id':0x1,'solution':'<p><strong>Alkalinization</strong>\x20of\x20the<strong>\x20urine</strong>\x20is\x20done\x20in\x20poisoning\x20with\x20acidic\x20drugs\x20such\x20as\x20<strong>barbiturates</strong>.\x20When\x20the\x20urine\x20is\x20alkaline,\x20weakly\x20acidic\x20drugs\x20like\x20barbiturates\x20are\x20present\x20in\x20<strong>highly\x20ionized</strong>\x20form\x20and\x20are\x20<strong>excreted</strong>\x20more<strong>\x20rapidly.</strong></p>\x0a<p>When\x20the\x20tubular\x20urine\x20is\x20made\x20more\x20alkaline,\x20weak\x20acids\x20like\x20barbiturates\x20become\x20highly\x20ionized\x20and\x20are\x20excreted\x20to\x20a\x20greater\x20extent.\x20Similarly,\x20acidification\x20of\x20urine\x20increases\x20the\x20excretion\x20of\x20weak\x20bases.\x20This\x20property\x20is\x20used\x20in\x20the\x20management\x20of\x20drug\x20overdose.</p>\x0a<table>\x0a<tbody>\x0a<tr>\x0a<td\x20style=\x22text-align:\x20center;\x22><strong>Drug</strong></td>\x0a<td\x20style=\x22text-align:\x20center;\x22><strong>Treatment\x20of\x20overdose</strong></td>\x0a</tr>\x0a<tr>\x0a<td>Weak\x20acids<br\x20/>(e.g.,\x20phenobarbital,\x20aspirin)</td>\x0a<td>Alkalinization\x20of\x20urine\x20with\x20<strong>sodium\x20bicarbonate</strong></td>\x0a</tr>\x0a<tr>\x0a<td>Weak\x20bases<br\x20/>(e.g.,\x20amphetamine)</td>\x0a<td>Acidification\x20of\x20urine\x20with\x20<strong>ammonium\x20chloride</strong></td>\x0a</tr>\x0a</tbody>\x0a</table>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x4ea08a(0x1dc),'choices':[{'id':0x1,'text':'Strontium'},{'id':0x2,'text':_0x4ea08a(0x3b2)},{'id':0x3,'text':_0x4ea08a(0x296)},{'id':0x4,'text':'Bisphosphonates'}],'correct_choice_id':0x4,'solution':'<p>Bisphosphonates\x20are\x20used\x20in\x20the\x20<strong>first-line\x20management\x20</strong>of\x20postmenopausal\x20osteoporosis.\x20X\x20Ray\x20shows\x20periarticular\x20osteopenia\x20around\x20the\x20knee\x20joint.</p>\x0a<p>Bisphosphonates\x20are\x20analogs\x20of\x20<strong>pyrophosphate</strong>.\x20They\x20specifically\x20inhibit\x20bone\x20resorption\x20and\x20thus\x20are\x20very\x20effective\x20for\x20the\x20treatment\x20of\x20postmenopausal\x20osteoporosis.</p>\x0a<p>Mechanism\x20of\x20action:</p>\x0a<p>Bisphosphonates\x20concentrate\x20at\x20sites\x20of\x20<strong>active\x20remodeling</strong>.\x20They\x20remain\x20in\x20the\x20matrix\x20until\x20the\x20bone\x20is\x20remodeled.\x20Then,\x20they\x20are\x20released\x20in\x20the\x20acid\x20environment\x20of\x20the\x20resorption\x20lacunae\x20and\x20induce\x20apoptosis\x20in\x20osteoclasts.</p>\x0a<p><strong>Other\x20Drugs:</strong></p>\x0a<ul>\x0a<li><strong>Denosumab\x20-</strong>\x20This\x20is\x20an\x20antibody\x20to\x20the\x20RANK\x20ligand.\x20It\x20prevents\x20the\x20activation\x20of\x20RANK\x20which\x20is\x20required\x20for\x20the\x20proliferation\x20of\x20osteoclasts.\x20Therefore,\x20it\x20decreases\x20bone\x20resorption.</li>\x0a<li><strong>Parathyroid\x20hormone\x20-\x20Teriparatide</strong>&nbsp;is\x20a\x20recombinant\x20parathyroid\x20hormone\x20analog.\x20At\x20low\x20and\x20intermittent\x20doses,\x20they\x20can\x20promote\x20bone\x20formation.</li>\x0a<li><strong>Selective\x20estrogen\x20receptor\x20modulators\x20(SERMs)\x20-</strong>\x20They\x20act\x20on\x20the\x20estrogen\x20receptors\x20and\x20prevent\x20bone\x20resorption.\x20Eg.&nbsp;<strong>raloxifene.</strong></li>\x0a<li><strong>Strontium\x20ranelate\x20-</strong>\x20It\x20is\x20thought\x20to\x20increase\x20bone\x20formation\x20and\x20reduce\x20bone\x20resorption.</li>\x0a</ul>','explanation_video':'','question_images':['https://cdn1.dailyrounds.org/uploads/63ed9db46ba442268a3c257ff193966a.JPEG'],'explanation_images':[]},{'text':_0x4ea08a(0x30e),'choices':[{'id':0x1,'text':_0x4ea08a(0x15d)},{'id':0x2,'text':_0x4ea08a(0x2f2)},{'id':0x3,'text':_0x4ea08a(0x272)},{'id':0x4,'text':_0x4ea08a(0x3d3)}],'correct_choice_id':0x3,'solution':'<p><span\x20data-preserver-spaces=\x22true\x22>The\x20given\x20image\x20shows\x20a\x20depressed\x20nasal\x20bridge\x20(saddle\x20nose).\x20This\x20image\x20along\x20with\x20the\x20stippling\x20of\x20bone\x20epiphyses\x20points\x20to\x20<strong>fetal\x20warfarin\x20syndrome\x20</strong>or<strong>\x20warfarin\x20embryopathy</strong>.\u00a0</span></p>\x0a<p><strong><span\x20data-preserver-spaces=\x22true\x22>Features:</span></strong></p>\x0a<ul>\x0a<li><span\x20data-preserver-spaces=\x22true\x22>Repeated\x20abortions</span></li>\x0a<li><span\x20data-preserver-spaces=\x22true\x22>CNS\x20abnormalities</span></li>\x0a<li><span\x20data-preserver-spaces=\x22true\x22>Depressed\x20nasal\x20bridge/absent\x20nasal\x20bone/saddle\x20nose\x20at\x20birth</span></li>\x0a<li><span\x20data-preserver-spaces=\x22true\x22>Bleeding\x20diathesis\x20at\x20birth</span></li>\x0a<li><span\x20data-preserver-spaces=\x22true\x22>Growth\x20retardation\x20-\x20hypoplasia\x20of\x20nose,\x20eye\x20sockets,\x20and\x20long\x20bones\x20with\x20stippling\x20of\x20epiphyses\u00a0</span></li>\x0a</ul>\x0a<p><span\x20data-preserver-spaces=\x22true\x22><strong>Anticoagulation\x20in\x20pregnancy:</strong></span></p>\x0a<ul>\x0a<li><span\x20data-preserver-spaces=\x22true\x22>Warfarin:\x20Although\x20safe\x20for\x20the\x20mother,\x20it\x20can\x20lead\x20to\u00a0</span><strong><span\x20data-preserver-spaces=\x22true\x22>warfarin\x20embryopathy</span></strong><span\x20data-preserver-spaces=\x22true\x22>,\x20miscarriage,\x20IUGR,\x20and\x20stillbirths.</span></li>\x0a<li><span\x20data-preserver-spaces=\x22true\x22>Heparin:\x20It\x20is\x20safe\x20for\x20the\x20fetus</span><span\x20data-preserver-spaces=\x22true\x22>\u00a0but\x20is\x20less\x20effective\x20than\x20warfarin.</span></li>\x0a<li><span\x20data-preserver-spaces=\x22true\x22>LMWH:\x20It\x20is\x20inadequate,\x20and\x20ACOG\x20does\x20not\x20recommend\x20its\x20use\x20in\x20pregnant\x20women\x20with\x20prosthetic\x20heart\x20valves.</span></li>\x0a</ul>\x0a<table\x20class=\x22t1\x22\x20cellspacing=\x220\x22\x20cellpadding=\x220\x22>\x0a<tbody>\x0a<tr>\x0a<td\x20class=\x22td1\x22\x20valign=\x22top\x22>\x0a<p\x20class=\x22p1\x22><strong>Period\x20of\x20gestation</strong></p>\x0a</td>\x0a<td\x20class=\x22td1\x22\x20valign=\x22top\x22>\x0a<p\x20class=\x22p1\x22><strong>Anticoagulant</strong></p>\x0a</td>\x0a</tr>\x0a<tr>\x0a<td\x20class=\x22td1\x22\x20valign=\x22top\x22>\x0a<p\x20class=\x22p1\x22>Till\x2012\x20completed\x20weeks</p>\x0a</td>\x0a<td\x20class=\x22td1\x22\x20valign=\x22top\x22>\x0a<p\x20class=\x22p1\x22>LMWH\x20or\x20UFH</p>\x0a</td>\x0a</tr>\x0a<tr>\x0a<td\x20class=\x22td1\x22\x20valign=\x22top\x22>\x0a<p\x20class=\x22p1\x22>13\x20to\x2036\x20weeks</p>\x0a</td>\x0a<td\x20class=\x22td1\x22\x20valign=\x22top\x22>\x0a<p\x20class=\x22p1\x22>Warfarin</p>\x0a</td>\x0a</tr>\x0a<tr>\x0a<td\x20class=\x22td1\x22\x20valign=\x22top\x22>\x0a<p\x20class=\x22p1\x22>36\x20weeks\x20to\x206\x20hours\x20before\x20delivery</p>\x0a</td>\x0a<td\x20class=\x22td1\x22\x20valign=\x22top\x22>\x0a<p\x20class=\x22p1\x22>LMWH\x20or\x20UFH</p>\x0a</td>\x0a</tr>\x0a<tr>\x0a<td\x20class=\x22td1\x22\x20valign=\x22top\x22>\x0a<p\x20class=\x22p1\x22>6\x20hours\x20after\x20vaginal\x20and\x2024\x20hours\x20after\x20cesarian\x20section</p>\x0a</td>\x0a<td\x20class=\x22td1\x22\x20valign=\x22top\x22>\x0a<p\x20class=\x22p1\x22>LMWH\x20or\x20UFH\x20(ACOG\x20recommendation)</p>\x0a</td>\x0a</tr>\x0a</tbody>\x0a</table>\x0a<p><span\x20data-preserver-spaces=\x22true\x22>If\x20delivery\x20occurs\x20while\x20the\x20anticoagulant\x20is\x20still\x20effective,\x20and\x20excessive\x20bleeding\x20happens,\x20then\x20<strong>protamine\x20sulfate</strong>\x20is\x20given\x20intravenously.\u00a0</span></p>\x0a<p><span\x20data-preserver-spaces=\x22true\x22>Anticoagulation\x20of\x20pregnant\x20women:</span></p>\x0a<ul>\x0a<li><span\x20data-preserver-spaces=\x22true\x22>The\x20patient\x20taking\x20warfarin\x20should\x20discontinue\x20it\x20as\x20soon\x20as\x20pregnancy\x20is\x20diagnosed\x20and\x20replace\x20it\x20with\u00a0</span><strong><span\x20data-preserver-spaces=\x22true\x22>heparin\x205,000\x20units\x20twice\x20daily\x20subcutaneously\x20up\x20to\x20the\x2012th\x20week\x20of\x20gestation</span></strong><span\x20data-preserver-spaces=\x22true\x22>.\u00a0</span></li>\x0a<li><span\x20data-preserver-spaces=\x22true\x22>Heparin\x20is\x20then\x20replaced\x20by\u00a0</span><strong><span\x20data-preserver-spaces=\x22true\x22>a\x20warfarin\x20tablet\x20of\x203\x20mg\x20daily</span></strong><span\x20data-preserver-spaces=\x22true\x22>\u00a0to\x20be\x20taken\x20at\x20the\x20same\x20time\x20each\x20day\x20and\x20continued\u00a0</span><strong><span\x20data-preserver-spaces=\x22true\x22>up\x20to\x2036\x20weeks\x20</span></strong>in\x20patients\x20with\x20a\x20high\x20risk\x20of\x20thrombosis.</li>\x0a<li><span\x20data-preserver-spaces=\x22true\x22>Thereafter,\x20warfarin\x20is\x20replaced\x20by\u00a0</span><strong><span\x20data-preserver-spaces=\x22true\x22>heparin,\x20which\x20is\x20discontinued\x206\x20hours</span></strong><span\x20data-preserver-spaces=\x22true\x22>\u00a0just\x20before\x20delivery.</span></li>\x0a<li><span\x20data-preserver-spaces=\x22true\x22>Heparin\x20(unfractionated\x20or\x20LMWH)\x20is\x20restarted\x206\x20hours\x20after\x20vaginal\x20delivery\x20and\x2024\x20hours\x20after\x20the\x20cesarean\x20section.</span></li>\x0a<li><span\x20data-preserver-spaces=\x22true\x22>Unfractionated\x20heparin\x20(UFH),\x20LMWH,\x20and\x20warfarin\x20therapy\x20are\u00a0</span><strong><span\x20data-preserver-spaces=\x22true\x22>not\x20contraindicated</span></strong><span\x20data-preserver-spaces=\x22true\x22>\u00a0in\x20breastfeeding.</span></li>\x0a</ul>','explanation_video':'','question_images':[_0x4ea08a(0x3f2)],'explanation_images':[_0x4ea08a(0x3f6)]},{'text':_0x4ea08a(0x32e),'choices':[{'id':0x1,'text':_0x4ea08a(0x388)},{'id':0x2,'text':_0x4ea08a(0x11b)},{'id':0x3,'text':'Diltiazem'},{'id':0x4,'text':'Adenosine'}],'correct_choice_id':0x4,'solution':_0x4ea08a(0x11e),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x4ea08a(0x196),'choices':[{'id':0x1,'text':_0x4ea08a(0x240)},{'id':0x2,'text':_0x4ea08a(0x3d9)},{'id':0x3,'text':_0x4ea08a(0x3ea)},{'id':0x4,'text':_0x4ea08a(0x313)}],'correct_choice_id':0x1,'solution':'<p>The\x20given\x20clinical\x20scenario\x20with\x20<strong>acute\x20onset\x20pain</strong>\x20and\x20<strong>swelling</strong>\x20<span\x20data-preserver-spaces=\x22true\x22>over\x20the\x20<strong>first\x20metatarsophalangeal\x20joint\x20</strong>of\x20the\x20<strong>left\x20foot\u00a0</strong></span>suggests\x20the\x20diagnosis\x20of\u00a0<strong>acute\x20gout</strong>.\u00a0<strong>Losartan<span\x20data-preserver-spaces=\x22true\x22>\u00a0</span></strong><span\x20data-preserver-spaces=\x22true\x22>can\x20be\x20<strong>safely\x20administered</strong>\x20to\x20this\x20patient\x20as\x20it\x20is\x20a\x20<strong>uricosuric\x20drug</strong>.</span></p>\x0a<p><strong>Losartan</strong>\x20is\x20competitive\x20<strong>angiotensin\x20I\x20(AT1)\x20receptor\x20antagonist</strong>,\u00a0which\u00a0binds\x20to\x20the\x20AT<sub>1</sub>\u00a0receptor\x20with\x20high\x20affinity.\x20Uses\x20of\x20losartan\x20are:</p>\x0a<ul>\x0a<li>Antihypertensive</li>\x0a<li>Renoprotective\x20drug\x20in\x20diabetes\x20mellitus</li>\x0a<li>Stroke\x20prophylaxis</li>\x0a<li>Portal\x20hypertension\x20in\x20cirrhosis\x20without\x20compromising\x20renal\x20function</li>\x0a<li>Anti-aggregant\x20as\x20it\x20is\x20a\x20competitive\x20antagonist\x20of\x20the\x20thromboxane\x20A2\x20receptor\u00a0</li>\x0a<li><strong>Uricosuric\x20drug</strong>\x20as\x20it\x20inhibits\u00a0reabsorption\x20and\x20actively\x20secretes\x20uric\x20acid\x20in\x20the\x20proximal\x20convoluted\x20tubule</li>\x0a</ul>\x0a<p><span\x20data-preserver-spaces=\x22true\x22>Adverse\x20effects\x20include\x20fetopathic\x20potential,\x20hypotension,\x20renal\x20insufficiency,\x20and\x20hyperkalemia.\u00a0</span></p>\x0a<p><span\x20data-preserver-spaces=\x22true\x22>Other\x20options:</span></p>\x0a<p><span\x20data-preserver-spaces=\x22true\x22>Option\x20B:\u00a0<strong>Atenolol</strong>\x20is\x20a\x20<strong>beta\x20blocker</strong>\x20that\x20has\x20been\x20proven\x20to\x20increase\x20serum\x20uric\x20acid\x20levels;\x20hence,\x20it\x20is\x20avoided.</span></p>\x0a<p><span\x20data-preserver-spaces=\x22true\x22>Option\x20C:\u00a0<strong>Hydrochlorothiazide\u00a0</strong>is\x20a\x20<strong>thiazide\x20diuretic;\u00a0</strong>it\x20is\x20not\x20used\x20in\x20patients\x20with\x20gout\x20as\x20it\x20increases\x20the\x20uric\x20acid\x20level.</span></p>\x0a<p><span\x20data-preserver-spaces=\x22true\x22>Option\x20D:\u00a0<strong>Furosemide</strong>\x20is\x20a\x20<strong>loop\x20diuretic</strong>\x20that\x20causes\x20hyperuricemia\x20due\x20to\x20increased\x20reabsorption\x20of\x20uric\x20acid.\x20It\x20is\u00a0</span><span\x20data-preserver-spaces=\x22true\x22>not\x20used\x20in\x20patients\x20with\x20gout.</span></p>','explanation_video':'','question_images':[_0x4ea08a(0x166)],'explanation_images':[]},{'text':'Which\x20of\x20the\x20following\x20statement\x20best\x20describes\x20a\x20partial\x20agonist?','choices':[{'id':0x1,'text':_0x4ea08a(0x40f)},{'id':0x2,'text':'High\x20affinity\x20and\x20low\x20intrinsic\x20activity'},{'id':0x3,'text':_0x4ea08a(0x30f)},{'id':0x4,'text':_0x4ea08a(0x25c)}],'correct_choice_id':0x2,'solution':'<p>Partial\x20agonists\x20have\x20<strong>high\x20affinity\x20and\x20low\x20intrinsic\x20activity.</strong></p>\x0a<p>According\x20to\x20the\x20<strong>receptor\x20occupation\x20theory</strong>,\x20the\x20ability\x20of\x20a\x20drug\x20to\x20bind\x20to\x20a\x20receptor\x20is\x20its\x20<strong>affinity,</strong>\x20and\x20the\x20ability\x20to\x20induce\x20functional\x20change\x20in\x20the\x20receptor\x20is\x20designated\x20as\x20the<strong>\x20intrinsic\x20activity\x20(IA)</strong>\x20of\x20the\x20drug.\x20These\x202\x20properties\x20are<strong>\x20independent</strong>\x20of\x20each\x20other.</p>\x0a<ul>\x0a<li><strong>Full\x20agonists</strong>:\x20These\x20agents\x20have\x20both\x20affinity\x20and\x20maximum\x20intrinsic\x20activity.\x20Examples\x20are\x20histamine,\x20adrenaline,\x20etc.</li>\x0a<li><strong>Partial\x20agonists</strong>:\x20They\x20have\x20affinity\x20but\x20submaximal\x20intrinsic\x20activity.\x20e.g\x20pentazocine\x20on\x20&micro;\x20opiod\x20receptors.</li>\x0a<li><strong>Inverse\x20agonists</strong>\x20are\x20drugs\x20that\x20have\x20an\x20affinity\x20for\x20a\x20receptor\x20but\x20the\x20intrinsic\x20activity\x20is\x20opposite\x20to\x20that\x20of\x20an\x20agonist.\x20Eg:\x20chlorpheniramine\x20on\x20H1\x20receptors.</li>\x0a<li><strong>Competitive\x20antagonists</strong>:\x20These\x20agents\x20have\x20affinity\x20and\x20no\x20intrinsic\x20activity.\x20Eg:propanolol,\x20atropine\x20etc.</li>\x0a</ul>\x0a<p>The\x20intrinsic\x20activities\x20of\x20the\x20above\x20groups\x20of\x20drugs\x20are\x20given\x20below:</p>\x0a<table\x20style=\x22width:\x20310px;\x20height:\x20200px;\x22>\x0a<tbody>\x0a<tr\x20style=\x22height:\x2031px;\x22>\x0a<td\x20style=\x22height:\x2031px;\x20width:\x20155.766px;\x22>\x0a<p><strong>Type\x20of\x20drugs</strong></p>\x0a</td>\x0a<td\x20style=\x22height:\x2031px;\x20width:\x20138.234px;\x22>\x0a<p><strong>Intrinsic\x20activity</strong></p>\x0a</td>\x0a</tr>\x0a<tr\x20style=\x22height:\x2031px;\x22>\x0a<td\x20style=\x22height:\x2031px;\x20width:\x20155.766px;\x20text-align:\x20center;\x22>\x0a<p>Agonists</p>\x0a</td>\x0a<td\x20style=\x22height:\x2031px;\x20width:\x20138.234px;\x20text-align:\x20center;\x22>\x0a<p>1</p>\x0a</td>\x0a</tr>\x0a<tr\x20style=\x22height:\x2031px;\x22>\x0a<td\x20style=\x22height:\x2031px;\x20width:\x20155.766px;\x20text-align:\x20center;\x22>\x0a<p>Partial\x20agonists</p>\x0a</td>\x0a<td\x20style=\x22height:\x2031px;\x20width:\x20138.234px;\x20text-align:\x20center;\x22>\x0a<p>&gt;0\x20to\x20&lt;1</p>\x0a</td>\x0a</tr>\x0a<tr\x20style=\x22height:\x2031px;\x22>\x0a<td\x20style=\x22height:\x2031px;\x20width:\x20155.766px;\x20text-align:\x20center;\x22>\x0a<p>Competitive\x20antagonists</p>\x0a</td>\x0a<td\x20style=\x22height:\x2031px;\x20width:\x20138.234px;\x20text-align:\x20center;\x22>\x0a<p>0</p>\x0a</td>\x0a</tr>\x0a<tr\x20style=\x22height:\x2031px;\x22>\x0a<td\x20style=\x22height:\x2031px;\x20width:\x20155.766px;\x20text-align:\x20center;\x22>\x0a<p>Inverse\x20agonists</p>\x0a</td>\x0a<td\x20style=\x22height:\x2031px;\x20width:\x20138.234px;\x20text-align:\x20center;\x22>\x0a<p>&lt;0\x20to\x20-1</p>\x0a</td>\x0a</tr>\x0a</tbody>\x0a</table>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x4ea08a(0x35a),'choices':[{'id':0x1,'text':_0x4ea08a(0x3a1)},{'id':0x2,'text':'Chloroquine'},{'id':0x3,'text':_0x4ea08a(0x267)},{'id':0x4,'text':'Apraclonidine'}],'correct_choice_id':0x2,'solution':_0x4ea08a(0x2bc),'explanation_video':'','question_images':[],'explanation_images':[_0x4ea08a(0x45f),_0x4ea08a(0x1e7)]},{'text':_0x4ea08a(0x3c0),'choices':[{'id':0x1,'text':_0x4ea08a(0x2e8)},{'id':0x2,'text':_0x4ea08a(0x41d)},{'id':0x3,'text':_0x4ea08a(0x21e)},{'id':0x4,'text':_0x4ea08a(0x329)}],'correct_choice_id':0x3,'solution':_0x4ea08a(0x39b),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x4ea08a(0x183),'choices':[{'id':0x1,'text':'Mefenamic\x20acid'},{'id':0x2,'text':_0x4ea08a(0x185)},{'id':0x3,'text':_0x4ea08a(0x448)},{'id':0x4,'text':_0x4ea08a(0x13c)}],'correct_choice_id':0x2,'solution':'<p\x20class=\x22p1\x22>The\x20clinical\x20history\x20suggests\x20an<strong>\x20adverse\x20reaction</strong>\x20to\x20the\x20given\x20antipyretic\x20medication\x20and\x20describes\x20<strong>Reye\x27s\x20syndrome</strong>.\x20Reye\x27s\x20syndrome\x20can\x20be\x20precipitated\x20in\x20children\x20with\x20<strong>viral\x20infection</strong>\x20and\x20concomitant\x20use\x20of\x20<strong>salicylates</strong>\x20like\x20<strong>aspirin</strong>.</p>\x0a<p\x20class=\x22p1\x22>Reye\x20syndrome\x20is\x20an\x20<strong>acute\x20encephalopathy</strong>\x20that\x20may\x20follow\x20a\x20viral\x20upper\x20respiratory\x20tract\x20infection\x20(influenza\x20or\x20varicella).\x20It\x20is\x20precipitated\x20in\x20a\x20genetically\x20susceptible\x20person\x20by\x20the\x20interaction\x20between\x20viral\x20infection\x20and\x20exposure\x20to&nbsp;<strong>salicylates</strong>\x20and/or\x20antiemetics.</p>\x0a<p\x20class=\x22p1\x22>Clinically\x20children\x20present\x20with\x20acute\x20onset\x20<strong>vomiting</strong>\x20and\x20features\x20of\x20<strong>encephalopathy</strong>\x20like\x20delirium,\x20altered\x20consciousness,\x20confusion,\x20and\x20lethargy.</p>\x0a<p\x20class=\x22p1\x22><strong>Liver\x20dysfunction</strong>\x20is\x20present\x20in\x20all\x20cases\x20and\x20presents\x20with\x20coagulopathy\x20and\x20laboratory\x20evidence\x20of\x20elevated\x20serum\x20levels\x20of\x20aspartate\x20aminotransferase,\x20alanine\x20aminotransferase,\x20and\x20ammonia.\x20But,\x20<strong>bilirubin</strong>\x20levels\x20remain\x20<strong>normal</strong>\x20and\x20the\x20patient\x20does\x20not\x20develop\x20jaundice.</p>\x0a<p\x20class=\x22p1\x22>A\x20<strong>biopsy</strong>\x20of\x20the\x20liver\x20in\x20a\x20patient\x20with\x20Reye\x27s\x20syndrome\x20shows\x20<strong>microvesicular\x20infiltration</strong>\x20of\x20<strong>fat</strong>\x20in\x20the\x20<strong>hepatocytes.&nbsp;</strong>Reye\x20syndrome\x20is\x20a\x20life-threatening\x20adverse\x20effect,\x20and\x20patients\x20must\x20also\x20be\x20screened\x20for\x20fatty\x20acid\x20oxidation\x20and\x20fatty\x20acid\x20transport\x20defects.</p>\x0a<p>Another\x20salicylate\x20medication\x20that\x20risks\x20the\x20development\x20of\x20Reye\x27s\x20syndrome\x20is&nbsp;<strong>bismuth\x20subsalicylate</strong>.</p>\x0a<p>Other\x20options:</p>\x0a<p><strong>Mefenamic\x20acid</strong>,\x20<strong>ibuprofen</strong>,\x20and\x20<strong>acetaminophen\x20</strong>are\x20non-steroidal\x20anti-inflammatory\x20drugs\x20that\x20can\x20be\x20used\x20as\x20antipyretics\x20in\x20children\x20and\x20are\x20not\x20associated\x20with\x20the\x20development\x20of\x20Reye\x27s\x20syndrome.</p>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x4ea08a(0x460),'choices':[{'id':0x1,'text':_0x4ea08a(0x3ed)},{'id':0x2,'text':_0x4ea08a(0x324)},{'id':0x3,'text':_0x4ea08a(0x236)},{'id':0x4,'text':'Allopurinol'}],'correct_choice_id':0x3,'solution':'<p>The\x20drug\x20that\x20catalyzes\x20the\x20enzymatic\x20oxidation\x20of\x20uric\x20acid\x20into\x20allantoin\x20for\x20the\x20treatment\x20of\x20chronic\x20gout\x20is<strong>\x20pegloticase.\x20</strong></p>\x0a<p>Pegloticase\x20is\x20a\x20<strong>pegylated\x20uricase</strong>\x20(urate\x20oxidase)\x20that\x20catalyzes\x20the\x20enzymatic\x20oxidation\x20of\x20<strong>uric\x20acid\x20into\x20allantoin</strong>,\x20which\x20is\x20a\x20more\x20soluble\x20and\x20inactive\x20metabolite.\u00a0It\x20is\x20used\x20in\x20the\x20treatment\x20of\x20<strong>severe</strong>,\u00a0<strong>refractory\x20chronic\x20gout</strong>\x20or\x20in\x20cases\x20where\x20other\x20urate-lowering\x20therapies\x20are\x20contraindicated.\x20The\x20efficacy\x20of\x20this\x20drug\x20gets\x20lowered\x20if\x20antibodies\x20are\x20produced\x20against\x20the\x20drug,\x20which\x20occurs\x20in\x20many\x20patients.\x20This\x20also\x20increases\x20the\x20risk\x20of\x20infusion\x20reactions.\u00a0</p>\x0a<div\x20class=\x22page\x22\x20title=\x22Page\x20711\x22>\x0a<div\x20class=\x22section\x22>\x0a<div\x20class=\x22layoutArea\x22>\x0a<div\x20class=\x22column\x22>\x0a<div\x20class=\x22page\x22\x20title=\x22Page\x20711\x22>\x0a<div\x20class=\x22section\x22>\x0a<div\x20class=\x22layoutArea\x22>\x0a<div\x20class=\x22column\x22>\x0a<p><strong>Rasburicase</strong>\x20is\x20a\x20<strong>recombinant\x20uricase</strong>.\x20It\x20is\x20indicated\x20for\x20the\x20initial\x20management\x20of\x20elevated\x20plasma\x20uric\x20acid\x20levels\x20in\x20patients\x20with\x20malignancies\x20who\x20are\x20on\x20chemotherapy.\x20The\x20efficacy\x20is\x20limited\x20by\x20the\x20production\x20of\x20antibodies\x20to\x20the\x20drug.</p>\x0a</div>\x0a</div>\x0a</div>\x0a</div>\x0a</div>\x0a</div>\x0a</div>\x0a</div>\x0a<p><strong>Gout</strong>\x20occurs\x20due\x20to\x20the\x20precipitation\x20of\x20urate\x20crystals\x20in\x20the\x20tissues\x20with\x20a\x20subsequent\x20inflammatory\x20response.\x20In\x20an\x20acute\x20episode\x20of\x20gout,\x20there\x20is\x20painful\x20distal\x20monoarthritis\x20which\x20can\x20lead\x20to\x20joint\x20destruction,\x20subcutaneous\x20tophi,\x20and\x20renal\x20calculi.\x20Management\x20of\x20gout\x20includes:</p>\x0a<div\x20class=\x22page\x22\x20title=\x22Page\x20708\x22>\x0a<div\x20class=\x22section\x22>\x0a<div\x20class=\x22layoutArea\x22>\x0a<div\x20class=\x22column\x22>\x0a<ul>\x0a<li>Reduction\x20of\x20pain\x20and\x20inflammation:\x20NSAIDs,\x20colchicine,\x20glucocorticoids</li>\x0a<li>Inhibition\x20of\x20the\x20formation\x20of\x20urate:\x20Allopurinol,\x20febuxostat</li>\x0a<li>Promotion\x20of\x20urate\x20excretion:\x20Probenecid,\x20lesinurad</li>\x0a</ul>\x0a</div>\x0a</div>\x0a</div>\x0a</div>\x0a<p>Other\x20options:\u00a0</p>\x0a<p>Option\x20A:\x20<strong>Colchicine</strong>\x20acts\x20by\x20<strong>preventing\x20the\x20polymerization\x20of\x20microtubules\x20by\x20tubulin</strong>,\x20this\x20<strong>reduces\x20neutrophil\x20recruitment</strong>\x20to\x20inflamed\x20tissue\x20and\x20also\x20<strong>decreases\x20the\x20secretion\x20of\x20chemotactic\x20factors</strong>\x20by\x20activated\x20neutrophils.\x20Overall\x20reducing\x20the\x20inflammatory\x20response.</p>\x0a<p>Option\x20B:\u00a0<strong>Febuxostat</strong>\x20is\x20a\u00a0<strong>xanthine\x20oxidase\x20inhibitor</strong>\x20approved\x20for\x20the\x20<strong>treatment\x20of\x20hyperuricemia</strong>\x20in\x20patients\x20with\x20gout.</p>\x0a<p>Option\x20D:\x20<strong>Allopurinol</strong>\x20by\x20<strong>inhibiting\x20the\x20xanthine\x20oxidase</strong>\x20enzyme\x20prevents\x20the\x20conversion\x20of\x20xanthine\x20to\x20uric\x20acid.</p>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x4ea08a(0x153),'choices':[{'id':0x1,'text':'Raltegravir'},{'id':0x2,'text':_0x4ea08a(0x1f0)},{'id':0x3,'text':_0x4ea08a(0x382)},{'id':0x4,'text':'Zidovudine'}],'correct_choice_id':0x1,'solution':'<p>Step\x205\x20in\x20the\x20given\x20life\x20cycle\x20shows\x20the\x20<strong>integration</strong>\x20of\x20the\x20<strong>viral\x20DNA</strong>\x20into\x20the\x20<strong>host\x20genome</strong>.\x20<strong>Raltegravir</strong>\x20is\x20an\x20integrase\x20inhibitor\x20and\x20is\x20active\x20against\x20both\x20<strong>HIV-1</strong>\x20and\x20<strong>HIV-2</strong>.\x20It\x20can\x20be\x20used\x20in\x20<strong>adults</strong>\x20and\x20<strong>children</strong>&nbsp;<strong>&gt;1\x20month\x20old.&nbsp;</strong></p>\x0a<p>It\x20is\x20advised\x20for\x20patients\x20to\x20consume\x20<strong>antacids</strong>\x20and\x20<strong>sucralfate,</strong>\x206\x20hours\x20before\x20or\x202\x20hours\x20after\x20raltegravir\x20intake.</p>\x0a<p>It\x20may\x20cause\x20<strong>headaches,\x20nausea,\x20weakness</strong>\x20and\x20<strong>fatigue.</strong>\x20Rarely,\x20it\x20can\x20lead\x20to\x20drug\x20reactions\x20with\x20eosinophilia\x20and\x20systemic\x20symptoms\x20(DRESS)\x20syndrome.</p>\x0a<p>The\x20steps\x20involved\x20in\x20the\x20lifecycle\x20of\x20HIV\x20as\x20given\x20in\x20the\x20image\x20are\x20described\x20as\x20follows:</p>\x0a<ul>\x0a<li>Step\x201:\x20Binding\x20of\x20HIV-1\x20to\x20the\x20cell\x20membrane\x20of\x20a\x20CD4+\x20cell</li>\x0a<li>Step\x202:\x20HIV-1\x20enters\x20the\x20cell\x20via\x20interaction\x20with\x20the\x20membrane\x20glycoproteins</li>\x0a<li>Step\x203:\x20Reverse\x20transcription\x20of\x20the\x20viral\x20genetic\x20material\x20using\x20the\x20virus\x27\x20reverse\x20transcriptase\x20enzyme</li>\x0a<li>Step\x204:\x20The\x20HIV-1\x20genome\x20travels\x20into\x20the\x20nucleus</li>\x0a<li>Step\x205:\x20The\x20viral\x20genome\x20integrates\x20into\x20the\x20host\x27s\x20DNA\x20through\x20the\x20integrase\x20enzyme</li>\x0a<li>Step\x206:\x20The\x20HIV-1\x20proviral\x20genome\x20undergoes\x20transcription\x20with\x20the\x20host\x20DNA</li>\x0a<li>Step\x207:\x20The\x20viral\x20messenger\x20RNA\x20(mRNA)\x20undergoes\x20translation\x20to\x20produce\x20new\x20viral\x20proteins</li>\x0a<li>Steps\x208\x20and\x209:\x20Assembly\x20and\x20maturation\x20of\x20the\x20virion</li>\x0a</ul>','explanation_video':'','question_images':[_0x4ea08a(0x262)],'explanation_images':['https://dhmbxeygs57ff.cloudfront.net/uploads/61c1774501b74506af250308d493739ax850x704.PNG']},{'text':'Which\x20of\x20the\x20following\x20drugs\x20acts\x20through\x20the\x20receptor\x20marked\x20in\x20the\x20given\x20image?','choices':[{'id':0x1,'text':'Abciximab'},{'id':0x2,'text':_0x4ea08a(0x3d2)},{'id':0x3,'text':_0x4ea08a(0x1ba)},{'id':0x4,'text':_0x4ea08a(0x2c3)}],'correct_choice_id':0x3,'solution':_0x4ea08a(0x461),'explanation_video':'','question_images':['https://cdn1.dailyrounds.org/uploads/89aaa2869da74867b1d5a9f2879c5d54.JPEG'],'explanation_images':[_0x4ea08a(0x129)]},{'text':_0x4ea08a(0x1b7),'choices':[{'id':0x1,'text':_0x4ea08a(0x2c9)},{'id':0x2,'text':_0x4ea08a(0x1d7)},{'id':0x3,'text':_0x4ea08a(0x2e5)},{'id':0x4,'text':_0x4ea08a(0x354)}],'correct_choice_id':0x2,'solution':_0x4ea08a(0x2a2),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':'A\x2048-year-old\x20man\x20is\x20diagnosed\x20with\x20diabetes\x20mellitus\x20type\x202.\x20He\x20says\x20that\x20he\x20does\x20not\x20prefer\x20injections.\x20He\x20had\x201\x20episode\x20of\x20pancreatitis\x203\x20years\x20back\x20and\x20has\x20a\x20history\x20of\x20colon\x20cancer\x20in\x20his\x20family.\x20He\x20also\x20has\x20been\x20diagnosed\x20with\x20heart\x20failure\x20and\x20has\x20been\x20taking\x20medications.\x20Which\x20of\x20the\x20following\x20drugs\x20can\x20be\x20given\x20to\x20this\x20patient?','choices':[{'id':0x1,'text':'Pioglitazone'},{'id':0x2,'text':_0x4ea08a(0x1dd)},{'id':0x3,'text':_0x4ea08a(0x3a9)},{'id':0x4,'text':_0x4ea08a(0x20f)}],'correct_choice_id':0x3,'solution':_0x4ea08a(0x15a),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x4ea08a(0x285),'choices':[{'id':0x1,'text':_0x4ea08a(0x3c6)},{'id':0x2,'text':'Timolol'},{'id':0x3,'text':'Brimonidine'},{'id':0x4,'text':'Latanoprost'}],'correct_choice_id':0x2,'solution':'<p><strong>Timolol</strong>\x20is\x20a\x20<strong>non-selective\x20beta-blocker.\x20</strong>Beta-blockers\x20reduce\x20intra-ocular\x20pressure\x20primarily\x20by<strong>\x20reducing\x20aqueous\x20humor</strong>\x20production.\x20Another\x20hypothesis\x20states\x20that\x20by\x20reducing\x20ocular\x20blood\x20flow,\x20there\x20may\x20be\x20a\x20decrease\x20in\x20ultrafiltration\x20responsible\x20for\x20aqueous\x20production.\u00a0</p>\x0a<p><strong>Netarsudil</strong>\x20is\x20a\x20rho-kinase\x20inhibitor\x20that\x20acts\x20by\x20increasing\x20trabecular\x20outflow.</p>\x0a<p><strong>Brimonidine</strong>\u00a0is\x20an\x20alpha-agonist\x20that\x20has\x20a\x20small\x20effect\x20on\x20increasing\x20both\x20uveoscleral\x20and\x20trabecular\x20outflow.\u00a0</p>\x0a<p><strong>Latanoprost</strong>\x20is\x20a\x20prostaglandin\x20PGF2-alpha\x20analog\x20that\x20primarily\x20acts\x20by\x20releasing\x20matrix\x20metalloproteinases,\x20thereby\x20increasing\x20trabecular\x20and\x20uveoscleral\x20outflow.</p>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x4ea08a(0x1c7),'choices':[{'id':0x1,'text':_0x4ea08a(0x403)},{'id':0x2,'text':_0x4ea08a(0x414)},{'id':0x3,'text':_0x4ea08a(0x136)},{'id':0x4,'text':_0x4ea08a(0x25d)}],'correct_choice_id':0x4,'solution':'<p><strong>Iloprost\x20</strong>is\x20a<strong>\x20prostacyclin\x20analog\x20</strong>indicated\x20in\x20the\x20management\x20of\x20<strong>pulmonary\x20artery\x20hypertension</strong>.\x20It\x20falls\x20under\x20the\x20category\x20of&nbsp;IP\x20receptor\x20(prostacyclin\x20receptor)\x20agonists.</p>\x0a<p\x20class=\x22p1\x22>Other\x20drugs\x20falling\x20under\x20the\x20category\x20of\x20<strong>IP\x20receptor\x20agonists</strong>\x20are:</p>\x0a<ul>\x0a<li\x20class=\x22p1\x22>\x0a<p\x20class=\x22p1\x22>Epoprostenol</p>\x0a</li>\x0a<li\x20class=\x22p1\x22>\x0a<p\x20class=\x22p1\x22>Treprostinil</p>\x0a</li>\x0a<li\x20class=\x22p1\x22>\x0a<p\x20class=\x22p1\x22>Iloprost</p>\x0a</li>\x0a<li\x20class=\x22p1\x22>\x0a<p\x20class=\x22p1\x22>Selexipag</p>\x0a</li>\x0a</ul>\x0a<p>Option\x20A:\x20Sildenafil\x20is\x20a\x20PDE-5\x20inhibitor.&nbsp;</p>\x0a<p\x20class=\x22p1\x22>Option\x20B:\x20Misoprostol\x20is\x20a\x20synthetic\x20PGE1\x20analog.&nbsp;</p>\x0a<p>Option\x20C:\x20Dinoprost\x20is\x20a\x20natural\x20PGF2-alpha\x20preparation.\x20It\x20should&nbsp;not\x20be\x20confused\x20with\x20dinoprostone\x20which\x20is\x20a\x20synthetic\x20analogue\x20of\x20PGE2.</p>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x4ea08a(0x424),'choices':[{'id':0x1,'text':_0x4ea08a(0x175)},{'id':0x2,'text':'Varenicline'},{'id':0x3,'text':_0x4ea08a(0x322)},{'id':0x4,'text':_0x4ea08a(0x31c)}],'correct_choice_id':0x3,'solution':_0x4ea08a(0x194),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':'A\x2035-year-old\x20man\x20presents\x20with\x20complaints\x20of\x20palpitations.\x20Examination\x20reveals\x20he\x20is\x20hemodynamically\x20stable.\x20The\x20consultant\x20asks\x20you\x20to\x20administer\x20lidocaine\x20as\x20his\x20ECG\x20was\x20suggestive\x20of\x20monomorphic\x20ventricular\x20tachycardia.\x20The\x20drug\x20you\x20have\x20administered\x20belongs\x20to\x20which\x20class\x20of\x20anti-arrhythmic\x20drugs?','choices':[{'id':0x1,'text':_0x4ea08a(0x41b)},{'id':0x2,'text':_0x4ea08a(0x16d)},{'id':0x3,'text':_0x4ea08a(0x212)},{'id':0x4,'text':'Class\x20IIB'}],'correct_choice_id':0x3,'solution':_0x4ea08a(0x37d),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':'A\x2052-year-old\x20male\x20complained\x20of\x20occasional\x20acute\x20attacks\x20of\x20intense\x20panic\x20and\x20anxiety\x20with\x20marked\x20physical\x20symptoms,\x20including\x20shortness\x20of\x20breath,\x20palpitations,\x20sweating,\x20tremors,\x20and\x20fear\x20of\x20impending\x20doom.\x20Which\x20of\x20the\x20following\x20drugs\x20can\x20be\x20used\x20to\x20treat\x20the\x20given\x20condition?','choices':[{'id':0x1,'text':_0x4ea08a(0x366)},{'id':0x2,'text':_0x4ea08a(0x3be)},{'id':0x3,'text':_0x4ea08a(0x192)},{'id':0x4,'text':_0x4ea08a(0x22e)}],'correct_choice_id':0x3,'solution':_0x4ea08a(0x2e6),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x4ea08a(0x2b5),'choices':[{'id':0x1,'text':'Forms\x20pores\x20in\x20the\x20fungal\x20cell\x20wall'},{'id':0x2,'text':_0x4ea08a(0x2b2)},{'id':0x3,'text':_0x4ea08a(0x1a6)},{'id':0x4,'text':_0x4ea08a(0x1c5)}],'correct_choice_id':0x4,'solution':_0x4ea08a(0x410),'explanation_video':'','question_images':[_0x4ea08a(0x158)],'explanation_images':[]},{'text':_0x4ea08a(0x311),'choices':[{'id':0x1,'text':'Riociguat'},{'id':0x2,'text':_0x4ea08a(0x3f9)},{'id':0x3,'text':_0x4ea08a(0x359)},{'id':0x4,'text':_0x4ea08a(0x239)}],'correct_choice_id':0x2,'solution':_0x4ea08a(0x223),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x4ea08a(0x3f1),'choices':[{'id':0x1,'text':_0x4ea08a(0x233)},{'id':0x2,'text':_0x4ea08a(0x379)},{'id':0x3,'text':_0x4ea08a(0x180)},{'id':0x4,'text':_0x4ea08a(0x279)}],'correct_choice_id':0x2,'solution':_0x4ea08a(0x3a2),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':'A\x2058-year-old\x20man\x20was\x20treated\x20with\x20an\x20intravenous\x20diuretic\x20for\x20heart\x20failure.\x20Now\x20he\x20presents\x20with\x20\x20tinnitus,\x20\x20vertigo,\x20a\x20sense\x20of\x20fullness\x20in\x20the\x20ears\x20and\x20difficulty\x20in\x20hearing\x20from\x20the\x20right\x20ear.\x20Examination\x20shows\x20Webers\x20test\x20localised\x20to\x20the\x20left\x20ear\x20and\x20Rinnes\x20test\x20shows\x20AC>BC\x20in\x20both\x20ears.\x20\x20The\x20responsible\x20offending\x20agent\x20acts\x20most\x20likely\x20in\x20which\x20part\x20of\x20the\x20nephron?','choices':[{'id':0x1,'text':'Descending\x20limb\x20of\x20the\x20loop\x20of\x20Henle'},{'id':0x2,'text':'Thick\x20ascending\x20limb\x20of\x20the\x20loop\x20of\x20Henle'},{'id':0x3,'text':'Proximal\x20convoluted\x20tubule'},{'id':0x4,'text':_0x4ea08a(0x276)}],'correct_choice_id':0x2,'solution':_0x4ea08a(0x34d),'explanation_video':'','question_images':[_0x4ea08a(0x383)],'explanation_images':[]},{'text':_0x4ea08a(0x41e),'choices':[{'id':0x1,'text':'Neostigmine'},{'id':0x2,'text':_0x4ea08a(0x3db)},{'id':0x3,'text':_0x4ea08a(0x314)},{'id':0x4,'text':_0x4ea08a(0x42a)}],'correct_choice_id':0x3,'solution':_0x4ea08a(0x43d),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x4ea08a(0x428),'choices':[{'id':0x1,'text':_0x4ea08a(0x267)},{'id':0x2,'text':_0x4ea08a(0x1a1)},{'id':0x3,'text':_0x4ea08a(0x330)},{'id':0x4,'text':_0x4ea08a(0x1c0)}],'correct_choice_id':0x1,'solution':_0x4ea08a(0x155),'explanation_video':'','question_images':[],'explanation_images':[_0x4ea08a(0x116)]},{'text':_0x4ea08a(0x1af),'choices':[{'id':0x1,'text':_0x4ea08a(0x2e3)},{'id':0x2,'text':_0x4ea08a(0x426)},{'id':0x3,'text':'Calcium\x20channel\x20blocker'},{'id':0x4,'text':_0x4ea08a(0x135)}],'correct_choice_id':0x2,'solution':_0x4ea08a(0x405),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x4ea08a(0x21b),'choices':[{'id':0x1,'text':_0x4ea08a(0x434)},{'id':0x2,'text':_0x4ea08a(0x2fa)},{'id':0x3,'text':_0x4ea08a(0x1b5)},{'id':0x4,'text':_0x4ea08a(0x2bd)}],'correct_choice_id':0x3,'solution':_0x4ea08a(0x28d),'explanation_video':'','question_images':['https://cdn1.dailyrounds.org/uploads/f507dd5f24b54315a2176596e260a962.JPEG'],'explanation_images':[]},{'text':'A\x20drug\x20is\x20instilled\x20into\x20the\x20right\x20eye\x20of\x20the\x20rabbit,\x20and\x20the\x20left\x20eye\x20is\x20used\x20as\x20the\x20control.\x20The\x20findings\x20obtained\x20after\x20some\x20time\x20are\x20shown\x20in\x20the\x20table\x20and\x20image\x20given\x20below.','choices':[{'id':0x1,'text':_0x4ea08a(0x265)},{'id':0x2,'text':_0x4ea08a(0x14c)},{'id':0x3,'text':'Pilocarpine'},{'id':0x4,'text':'Atropine'}],'correct_choice_id':0x4,'solution':'<p>On\x20instillation\x20of\x20the\x20drug,\x20there\x20is\x20<strong>mydriasis</strong>\x20in\x20the\x20eye\x20and\x20<strong>loss\x20of\x20light\x20reflex</strong>.\x20The\x20drug\x20is\x20likely\x20to\x20be\x20<strong>atropine</strong>.\x20It\x20is\x20an\x20anticholinergic\x20agent.\x20It\x20causes\x20mydriasis,\x20cycloplegia,\x20loss\x20of\x20light\x20reflex,\x20and\x20impaired\x20accommodation.</p>\x0a<p>Autonomic\x20supply\x20of\x20the\x20eye:</p>\x0a<p>The\x20<strong>radial\x20muscle</strong>\x20of\x20the\x20iris\x20is\x20controlled\x20by\u00a0<strong></strong><span\x20class=\x22s1\x22><strong>1\x20adrenergic\x20receptor</strong>.\x20Stimulation\x20of\x20this\x20receptor\x20causes\x20<strong>mydriasis.\u00a0</strong></span></p>\x0a<p><span\x20class=\x22s1\x22>The<strong>\x20sphincter\x20muscle\x20</strong>of\x20the\x20iris\x20is\x20controlled\x20by\x20the\u00a0</span><strong>M<span\x20class=\x22s1\x22>3\x20and</span>\u00a0M</strong><span\x20class=\x22s1\x22><strong>2\x20cholinergic\x20receptors.</strong>\x20Stimulation\x20of\x20these\x20receptors\x20causes\x20<strong>miosis.</strong></span></p>\x0a<p><span\x20class=\x22s1\x22><strong>The\x20ciliary\x20muscle\x20</strong>is\x20supplied\x20by\x20the\u00a0</span><strong></strong><span\x20class=\x22s1\x22><strong>2</strong>\x20adrenergic\x20receptors\x20as\x20well\x20as\u00a0</span><strong>M<span\x20class=\x22s1\x22>3\x20and</span>\u00a0M</strong><span\x20class=\x22s1\x22><strong>2</strong>\x20cholinergic\x20receptors.\x20The\u00a0<strong>2</strong>\u00a0receptors\x20cause\x20relaxation\x20of\x20the\x20ciliary\x20muscle,\x20which\x20helps\x20in\x20<strong>far\x20vision,</strong>\x20while\u00a0<strong>M3\x20and\x20M2\u00a0</strong>receptors\x20cause\x20contraction\x20of\x20the\x20ciliary\x20muscle,\x20which\x20helps\x20in\u00a0<strong>near\x20vision.</strong></span></p>\x0a<p><span\x20class=\x22s1\x22><strong>Lacrimal\x20glands\x20are\x20supplied\x20by\x20the\u00a0</strong></span>\x20receptors\x20and\x20M3\x20and\x20M2\x20receptors.\x20They\x20increase\x20lacrimal\x20secretion.</p>\x0a<p>Effects\x20of\x20various\x20drugs\x20on\x20the\x20eye</p>\x0a<table\x20style=\x22height:\x20217px;\x20width:\x20733px;\x22>\x0a<tbody>\x0a<tr>\x0a<td\x20style=\x22width:\x20134px;\x20text-align:\x20center;\x22><strong>Class</strong></td>\x0a<td\x20style=\x22width:\x20134px;\x20text-align:\x20center;\x22><strong>Muscarinic\x20receptor\x20antagonist</strong></td>\x0a<td\x20style=\x22width:\x20134px;\x20text-align:\x20center;\x22><strong>Cholinesterase\x20inhibitors</strong></td>\x0a<td\x20style=\x22width:\x20135px;\x20text-align:\x20center;\x22><strong>Muscarinic\x20receptor\x20agonist</strong></td>\x0a<td\x20style=\x22width:\x20135px;\x20text-align:\x20center;\x22><strong>Adrenergic\x20agonist</strong></td>\x0a<td\x20style=\x22width:\x20162px;\x20text-align:\x20center;\x22><strong>Local\x20anesthetic</strong></td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x20134px;\x22>Drugs</td>\x0a<td\x20style=\x22width:\x20134px;\x22><strong>Atropine</strong>,\x20homatropine,\x20Scopalamine,\x20Tropicamide</td>\x0a<td\x20style=\x22width:\x20134px;\x22><strong>Physostigmine</strong>,\x20neostigmine,\x20pyridostigmine,\x20organophosphorus\x20compounds,\x20etc</td>\x0a<td\x20style=\x22width:\x20135px;\x22><strong>Pilocarpine</strong></td>\x0a<td\x20style=\x22width:\x20135px;\x22>Epinephrine</td>\x0a<td\x20style=\x22width:\x20162px;\x22><strong>Cocaine</strong></td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x20134px;\x22>Mechanism\x20of\x20action\x20in\x20the\x20eye</td>\x0a<td\x20style=\x22width:\x20134px;\x22><strong>Blocks\x20M3\x20and\x20M2</strong>\x20receptors</td>\x0a<td\x20style=\x22width:\x20134px;\x22><strong>Stimulates\x20M3\x20and\x20M2</strong>\x20receptors</td>\x0a<td\x20style=\x22width:\x20135px;\x22><strong>Stimulates\x20M3\x20and\x20M2</strong>\x20receptors\x20in\x20the\x20eye</td>\x0a<td\x20style=\x22width:\x20135px;\x22><strong>Stimulates\u00a0</strong><span\x20class=\x22s1\x22><strong>1\x20</strong>receptor\u00a0\x20in\x20the\x20eye</span></td>\x0a<td\x20style=\x22width:\x20162px;\x22><strong>Blocks\x20sodium\x20channel</strong>\x20and\x20blocks\x20<strong>norepinephrine\x20transporter</strong></td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x20134px;\x22>Effect\x20on\x20iris</td>\x0a<td\x20style=\x22width:\x20134px;\x22>Mydriasis</td>\x0a<td\x20style=\x22width:\x20134px;\x22>Miosis</td>\x0a<td\x20style=\x22width:\x20135px;\x22>Miosis</td>\x0a<td\x20style=\x22width:\x20135px;\x22>Mydriasis</td>\x0a<td\x20style=\x22width:\x20162px;\x22>Mydriasis</td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x20134px;\x22>Corneal\x20reflex</td>\x0a<td\x20style=\x22width:\x20134px;\x22>Present</td>\x0a<td\x20style=\x22width:\x20134px;\x22>Present</td>\x0a<td\x20style=\x22width:\x20135px;\x22>Present</td>\x0a<td\x20style=\x22width:\x20135px;\x22>Present</td>\x0a<td\x20style=\x22width:\x20162px;\x22>Absent</td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x20134px;\x22>Light\x20reflex</td>\x0a<td\x20style=\x22width:\x20134px;\x22><strong>Absent</strong></td>\x0a<td\x20style=\x22width:\x20134px;\x22>Present</td>\x0a<td\x20style=\x22width:\x20135px;\x22>Present</td>\x0a<td\x20style=\x22width:\x20135px;\x22>Present</td>\x0a<td\x20style=\x22width:\x20162px;\x22>Present</td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x20134px;\x22>Lacrimal\x20secretions</td>\x0a<td\x20style=\x22width:\x20134px;\x22>Decreased</td>\x0a<td\x20style=\x22width:\x20134px;\x22>Increased</td>\x0a<td\x20style=\x22width:\x20135px;\x22>Increased</td>\x0a<td\x20style=\x22width:\x20135px;\x22>\u00a0Increased</td>\x0a<td\x20style=\x22width:\x20162px;\x22>---</td>\x0a</tr>\x0a</tbody>\x0a</table>','explanation_video':'','question_images':['https://cdn1.dailyrounds.org/uploads/38cc05b0933e4f65a83a650431d5c197.JPEG'],'explanation_images':[]},{'text':_0x4ea08a(0x326),'choices':[{'id':0x1,'text':_0x4ea08a(0x1f4)},{'id':0x2,'text':_0x4ea08a(0x318)},{'id':0x3,'text':_0x4ea08a(0x3f7)},{'id':0x4,'text':_0x4ea08a(0x2b4)}],'correct_choice_id':0x3,'solution':_0x4ea08a(0x211),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x4ea08a(0x34a),'choices':[{'id':0x1,'text':'Stop\x20NSAIDs\x20and\x20chew\x20capsule\x20pantoprazole\x20for\x20rapid\x20action'},{'id':0x2,'text':_0x4ea08a(0x213)},{'id':0x3,'text':'Use\x20a\x20combination\x20of\x20antacid\x20and\x20cimetidine\x20for\x20rapid\x20healing'},{'id':0x4,'text':_0x4ea08a(0x151)}],'correct_choice_id':0x2,'solution':_0x4ea08a(0x374),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x4ea08a(0x306),'choices':[{'id':0x1,'text':_0x4ea08a(0x19f)},{'id':0x2,'text':_0x4ea08a(0x17b)},{'id':0x3,'text':_0x4ea08a(0x344)},{'id':0x4,'text':_0x4ea08a(0x386)}],'correct_choice_id':0x2,'solution':_0x4ea08a(0x1e5),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x4ea08a(0x3d4),'choices':[{'id':0x1,'text':_0x4ea08a(0x2fd)},{'id':0x2,'text':_0x4ea08a(0x263)},{'id':0x3,'text':_0x4ea08a(0x182)},{'id':0x4,'text':_0x4ea08a(0x33c)}],'correct_choice_id':0x1,'solution':_0x4ea08a(0x138),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x4ea08a(0x2f6),'choices':[{'id':0x1,'text':_0x4ea08a(0x176)},{'id':0x2,'text':'Ischemic\x20stroke\x20within\x20the\x20last\x203\x20months'},{'id':0x3,'text':_0x4ea08a(0x22a)},{'id':0x4,'text':_0x4ea08a(0x44c)}],'correct_choice_id':0x4,'solution':_0x4ea08a(0x2d8),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':'Which\x20of\x20the\x20following\x20antifungal\x20drugs\x20is\x20matched\x20correctly\x20with\x20its\x20mechanism\x20of\x20action\x20based\x20on\x20the\x20image\x20given\x20below?','choices':[{'id':0x1,'text':_0x4ea08a(0x210)},{'id':0x2,'text':_0x4ea08a(0x11c)},{'id':0x3,'text':_0x4ea08a(0x148)},{'id':0x4,'text':_0x4ea08a(0x28f)}],'correct_choice_id':0x3,'solution':_0x4ea08a(0x309),'explanation_video':'','question_images':[_0x4ea08a(0x328)],'explanation_images':[]},{'text':'A\x2055-year-old\x20female\x20patient\x20came\x20to\x20the\x20hospital\x20with\x20a\x20history\x20of\x20headaches,\x20seizures,\x20memory\x20loss,\x20and\x20mood\x20changes.\x20\x20The\x20given\x20image\x20is\x20obtained\x20by\x20doing\x20an\x20MRI\x20scan.\x20Which\x20of\x20the\x20following\x20drugs\x20is\x20useful\x20in\x20this\x20condition?','choices':[{'id':0x1,'text':'Streptozocin'},{'id':0x2,'text':_0x4ea08a(0x2c0)},{'id':0x3,'text':_0x4ea08a(0x390)},{'id':0x4,'text':_0x4ea08a(0x30b)}],'correct_choice_id':0x2,'solution':_0x4ea08a(0x2de),'explanation_video':'','question_images':['https://cdn1.dailyrounds.org/uploads/3e9c4d7e004740ebade58c2cdf79f4e3.JPEG'],'explanation_images':[]},{'text':_0x4ea08a(0x362),'choices':[{'id':0x1,'text':'Recombinant\x20human\x20erythropoietin'},{'id':0x2,'text':_0x4ea08a(0x3ba)},{'id':0x3,'text':'Recombinant\x20human\x20IL-11'},{'id':0x4,'text':'Thrombopoietin\x20receptor\x20agonist'}],'correct_choice_id':0x4,'solution':_0x4ea08a(0x140),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x4ea08a(0x439),'choices':[{'id':0x1,'text':'It\x20is\x20one\x20of\x20the\x20cardiac\x20glycosides'},{'id':0x2,'text':_0x4ea08a(0x440)},{'id':0x3,'text':_0x4ea08a(0x13a)},{'id':0x4,'text':_0x4ea08a(0x3d7)}],'correct_choice_id':0x4,'solution':'<p><strong>Hypomagnesemia</strong>\x20increases\x20the\x20risk\x20of\x20digitalis-induced\x20arrhythmia.&nbsp;</p>\x0a<p>Digoxin\x20is\x20one\x20of\x20the\x20cardiac\x20glycosides\x20which\x20is\x20derived\x20from\x20the&nbsp;<strong>digitalis\x20plant</strong>\x20and\x20used\x20clinically.</p>\x0a<p>It\x20inhibits\x20<strong>Na<sup>+</sup>/K<sup>+&nbsp;</sup>ATPase</strong>,\x20a\x20membrane-bound\x20transporter\x20to\x20increase\x20intracellular\x20sodium.\x20As\x20a\x20result,\x20there\x20is\x20less\x20expulsion\x20of\x20calcium\x20from\x20the\x20cell\x20by\x20sodium-calcium\x20exchanger\x20(<strong>NCX).&nbsp;</strong>Increased\x20calcium\x20inside\x20the\x20myocyte\x20leads\x20to<strong>&nbsp;an\x20increase\x20</strong>in\x20cardiac\x20contractility.</p>\x0a<p>Digoxin\x20is\x2065&ndash;80%\x20absorbed\x20after\x20oral\x20administration.\x20An\x20almost\x20two-third\x20of\x20the\x20metabolite\x20is\x20excreted\x20unchanged\x20by\x20<strong>kidney</strong>\x20with\x20half-life\x20of\x2036-40\x20hours.</p>\x0a<p>The\x20most\x20common\x20cardiac\x20manifestations\x20of\x20digitalis\x20toxicity\x20include\x20atrioventricular\x20junctional\x20rhythm,\x20<strong>premature\x20ventricular\x20depolarizations,\x20</strong>ventricular\x20bigeminy,<strong>\x20ventricular\x20tachycardia,</strong>\x20and<strong>\x20second-degree\x20AV\x20blockade</strong>.\x20After\x20cardiovascular\x20system,\x20nausea,\x20vomiting,\x20diarrhea\x20i.e.,\x20<strong>GIT\x20effects\x20</strong>are\x20more\x20pronounced.&nbsp;<strong>Altered\x20color\x20perception</strong>\x20can\x20also\x20be\x20seen\x20in\x20case\x20of\x20digoxin\x20toxicity.</p>\x0a<p>Factors\x20that\x20increase\x20the\x20risk\x20of\x20digoxin\x20toxicity\x20are:</p>\x0a<ul>\x0a<li><strong>Hypercalcemia</strong></li>\x0a<li><strong>Hypomagnesemia</strong></li>\x0a<li><strong>Hypokalemia</strong>-\x20It\x20increases\x20the\x20binding\x20of\x20the\x20digoxin\x20to\x20the&nbsp;Na<span\x20class=\x22s1\x22>+</span>/K<span\x20class=\x22s1\x22>+&nbsp;</span>ATPase\x20pump.&nbsp;</li>\x0a<li>Drugs\x20causing\x20hypokalemia-\x20Diuretics,\x20amphotericin\x20B,\x20corticosteroids</li>\x0a<li>Drugs\x20that\x20decrease\x20digoxin\x20elimination\x20(inhibitors\x20of\x20P-glycoprotein)-&nbsp;Amiodarone,\x20quinidine,\x20verapamil,\x20diltiazem,\x20cyclosporine,\x20itraconazole,\x20propafenone,\x20and\x20flecainide</li>\x0a<li>Renal\x20failure</li>\x0a<li>Hypothyroidism</li>\x0a</ul>','explanation_video':'','question_images':[],'explanation_images':[]}],quizName='Pharmacology\x20Test';const quizFilename=_0x4ea08a(0x271);let hierarchy=[_0x4ea08a(0x3e9),'NEET\x20PG\x20Test\x20Series\x20Subject\x20Wise',_0x4ea08a(0x29e)];if(window[_0x4ea08a(0x25f)]['pathname'][_0x4ea08a(0x159)](_0x4ea08a(0x36a))){const customData=JSON['parse'](localStorage['getItem'](_0x4ea08a(0x2e1)));if(customData){const WbDnJv=_0x4ea08a(0x242)[_0x4ea08a(0x25a)]('|');let HRafcU=0x0;while(!![]){switch(WbDnJv[HRafcU++]){case'0':document[_0x4ea08a(0x1ea)]=quizName+'\x20-\x20Brain\x20And\x20Scalpel';continue;case'1':document[_0x4ea08a(0x266)]('totalQuestions')[_0x4ea08a(0x38e)]=questionsData['length'];continue;case'2':questionsData=customData[_0x4ea08a(0x3b9)];continue;case'3':document['getElementById'](_0x4ea08a(0x1a0))['textContent']=hierarchy[_0x4ea08a(0x1b3)](_0x4ea08a(0x1ce));continue;case'4':hierarchy=customData[_0x4ea08a(0x1c2)];continue;case'5':quizName=customData[_0x4ea08a(0x225)];continue;}break;}}}let currentQuestionIndex=0x0,selectedOption=null,currentMode='study',timer=null,timeRemaining=0x0,questionStartTime=Date[_0x4ea08a(0x1b6)](),quizStartTime=Date[_0x4ea08a(0x1b6)](),isQuizCompleted=![],questionStates=new Array(questionsData[_0x4ea08a(0x3b4)])[_0x4ea08a(0x2ee)](null)[_0x4ea08a(0x3a7)](()=>({'status':_0x4ea08a(0x3f0),'bookmarked':![],'markedForReview':![],'selectedAnswer':null,'timeSpent':0x0})),stats={'correctAnswers':0x0,'incorrectAnswers':0x0,'totalAttempted':0x0,'totalTime':0x0,'notAttempted':questionsData['length']};function saveProgress(){const _0x2ce4c2=_0x4ea08a,_0x545c1f={'TGamg':_0x2ce4c2(0x463)};if(isQuizCompleted)return;const _0x451883=JSON[_0x2ce4c2(0x444)](localStorage[_0x2ce4c2(0x1f6)](_0x545c1f[_0x2ce4c2(0x23e)]))||{};_0x451883[quizFilename]={'questionStates':questionStates,'stats':stats,'currentQuestionIndex':currentQuestionIndex,'currentMode':currentMode,'status':_0x2ce4c2(0x2fb),'lastSeen':new Date()[_0x2ce4c2(0x208)]()},localStorage[_0x2ce4c2(0x292)](_0x2ce4c2(0x463),JSON['stringify'](_0x451883));}function loadProgress(){const _0x2b0890=_0x4ea08a,_0x11224c={'lKDXk':'userHistory','vkwOc':function(_0x524fbf,_0x1438a2){return _0x524fbf===_0x1438a2;},'ZZItd':_0x2b0890(0x447),'RFfYf':'gKTas','ZNpYk':_0x2b0890(0x45c)},_0x3f362c=JSON['parse'](localStorage[_0x2b0890(0x1f6)](_0x11224c[_0x2b0890(0x167)]))||{},_0x417449=_0x3f362c[quizFilename];if(_0x417449){if(_0x11224c['vkwOc'](_0x11224c[_0x2b0890(0x294)],_0x11224c['RFfYf']))_0x5b0005['innerHTML']+='<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>English\x20Explanation:</p><audio\x20src=\x22'+_0x4512b8[_0x2b0890(0x302)]+'\x22\x20controls\x20class=\x22w-full\x22></audio></div>';else{const _0x5c9646=_0x11224c[_0x2b0890(0x348)][_0x2b0890(0x25a)]('|');let _0x292ac2=0x0;while(!![]){switch(_0x5c9646[_0x292ac2++]){case'0':return!![];case'1':currentMode=_0x417449[_0x2b0890(0x11f)];continue;case'2':stats=_0x417449[_0x2b0890(0x18d)];continue;case'3':console[_0x2b0890(0x252)](_0x2b0890(0x3d5));continue;case'4':questionStates=_0x417449['questionStates'];continue;case'5':currentQuestionIndex=_0x417449[_0x2b0890(0x11d)];continue;}break;}}}return![];}function clearProgress(){const _0xe2cc19=_0x4ea08a,_0x2a1984={'LTUch':'userHistory','ytLHS':'Previous\x20progress\x20cleared.'},_0x1dc6b5=JSON[_0xe2cc19(0x444)](localStorage[_0xe2cc19(0x1f6)](_0x2a1984[_0xe2cc19(0x28e)]))||{};_0x1dc6b5[quizFilename]&&(delete _0x1dc6b5[quizFilename],localStorage[_0xe2cc19(0x292)](_0x2a1984['LTUch'],JSON[_0xe2cc19(0x423)](_0x1dc6b5)),console[_0xe2cc19(0x252)](_0x2a1984[_0xe2cc19(0x168)]));}function markQuizAsCompleted(){const _0x47ad08=_0x4ea08a,_0x220ced={'mvToL':_0x47ad08(0x463)},_0x5b0cfc=JSON[_0x47ad08(0x444)](localStorage[_0x47ad08(0x1f6)](_0x220ced[_0x47ad08(0x3b6)]))||{},_0x4d32d9=questionsData[_0x47ad08(0x3b4)],_0x343588=stats['correctAnswers']||0x0;_0x5b0cfc[quizFilename]={'score':_0x343588,'total':_0x4d32d9,'status':_0x47ad08(0x398),'completedOn':new Date()[_0x47ad08(0x208)]()},localStorage[_0x47ad08(0x292)]('userHistory',JSON['stringify'](_0x5b0cfc));}const urlParams=new URLSearchParams(window[_0x4ea08a(0x25f)][_0x4ea08a(0x308)]),startAt=parseInt(urlParams[_0x4ea08a(0x33a)](_0x4ea08a(0x21f))),resume=urlParams[_0x4ea08a(0x33a)](_0x4ea08a(0x2e9))===_0x4ea08a(0x35d);function goBack(){const _0x5538ca=_0x4ea08a,_0x5bb14c={'VPIIE':'index.html'};if(!isQuizCompleted)saveProgress();window[_0x5538ca(0x25f)][_0x5538ca(0x39e)]=document[_0x5538ca(0x2eb)]||_0x5bb14c[_0x5538ca(0x40a)];}function selectMode(_0x458f05){const _0x321848=_0x4ea08a,_0x52ef64={'rqUlz':'none','nOMpw':function(_0x2d42f0){return _0x2d42f0();}};currentMode=_0x458f05,document[_0x321848(0x266)](_0x321848(0x288))['style']['display']=_0x52ef64[_0x321848(0x290)],_0x52ef64['nOMpw'](initializeQuiz);}function initializeQuiz(){const _0x329eac=_0x4ea08a,_0x4ef837={'sktYw':_0x329eac(0x415),'EpdHW':function(_0x123794,_0x1f673c,_0x2fdaf0){return _0x123794(_0x1f673c,_0x2fdaf0);},'YgXZh':_0x329eac(0x45e),'oGztP':'markReviewBtn','XMspZ':function(_0x122767,_0x2e976f){return _0x122767===_0x2e976f;},'WHrJu':_0x329eac(0x1cd),'ooVGl':function(_0x1be3af,_0x45fd1c){return _0x1be3af===_0x45fd1c;},'LVpGB':_0x329eac(0x251),'Sulln':_0x329eac(0x163),'RBXRr':_0x329eac(0x39d),'Uzlwb':_0x329eac(0x15f),'secva':_0x329eac(0x373),'eDJjy':_0x329eac(0x464),'svsBD':_0x329eac(0x218),'GHCRq':_0x329eac(0x27f),'neANu':function(_0x1808af,_0x5663f0){return _0x1808af===_0x5663f0;},'ltLqJ':'timerContainer','gTFjv':_0x329eac(0x2b3),'TAFZS':function(_0xf60a5f,_0x30ad3c){return _0xf60a5f>=_0x30ad3c;},'yueiV':_0x329eac(0x150),'HNOjZ':function(_0x266bfd){return _0x266bfd();},'yDqgI':function(_0x520789){return _0x520789();}};quizStartTime=Date[_0x329eac(0x1b6)]();const _0x458b65=document[_0x329eac(0x266)](_0x4ef837[_0x329eac(0x173)]),_0xb60f41=document[_0x329eac(0x266)](_0x4ef837[_0x329eac(0x416)]),_0x353a63=document['getElementById'](_0x329eac(0x17d)),_0x501bbb=_0x4ef837[_0x329eac(0x462)](currentMode,_0x4ef837['WHrJu'])||_0x4ef837[_0x329eac(0x2be)](currentMode,_0x4ef837[_0x329eac(0x42b)]);document[_0x329eac(0x266)](_0x4ef837[_0x329eac(0x274)])[_0x329eac(0x157)][_0x329eac(0x44e)]=_0x501bbb?_0x4ef837['RBXRr']:_0x4ef837[_0x329eac(0x3d0)],document[_0x329eac(0x266)](_0x329eac(0x25b))['style'][_0x329eac(0x44e)]=_0x501bbb?_0x4ef837[_0x329eac(0x246)]:_0x329eac(0x15f),document[_0x329eac(0x266)](_0x4ef837[_0x329eac(0x1de)])[_0x329eac(0x157)]['display']=_0x501bbb?_0x4ef837['Uzlwb']:_0x4ef837['RBXRr'],document[_0x329eac(0x266)](_0x4ef837[_0x329eac(0x230)])[_0x329eac(0x157)][_0x329eac(0x44e)]=_0x501bbb?_0x4ef837[_0x329eac(0x3d0)]:_0x4ef837[_0x329eac(0x246)],_0x458b65[_0x329eac(0x157)][_0x329eac(0x44e)]=_0x501bbb?_0x4ef837[_0x329eac(0x246)]:_0x4ef837['svsBD'],_0xb60f41[_0x329eac(0x157)]['display']=_0x501bbb?_0x4ef837['svsBD']:_0x4ef837[_0x329eac(0x246)],_0x353a63[_0x329eac(0x157)]['display']=_0x501bbb?_0x4ef837['svsBD']:'none';(currentMode===_0x4ef837[_0x329eac(0x40d)]||_0x4ef837[_0x329eac(0x12b)](currentMode,_0x4ef837[_0x329eac(0x42b)]))&&document[_0x329eac(0x266)](_0x4ef837[_0x329eac(0x316)])[_0x329eac(0x217)]['remove'](_0x4ef837[_0x329eac(0x1e2)]);if(!isNaN(startAt)&&_0x4ef837[_0x329eac(0x171)](startAt,0x0)&&startAt<questionsData[_0x329eac(0x3b4)]){if(_0x4ef837[_0x329eac(0x449)]===_0x4ef837[_0x329eac(0x449)])currentQuestionIndex=startAt;else{const _0x126c5f=_0x4cc69a[_0x329eac(0x1c4)][_0x329eac(0x2b8)];if(_0x126c5f&&_0x126c5f[_0x329eac(0x2cf)](_0x4ef837['sktYw']))_0x4ef837['EpdHW'](_0x2fb08c,_0x23ee33,_0x126c5f);else _0x126c5f&&(_0x4e3308[_0x329eac(0x2b8)]=_0x126c5f);}}_0x4ef837[_0x329eac(0x26b)](loadBookmarkedQuestions),generateQuestionNav(),_0x4ef837[_0x329eac(0x174)](updateStats),_0x4ef837[_0x329eac(0x26b)](displayQuestion);}function generateQuestionNav(){const _0x5593ea=_0x4ea08a,_0x967e2={'hMhgo':_0x5593ea(0x27a),'qVjWL':function(_0x6952e7,_0x2252e3){return _0x6952e7<_0x2252e3;},'wUIXS':'button','LwEMJ':_0x5593ea(0x2c2)},_0x24723a=document[_0x5593ea(0x266)](_0x967e2[_0x5593ea(0x18c)]);_0x24723a['innerHTML']='';for(let _0x56df75=0x0;_0x967e2['qVjWL'](_0x56df75,questionsData[_0x5593ea(0x3b4)]);_0x56df75++){const _0x4d78f9=document[_0x5593ea(0x42c)](_0x967e2[_0x5593ea(0x29f)]);_0x4d78f9[_0x5593ea(0x38e)]=_0x56df75+0x1,_0x4d78f9[_0x5593ea(0x117)]=_0x967e2[_0x5593ea(0x37f)],_0x4d78f9['onclick']=()=>jumpToQuestion(_0x56df75),_0x4d78f9['id']=_0x5593ea(0x3ac)+_0x56df75,_0x24723a[_0x5593ea(0x2ac)](_0x4d78f9);}updateQuestionNav();}function updateQuestionNav(){const _0x38295c=_0x4ea08a,_0x1d706a={'VtogO':_0x38295c(0x2fe),'SMBtK':'questionNav','ZEMOE':'button','Uejrc':function(_0x5387aa,_0x5c34ce){return _0x5387aa+_0x5c34ce;},'mqZWQ':_0x38295c(0x2c2),'HjuvF':function(_0x12e696){return _0x12e696();},'VhznL':'customQuizData','LKIcd':function(_0x7dc153,_0x58da54){return _0x7dc153<_0x58da54;},'ygjws':function(_0xe4c4c0,_0x34dfb3){return _0xe4c4c0===_0x34dfb3;},'OILJM':_0x38295c(0x412),'iXJFc':'nav-btn-current','dGFWD':_0x38295c(0x161),'BNcHA':_0x38295c(0x433),'MLeuk':function(_0x503837,_0x1bf83a){return _0x503837===_0x1bf83a;},'eXoab':'study','HRSBz':'nav-btn-incorrect','SmQyI':function(_0x25c280,_0x1ef658){return _0x25c280!==_0x1ef658;},'XNtJN':_0x38295c(0x1b0)};for(let _0x2def1f=0x0;_0x1d706a[_0x38295c(0x20d)](_0x2def1f,questionsData[_0x38295c(0x3b4)]);_0x2def1f++){const _0x4b78a2=document['getElementById'](_0x38295c(0x3ac)+_0x2def1f),_0x41324=questionStates[_0x2def1f];let _0x1f76f9='';if(_0x1d706a['ygjws'](_0x2def1f,currentQuestionIndex)){if(_0x38295c(0x149)!==_0x1d706a['OILJM'])_0x1f76f9=_0x1d706a[_0x38295c(0x3e7)];else{if(_0x242837[_0x38295c(0x320)]()){const _0x2e0776=new _0x376f5f();_0x2e0776[_0x38295c(0x3da)](_0x48ba1e),_0x2e0776[_0x38295c(0x25e)](_0x5d0ed3);}else _0x46ecff[_0x38295c(0x201)](_0x1d706a[_0x38295c(0x24a)])&&(_0x587402['src']=_0x4d5e69);}}else{if(_0x41324['bookmarked'])_0x1f76f9=_0x38295c(0x2b0);else{if(_0x41324[_0x38295c(0x214)]){if(_0x38295c(0x161)!==_0x1d706a[_0x38295c(0x24d)]){const _0x4e2270=_0x4874b2[_0x38295c(0x266)](_0x1d706a['SMBtK']);_0x4e2270['innerHTML']='';for(let _0x5423e1=0x0;_0x5423e1<_0x1b3a15[_0x38295c(0x3b4)];_0x5423e1++){const _0x10e375=_0x7b2652['createElement'](_0x1d706a[_0x38295c(0x317)]);_0x10e375['textContent']=_0x1d706a['Uejrc'](_0x5423e1,0x1),_0x10e375[_0x38295c(0x117)]=_0x1d706a['mqZWQ'],_0x10e375['onclick']=()=>_0x3ad58b(_0x5423e1),_0x10e375['id']=_0x38295c(0x3ac)+_0x5423e1,_0x4e2270[_0x38295c(0x2ac)](_0x10e375);}_0x1d706a['HjuvF'](_0xf31a8e);}else _0x1f76f9=_0x1d706a[_0x38295c(0x364)];}else{if(_0x1d706a['MLeuk'](currentMode,_0x1d706a[_0x38295c(0x399)])||_0x1d706a[_0x38295c(0x387)](currentMode,'timed_study')){if(_0x1d706a['ygjws'](_0x41324[_0x38295c(0x255)],_0x38295c(0x16c)))_0x1f76f9=_0x38295c(0x20e);else{if(_0x1d706a['MLeuk'](_0x41324['status'],_0x38295c(0x465)))_0x1f76f9=_0x1d706a[_0x38295c(0x38d)];else _0x1f76f9=_0x38295c(0x199);}}else{if(_0x1d706a[_0x38295c(0x321)](_0x1d706a[_0x38295c(0x3a8)],_0x1d706a[_0x38295c(0x3a8)]))_0x3f1b5d['removeItem'](_0x1d706a[_0x38295c(0x365)]);else{if(_0x1d706a['SmQyI'](_0x41324[_0x38295c(0x400)],null))_0x1f76f9=_0x38295c(0x268);else _0x1f76f9=_0x38295c(0x199);}}}}}_0x4b78a2[_0x38295c(0x117)]=_0x38295c(0x2ae)+_0x1f76f9;}}function jumpToQuestion(_0x5d3e58){const _0x5d7e52=_0x4ea08a,_0x328b0b={'pBDAv':function(_0x470f4e,_0x38de5d){return _0x470f4e>=_0x38de5d;},'UgqQS':function(_0xc666da,_0x12370a){return _0xc666da<_0x12370a;},'hofhh':function(_0x1037f5){return _0x1037f5();},'FQEVd':function(_0x1a4f96){return _0x1a4f96();}};_0x328b0b[_0x5d7e52(0x3c2)](_0x5d3e58,0x0)&&_0x328b0b['UgqQS'](_0x5d3e58,questionsData['length'])&&(questionStartTime&&(questionStates[currentQuestionIndex][_0x5d7e52(0x284)]+=Date['now']()-questionStartTime),currentQuestionIndex=_0x5d3e58,_0x328b0b[_0x5d7e52(0x44d)](displayQuestion),_0x328b0b[_0x5d7e52(0x1a9)](saveProgress));}function updateStats(){const _0x1cf66f=_0x4ea08a,_0x2fffb2={'pDnCp':function(_0x512af5,_0x57eff5){return _0x512af5===_0x57eff5;},'hQndA':_0x1cf66f(0x401),'emASD':'timed_study','JdApq':'correctCount','JVFfR':_0x1cf66f(0x467),'KiBNF':function(_0x3f72b0,_0x4ef263){return _0x3f72b0>_0x4ef263;},'YnggQ':function(_0x2b7566,_0x3348b8){return _0x2b7566*_0x3348b8;},'vziKa':function(_0xf0b69c,_0x50f18c){return _0xf0b69c/_0x50f18c;},'qxITI':function(_0x2fad5b,_0x1aec59){return _0x2fad5b/_0x1aec59;},'oteYj':function(_0x5e603f,_0xe74013){return _0x5e603f%_0xe74013;},'iUiNH':function(_0x326059,_0x31a90f){return _0x326059+_0x31a90f;}};if(_0x2fffb2[_0x1cf66f(0x2a4)](currentMode,_0x2fffb2[_0x1cf66f(0x353)])||_0x2fffb2[_0x1cf66f(0x2a4)](currentMode,_0x2fffb2[_0x1cf66f(0x327)])){document[_0x1cf66f(0x266)](_0x2fffb2[_0x1cf66f(0x381)])[_0x1cf66f(0x38e)]=stats[_0x1cf66f(0x18a)],document[_0x1cf66f(0x266)](_0x1cf66f(0x190))[_0x1cf66f(0x38e)]=stats['incorrectAnswers'],document['getElementById'](_0x2fffb2['JVFfR'])[_0x1cf66f(0x38e)]=stats[_0x1cf66f(0x467)];const _0x3282a0=_0x2fffb2['KiBNF'](stats['totalAttempted'],0x0)?Math['round'](_0x2fffb2['YnggQ'](_0x2fffb2[_0x1cf66f(0x26a)](stats[_0x1cf66f(0x18a)],stats[_0x1cf66f(0x467)]),0x64)):0x0;document[_0x1cf66f(0x266)](_0x1cf66f(0x3bf))[_0x1cf66f(0x38e)]=_0x3282a0+'%',stats[_0x1cf66f(0x1e0)]=questionStates['reduce']((_0x5c675e,_0x45d2f0)=>_0x5c675e+_0x45d2f0[_0x1cf66f(0x284)],0x0);const _0x45b1af=Math[_0x1cf66f(0x1e9)](stats[_0x1cf66f(0x1e0)]/0x3e8),_0x175ee4=Math[_0x1cf66f(0x1e9)](_0x2fffb2[_0x1cf66f(0x2ea)](_0x45b1af,0x3c)),_0x1d6997=_0x2fffb2['oteYj'](_0x45b1af,0x3c);document[_0x1cf66f(0x266)](_0x1cf66f(0x284))['textContent']=_0x2fffb2[_0x1cf66f(0x1f5)](_0x175ee4+':',_0x1d6997[_0x1cf66f(0x44f)]()[_0x1cf66f(0x269)](0x2,'0'));}}function setupVideo(_0x5b5152,_0x1d058a){const _0x282a6d=_0x4ea08a,_0x1c6bb4={'AeUir':'performanceModal','YJknr':function(_0x129786,_0x4ee46f){return _0x129786>_0x4ee46f;},'EZMhV':function(_0x34cbbe,_0x16ef86){return _0x34cbbe+_0x16ef86;},'fuMTg':function(_0x1b13bd,_0x3bea06){return _0x1b13bd*_0x3bea06;},'TStIG':function(_0xd5acd6,_0x33247c){return _0xd5acd6+_0x33247c;},'nDmrp':function(_0x4384f4,_0x2cd495){return _0x4384f4*_0x2cd495;},'zZfVu':'scoreCircle','sryal':function(_0x42abd8,_0x3eb06a){return _0x42abd8/_0x3eb06a;},'qhtAG':'totalQuestionsResult','YVlUd':_0x282a6d(0x2f7),'lvXRy':_0x282a6d(0x3fd),'drqfW':function(_0x2887b3,_0x1b1be6){return _0x2887b3%_0x1b1be6;},'AdaTE':function(_0x1bcc58,_0x2dd896){return _0x1bcc58/_0x2dd896;},'aCCex':_0x282a6d(0x331),'BdxBP':function(_0x48193f,_0x38aa0a){return _0x48193f===_0x38aa0a;},'VdayE':_0x282a6d(0x406)};if(Hls[_0x282a6d(0x320)]()){const _0x4c3fc9=new Hls();_0x4c3fc9[_0x282a6d(0x3da)](_0x1d058a),_0x4c3fc9[_0x282a6d(0x25e)](_0x5b5152);}else{if(_0x5b5152[_0x282a6d(0x201)](_0x282a6d(0x2fe))){if(_0x1c6bb4[_0x282a6d(0x2a1)](_0x1c6bb4[_0x282a6d(0x1bb)],_0x1c6bb4[_0x282a6d(0x1bb)]))_0x5b5152['src']=_0x1d058a;else{const _0x2d228e=_0x4e7d6f[_0x282a6d(0x266)](_0x1c6bb4['AeUir']),_0x376263=_0x1c6bb4[_0x282a6d(0x2bb)](_0x1c6bb4[_0x282a6d(0x41f)](_0xa3a3e,_0x1e8d00),0x0)?_0x39be8c['round'](_0x1c6bb4[_0x282a6d(0x1bc)](_0x5d8aa7/_0x1c6bb4[_0x282a6d(0x2b7)](_0x6edff2,_0x256dfd),0x64)):0x0,_0x5f2fe7=_0x1c6bb4['nDmrp'](0x2,_0x18e71d['PI'])*0x41,_0x1579fe=_0x229bfa[_0x282a6d(0x266)](_0x1c6bb4[_0x282a6d(0x2c7)]);_0x1579fe[_0x282a6d(0x157)][_0x282a6d(0x2a5)]=_0x5f2fe7+'\x20'+_0x5f2fe7,_0x1579fe[_0x282a6d(0x157)][_0x282a6d(0x341)]=_0x5f2fe7-_0x1c6bb4[_0x282a6d(0x3de)](_0x1c6bb4['sryal'](_0x376263,0x64),_0x5f2fe7),_0x57a3f6[_0x282a6d(0x266)]('accuracyScore')[_0x282a6d(0x38e)]=_0x376263+'%',_0x1f6343[_0x282a6d(0x266)](_0x1c6bb4['qhtAG'])['textContent']=_0x4bdaa9['length'],_0x527139['getElementById'](_0x282a6d(0x12d))[_0x282a6d(0x38e)]=_0x51612b,_0x2cb210['getElementById'](_0x1c6bb4['YVlUd'])['textContent']=_0x1b929f,_0x2e8f05[_0x282a6d(0x266)](_0x1c6bb4[_0x282a6d(0x368)])[_0x282a6d(0x38e)]=_0x3a9cb4;const _0x592ad2=_0x5ade99[_0x282a6d(0x1e9)](_0x1c6bb4[_0x282a6d(0x27b)](_0x18f275,0xea60)),_0x262e00=_0x585bad[_0x282a6d(0x1e9)](_0x1c6bb4[_0x282a6d(0x27b)](_0x1c6bb4[_0x282a6d(0x2f0)](_0x10e016,0xea60),0x3e8));_0x16a4a9[_0x282a6d(0x266)](_0x282a6d(0x277))[_0x282a6d(0x38e)]=_0x592ad2+':'+_0x262e00['toString']()[_0x282a6d(0x269)](0x2,'0');const _0x3e5d63=_0x1c6bb4[_0x282a6d(0x27b)](_0x3bd559,_0x59b341[_0x282a6d(0x3b4)]),_0x4dded4=_0x1f213c[_0x282a6d(0x1e9)](_0x1c6bb4[_0x282a6d(0x454)](_0x3e5d63,0xea60)),_0x31783f=_0x172238['floor'](_0x1c6bb4[_0x282a6d(0x27b)](_0x3e5d63%0xea60,0x3e8));_0x8e486b[_0x282a6d(0x266)](_0x1c6bb4[_0x282a6d(0x142)])[_0x282a6d(0x38e)]=_0x4dded4+':'+_0x31783f['toString']()[_0x282a6d(0x269)](0x2,'0'),_0x2d228e[_0x282a6d(0x217)][_0x282a6d(0x3e8)]('hidden');}}}}function displayQuestion(){const _0x5b0e6d=_0x4ea08a,_0x21e435={'rbpiF':_0x5b0e6d(0x401),'hVeko':function(_0x468039,_0x5787dd){return _0x468039===_0x5787dd;},'jELyF':_0x5b0e6d(0x27f),'Gdfbv':_0x5b0e6d(0x190),'XKMXC':_0x5b0e6d(0x467),'YqWcd':function(_0x4bd6e3,_0x407aaf){return _0x4bd6e3/_0x407aaf;},'xhFpz':function(_0x2b6e2f,_0x13e456){return _0x2b6e2f+_0x13e456;},'UaisM':function(_0x395e15,_0x43f6ca){return _0x395e15/_0x43f6ca;},'DLwsZ':function(_0x4c2915,_0x975d8f){return _0x4c2915%_0x975d8f;},'hMPZt':'timeSpent','ksOWl':function(_0x724436,_0x5dcda2){return _0x724436+_0x5dcda2;},'oHpzO':function(_0xe70539,_0x228a8a){return _0xe70539!==_0x228a8a;},'xwQxr':_0x5b0e6d(0x2b9),'SCJio':function(_0x30cba5,_0x43a564){return _0x30cba5===_0x43a564;},'HyjQx':_0x5b0e6d(0x372),'knaFO':'border-green-500','SNPiI':function(_0x82d38d,_0x48983c){return _0x82d38d===_0x48983c;},'EugGp':_0x5b0e6d(0x1e6),'UGNVA':_0x5b0e6d(0x2da),'eoYkW':'Option\x20','Kjmoc':function(_0x524f64,_0x290fd4){return _0x524f64+_0x290fd4;},'QogJW':function(_0x27c5de,_0x43621b){return _0x27c5de===_0x43621b;},'Rgbwe':_0x5b0e6d(0x16c),'mBHWG':_0x5b0e6d(0x465),'xMYMC':'aAEHK','StSJP':_0x5b0e6d(0x14d),'tXKmX':_0x5b0e6d(0x1ee),'wBUln':function(_0x193b0a,_0x40fdc5){return _0x193b0a(_0x40fdc5);},'mhLyh':function(_0x1268bb,_0x49b666){return _0x1268bb===_0x49b666;},'jxiyd':_0x5b0e6d(0x37a),'CRUmq':function(_0x2a5da1,_0x7b0881){return _0x2a5da1*_0x7b0881;},'dpspM':function(_0x3dafd3){return _0x3dafd3();},'pMLYX':function(_0x26be50,_0x4786fc){return _0x26be50===_0x4786fc;},'myUsv':_0x5b0e6d(0x2b3),'AQIVH':'aNkCJ','nBjJh':'answered','MVEco':_0x5b0e6d(0x222),'meNXA':function(_0x37a625){return _0x37a625();},'wPuzA':_0x5b0e6d(0x251)};if(!questionsData||_0x21e435[_0x5b0e6d(0x123)](questionsData[_0x5b0e6d(0x3b4)],0x0)){document[_0x5b0e6d(0x266)](_0x21e435[_0x5b0e6d(0x3f5)])[_0x5b0e6d(0x408)]=_0x5b0e6d(0x1cb);return;};const _0x554b1a=questionsData[currentQuestionIndex];questionStartTime=Date['now'](),selectedOption=questionStates[currentQuestionIndex][_0x5b0e6d(0x400)];const _0x1e9c42=_0x21e435[_0x5b0e6d(0x466)]((currentQuestionIndex+0x1)/questionsData['length'],0x64);document[_0x5b0e6d(0x266)](_0x5b0e6d(0x41c))[_0x5b0e6d(0x157)][_0x5b0e6d(0x37c)]=_0x21e435[_0x5b0e6d(0x3b0)](_0x1e9c42,'%'),document[_0x5b0e6d(0x266)](_0x5b0e6d(0x2a7))['textContent']=_0x21e435[_0x5b0e6d(0x19d)](currentQuestionIndex,0x1),_0x21e435[_0x5b0e6d(0x301)](updateQuestionNav),document[_0x5b0e6d(0x266)]('prevBtn')[_0x5b0e6d(0x204)]=_0x21e435[_0x5b0e6d(0x1fb)](currentQuestionIndex,0x0),document[_0x5b0e6d(0x266)]('solutionContainer')['classList'][_0x5b0e6d(0x206)](_0x21e435[_0x5b0e6d(0x27c)]),document[_0x5b0e6d(0x266)](_0x21e435[_0x5b0e6d(0x3f5)])['innerHTML']=_0x554b1a[_0x5b0e6d(0x162)]||_0x5b0e6d(0x137);let _0x27a75b='';if(_0x554b1a[_0x5b0e6d(0x1f1)])_0x27a75b+=_0x5b0e6d(0x429)+_0x554b1a[_0x5b0e6d(0x1f1)]+_0x5b0e6d(0x1e8);if(_0x554b1a[_0x5b0e6d(0x2df)])_0x27a75b+='<div\x20class=\x22glass-light\x20p-4\x20mb-4\x22><video\x20src=\x22'+_0x554b1a['question_video']+'\x22\x20controls\x20class=\x22w-full\x20rounded-lg\x22></video></div>';if(_0x554b1a[_0x5b0e6d(0x17a)]){if(_0x21e435[_0x5b0e6d(0x45a)]===_0x21e435[_0x5b0e6d(0x45a)])_0x554b1a['question_images'][_0x5b0e6d(0x370)](_0x2d451a=>{const _0x291d45=_0x5b0e6d;if(_0x21e435[_0x291d45(0x2dd)](_0x21e435['xwQxr'],_0x291d45(0x2ff))){if(_0x2d451a)_0x27a75b+=_0x291d45(0x419)+_0x2d451a+_0x291d45(0x1d3);}else{if(_0x126aa6===_0x21e435[_0x291d45(0x413)]||_0x21e435['hVeko'](_0x551a10,_0x21e435[_0x291d45(0x250)])){_0x266a97['getElementById'](_0x291d45(0x245))['textContent']=_0xc33139[_0x291d45(0x18a)],_0x1237cd[_0x291d45(0x266)](_0x21e435['Gdfbv'])[_0x291d45(0x38e)]=_0x13ddd0[_0x291d45(0x287)],_0x17f963[_0x291d45(0x266)](_0x21e435['XKMXC'])['textContent']=_0x455190['totalAttempted'];const _0x39b8c0=_0x39120a['totalAttempted']>0x0?_0x538b41['round'](_0x21e435['YqWcd'](_0x1ab11f['correctAnswers'],_0x26bdca['totalAttempted'])*0x64):0x0;_0x518c89['getElementById'](_0x291d45(0x3bf))[_0x291d45(0x38e)]=_0x21e435['xhFpz'](_0x39b8c0,'%'),_0x3ca15a[_0x291d45(0x1e0)]=_0x14f77b[_0x291d45(0x3c5)]((_0x16dcfa,_0x554f25)=>_0x16dcfa+_0x554f25[_0x291d45(0x284)],0x0);const _0x574977=_0x3aac0e[_0x291d45(0x1e9)](_0x850206[_0x291d45(0x1e0)]/0x3e8),_0x3556f7=_0x2bfc6b[_0x291d45(0x1e9)](_0x21e435[_0x291d45(0x143)](_0x574977,0x3c)),_0x3f2d47=_0x21e435[_0x291d45(0x172)](_0x574977,0x3c);_0x4e1952[_0x291d45(0x266)](_0x21e435['hMPZt'])['textContent']=_0x21e435[_0x291d45(0x19d)](_0x3556f7,':')+_0x3f2d47[_0x291d45(0x44f)]()[_0x291d45(0x269)](0x2,'0');}}});else{const _0x43df1d=_0x21e435[_0x5b0e6d(0x2ef)](_0x176c80['selectedAnswer'],_0x5d2f53),_0x382120=_0x201558['id']===_0x27e6f4;let _0x1ea36c=_0x21e435[_0x5b0e6d(0x37b)];if(_0x382120)_0x1ea36c=_0x21e435[_0x5b0e6d(0x1bd)];else{if(_0x43df1d)_0x1ea36c='border-red-500';}return _0x5b0e6d(0x1c6)+_0x1ea36c+_0x5b0e6d(0x1fa)+_0x439e57[_0x5b0e6d(0x179)](_0x21e435[_0x5b0e6d(0x19d)](0x41,_0x4195cf))+'</span><span>'+_0x5e6ec7['text']+_0x5b0e6d(0x458);}}document[_0x5b0e6d(0x266)](_0x5b0e6d(0x3cd))[_0x5b0e6d(0x408)]=_0x27a75b;const _0x4b826d=document[_0x5b0e6d(0x266)](_0x5b0e6d(0x15c));_0x4b826d[_0x5b0e6d(0x408)]='',_0x4b826d[_0x5b0e6d(0x217)][_0x5b0e6d(0x3e8)](_0x21e435[_0x5b0e6d(0x22c)]),_0x554b1a['choices']&&Array[_0x5b0e6d(0x32b)](_0x554b1a[_0x5b0e6d(0x20a)])&&(_0x554b1a['choices']['forEach']((_0x5c494c,_0xbe0224)=>{const _0x5080fa=_0x5b0e6d,_0x14ec6d=String['fromCharCode'](0x41+_0xbe0224),_0x21fd5f=_0x21e435[_0x5080fa(0x3a0)](selectedOption,_0xbe0224),_0x38f52d=document[_0x5080fa(0x42c)](_0x21e435[_0x5080fa(0x404)]);_0x38f52d[_0x5080fa(0x408)]=_0x5080fa(0x132)+(_0x21fd5f?_0x21e435[_0x5080fa(0x3ff)]:'')+_0x5080fa(0x2bf)+_0xbe0224+_0x5080fa(0x349)+_0x14ec6d+'</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22option-text\x22>'+(_0x5c494c['text']||_0x21e435[_0x5080fa(0x1ec)](_0x21e435[_0x5080fa(0x2d5)],_0x21e435['Kjmoc'](_0xbe0224,0x1)))+_0x5080fa(0x42e),_0x4b826d[_0x5080fa(0x2ac)](_0x38f52d);}),_0x4b826d[_0x5b0e6d(0x3c8)](_0x21e435['MVEco'],function(_0x23eaac){const _0x5309aa=_0x5b0e6d;if(_0x21e435[_0x5309aa(0x2dd)](_0x21e435[_0x5309aa(0x342)],_0x21e435[_0x5309aa(0x342)]))_0x21e435['QogJW'](_0x24d7bb[_0x5309aa(0x20a)][_0x38cdfa[_0x5309aa(0x400)]]['id'],_0x537b63['correct_choice_id'])?(_0x4ebdcc++,_0x2a62dc[_0x5309aa(0x255)]=_0x21e435['Rgbwe']):(_0x56841e++,_0x5af721[_0x5309aa(0x255)]=_0x21e435[_0x5309aa(0x29c)]);else{const _0x39b33f=_0x23eaac[_0x5309aa(0x181)][_0x5309aa(0x23c)](_0x21e435[_0x5309aa(0x3d6)]);if(_0x39b33f){const _0x3d90df=parseInt(_0x39b33f['getAttribute'](_0x21e435[_0x5309aa(0x31b)]));_0x21e435['wBUln'](selectOption,_0x3d90df);}}})),_0x21e435['meNXA'](updateBookmarkButton),updateMarkReviewButton(),(_0x21e435[_0x5b0e6d(0x312)](currentMode,_0x21e435[_0x5b0e6d(0x250)])||currentMode===_0x21e435[_0x5b0e6d(0x224)])&&!isQuizCompleted&&startTimer();}function selectOption(_0x1354ff){const _0x8239d7=_0x4ea08a,_0x3f4794={'EjMjF':function(_0x4a9ff6,_0x579016){return _0x4a9ff6===_0x579016;},'xYWlb':_0x8239d7(0x3f3),'sXmgd':_0x8239d7(0x3aa),'MmnAI':_0x8239d7(0x3e6),'nWXgJ':_0x8239d7(0x18f),'Ahdpa':_0x8239d7(0x407),'koOYz':_0x8239d7(0x20c),'QOyJq':_0x8239d7(0x418),'XrYsd':function(_0x12ff01){return _0x12ff01();},'LROGi':'optionsContainer','yKsrC':_0x8239d7(0x42d),'FRCLn':function(_0x407aa3,_0x176b41){return _0x407aa3!==_0x176b41;},'ltWYc':function(_0x2be822,_0x18f039){return _0x2be822-_0x18f039;},'njiRE':_0x8239d7(0x14d),'wiyrw':_0x8239d7(0x401),'pwEto':function(_0x334fc7,_0x4324bd){return _0x334fc7===_0x4324bd;},'kyaIO':_0x8239d7(0x27f),'thhGm':function(_0x123597,_0x5bbd4d){return _0x123597!==_0x5bbd4d;},'CvPpU':'lWeAq','bpsEN':_0x8239d7(0x2db),'NntYI':_0x8239d7(0x3f0),'FhDdN':_0x8239d7(0x23f),'ZlAOF':function(_0x1c0af3){return _0x1c0af3();}},_0x2e3d72=document['getElementById'](_0x3f4794[_0x8239d7(0x26d)]);if(_0x2e3d72['classList'][_0x8239d7(0x24f)](_0x3f4794[_0x8239d7(0x220)]))return;questionStartTime&&(_0x3f4794[_0x8239d7(0x19e)](_0x8239d7(0x43e),_0x8239d7(0x43e))?(_0x5861e0++,_0x42c363(),_0x1dab4f()):(questionStates[currentQuestionIndex][_0x8239d7(0x284)]+=_0x3f4794[_0x8239d7(0x336)](Date[_0x8239d7(0x1b6)](),questionStartTime),questionStartTime=Date['now']()));selectedOption=_0x1354ff,questionStates[currentQuestionIndex][_0x8239d7(0x400)]=_0x1354ff,document[_0x8239d7(0x3dd)](_0x3f4794[_0x8239d7(0x1bf)])[_0x8239d7(0x370)]((_0x30d41d,_0x46b154)=>{const _0x58b788=_0x8239d7,_0x5cfbd1={'hmUrw':function(_0x43bc0e,_0x136f63){return _0x43bc0e(_0x136f63);},'petvn':function(_0x2651ce){return _0x2651ce();}};_0x3f4794['EjMjF'](_0x3f4794[_0x58b788(0x253)],_0x3f4794['sXmgd'])?_0x5cfbd1[_0x58b788(0x280)](_0x2444c4,_0x58b788(0x124))&&_0x5cfbd1[_0x58b788(0x3af)](_0x3836cc):_0x30d41d['classList']['toggle'](_0x58b788(0x2da),_0x46b154===_0x1354ff);});if(currentMode===_0x3f4794['wiyrw']||_0x3f4794[_0x8239d7(0x31d)](currentMode,_0x3f4794['kyaIO'])){if(_0x3f4794[_0x8239d7(0x391)](_0x3f4794[_0x8239d7(0x334)],_0x3f4794[_0x8239d7(0x2e4)]))_0x3f4794[_0x8239d7(0x2f5)](processAnswer);else{const _0x401508=_0x4aa2a7['getElementById'](_0x3f4794[_0x8239d7(0x19a)]),_0x288042=_0x12f0da['getElementById'](_0x3f4794[_0x8239d7(0x2ec)]),_0x19ab9a=_0x488bd3[_0x514080][_0x8239d7(0x214)];_0x401508[_0x8239d7(0x117)]=_0x19ab9a?_0x8239d7(0x197):_0x3f4794[_0x8239d7(0x395)],_0x288042['textContent']=_0x19ab9a?_0x3f4794[_0x8239d7(0x3b1)]:_0x3f4794[_0x8239d7(0x2e0)];}}else _0x3f4794[_0x8239d7(0x15e)](questionStates[currentQuestionIndex][_0x8239d7(0x255)],_0x3f4794[_0x8239d7(0x2d2)])&&(_0x3f4794[_0x8239d7(0x346)]!==_0x8239d7(0x39a)?(questionStates[currentQuestionIndex][_0x8239d7(0x255)]=_0x3f4794[_0x8239d7(0x220)],stats['totalAttempted']++,stats['notAttempted']--):(_0x47636e&&(_0x225568[_0xfb928e][_0x8239d7(0x284)]+=_0x435c40[_0x8239d7(0x1b6)]()-_0x516747),_0x3e1af6=_0x427fbb,_0x36526c(),_0x3f4794['XrYsd'](_0x360fbd))),_0x3f4794[_0x8239d7(0x2f5)](updateQuestionNav);_0x3f4794['ZlAOF'](saveProgress);}function processAnswer(){const _0x407e0a=_0x4ea08a,_0x1364d4={'dsRbW':_0x407e0a(0x1cb),'MaqzP':function(_0x3ac152,_0x232c96){return _0x3ac152===_0x232c96;},'xJmLO':_0x407e0a(0x3f0),'iRKhg':'SiVgA','kCPlU':_0x407e0a(0x2c5),'OuiVn':_0x407e0a(0x16c),'MAeyR':'incorrect','pCsmt':function(_0x242dad){return _0x242dad();},'WeZRJ':function(_0x17012d,_0xba970c){return _0x17012d(_0xba970c);}},_0x308017=questionsData[currentQuestionIndex],_0x18be04=_0x308017['correct_choice_id'];if(_0x1364d4[_0x407e0a(0x2cd)](selectedOption,null))return;const _0x58a7a6=_0x308017[_0x407e0a(0x20a)][selectedOption],_0x5d8ce2=_0x58a7a6['id']===_0x18be04;if(_0x1364d4[_0x407e0a(0x2cd)](questionStates[currentQuestionIndex][_0x407e0a(0x255)],_0x1364d4['xJmLO'])){if(_0x1364d4[_0x407e0a(0x343)]!==_0x1364d4[_0x407e0a(0x457)]){stats[_0x407e0a(0x467)]++,stats[_0x407e0a(0x141)]--;if(_0x5d8ce2)stats[_0x407e0a(0x18a)]++;else stats[_0x407e0a(0x287)]++;}else{_0x3983c5[_0x407e0a(0x266)]('questionText')[_0x407e0a(0x408)]=_0x1364d4[_0x407e0a(0x3ee)];return;}}questionStates[currentQuestionIndex][_0x407e0a(0x255)]=_0x5d8ce2?_0x1364d4[_0x407e0a(0x1ad)]:_0x1364d4[_0x407e0a(0x3ab)],_0x1364d4[_0x407e0a(0x397)](updateStats),_0x1364d4[_0x407e0a(0x446)](showInlineFeedback,_0x5d8ce2),updateQuestionNav();}function showInlineFeedback(_0x453b6f){const _0x857537=_0x4ea08a,_0x3d6409={'jVoSk':function(_0x2c2985,_0x22f40f){return _0x2c2985===_0x22f40f;},'VgqJQ':_0x857537(0x178),'DzLdy':_0x857537(0x2da),'arwHf':function(_0x3a2aa,_0x6efa91){return _0x3a2aa===_0x6efa91;},'BIjXP':_0x857537(0x16c),'IIAiB':function(_0xadb51d,_0xfda46f){return _0xadb51d!==_0xfda46f;},'TNTFG':_0x857537(0x15c),'SLcsK':_0x857537(0x14d),'isqms':'answered','uRkiZ':function(_0x4f68c4){return _0x4f68c4();}};if(_0x3d6409[_0x857537(0x1b4)](currentMode,_0x857537(0x401))&&_0x3d6409['IIAiB'](currentMode,'timed_study'))return;const _0x5cdb23=document[_0x857537(0x266)](_0x3d6409[_0x857537(0x443)]),_0x3b4200=_0x5cdb23[_0x857537(0x3dd)](_0x3d6409[_0x857537(0x3b3)]),_0xe1a8e1=questionsData[currentQuestionIndex],_0x25d7d0=_0xe1a8e1['correct_choice_id'];let _0x8212d8=_0xe1a8e1[_0x857537(0x20a)][_0x857537(0x128)](_0x439110=>_0x439110['id']===_0x25d7d0);_0x5cdb23[_0x857537(0x217)]['add'](_0x3d6409[_0x857537(0x293)]),_0x3b4200[_0x857537(0x370)]((_0x5f04f6,_0x43fb4a)=>{const _0x56e0e5=_0x857537;if(_0x3d6409[_0x56e0e5(0x3df)](_0x3d6409[_0x56e0e5(0x13b)],_0x56e0e5(0x178))){_0x5f04f6[_0x56e0e5(0x217)][_0x56e0e5(0x3e8)](_0x3d6409[_0x56e0e5(0x44a)]);if(_0x3d6409[_0x56e0e5(0x22f)](_0x43fb4a,_0x8212d8))_0x5f04f6[_0x56e0e5(0x217)]['add'](_0x3d6409[_0x56e0e5(0x34b)]);else{if(_0x3d6409[_0x56e0e5(0x22f)](_0x43fb4a,selectedOption)&&!_0x453b6f)_0x5f04f6[_0x56e0e5(0x217)]['add']('incorrect');}}else{const _0x2bd1ef=_0x26f460['apply'](_0x5b358c,arguments);return _0x3a908a=null,_0x2bd1ef;}}),_0x3d6409[_0x857537(0x43a)](showSolution);}function showSolution(){const _0x4f0ce2=_0x4ea08a,_0x38aeb0={'hqlAO':_0x4f0ce2(0x2da),'RtdJS':function(_0x2fef18,_0xab4f8d){return _0x2fef18===_0xab4f8d;},'elgAm':function(_0x5d6fca,_0x1c0dde){return _0x5d6fca!==_0x1c0dde;},'hajCa':_0x4f0ce2(0x402),'pVFfu':_0x4f0ce2(0x133),'TgeoZ':function(_0x544ce0,_0x156e1d){return _0x544ce0!==_0x156e1d;},'uaPwa':'study','yEHYa':_0x4f0ce2(0x27f),'lRAAB':_0x4f0ce2(0x27e),'scWre':_0x4f0ce2(0x31f),'ANVgF':_0x4f0ce2(0x2b3),'BhKhB':_0x4f0ce2(0x415),'krqBd':function(_0x503a5d,_0x4cb0d3,_0x30e53a){return _0x503a5d(_0x4cb0d3,_0x30e53a);},'bOBSA':_0x4f0ce2(0x254),'msbFT':'enrsj','iYfUp':'solutionAudio','DCZTZ':_0x4f0ce2(0x1ab),'Obwzu':_0x4f0ce2(0x453)};if(_0x38aeb0[_0x4f0ce2(0x431)](currentMode,_0x38aeb0[_0x4f0ce2(0x40b)])&&_0x38aeb0[_0x4f0ce2(0x431)](currentMode,_0x38aeb0[_0x4f0ce2(0x2d1)]))return;const _0x4c5555=questionsData[currentQuestionIndex];document[_0x4f0ce2(0x266)](_0x38aeb0[_0x4f0ce2(0x200)])[_0x4f0ce2(0x408)]=_0x4c5555[_0x4f0ce2(0x32f)]||_0x38aeb0[_0x4f0ce2(0x45b)];const _0x28469=document['getElementById'](_0x4f0ce2(0x2c6)),_0x9b5f28=document[_0x4f0ce2(0x266)](_0x4f0ce2(0x23b)),_0x1c98da=_0x4c5555[_0x4f0ce2(0x139)];if(_0x1c98da){_0x28469[_0x4f0ce2(0x217)][_0x4f0ce2(0x3e8)](_0x38aeb0[_0x4f0ce2(0x2af)]);if(_0x1c98da[_0x4f0ce2(0x2cf)](_0x38aeb0['BhKhB']))_0x38aeb0['krqBd'](setupVideo,_0x9b5f28,_0x1c98da);else _0x9b5f28[_0x4f0ce2(0x2b8)]=_0x1c98da;}else _0x38aeb0[_0x4f0ce2(0x437)](_0x38aeb0['bOBSA'],_0x38aeb0[_0x4f0ce2(0x2d9)])?_0x370b04[_0x4f0ce2(0x217)][_0x4f0ce2(0x14e)](_0x38aeb0['hqlAO'],_0x38aeb0[_0x4f0ce2(0x437)](_0x4c71ee,_0xa8098f)):_0x28469[_0x4f0ce2(0x217)][_0x4f0ce2(0x206)](_0x38aeb0[_0x4f0ce2(0x2af)]);const _0x277b24=document['getElementById'](_0x38aeb0['iYfUp']);_0x277b24[_0x4f0ce2(0x408)]='';_0x4c5555[_0x4f0ce2(0x302)]&&(_0x277b24[_0x4f0ce2(0x408)]+=_0x4f0ce2(0x26f)+_0x4c5555[_0x4f0ce2(0x302)]+_0x4f0ce2(0x1e8));_0x4c5555[_0x4f0ce2(0x3b7)]&&(_0x277b24[_0x4f0ce2(0x408)]+=_0x4f0ce2(0x371)+_0x4c5555[_0x4f0ce2(0x3b7)]+'\x22\x20controls\x20class=\x22w-full\x22></audio></div>');const _0x25864b=document['getElementById'](_0x38aeb0['DCZTZ']);_0x25864b[_0x4f0ce2(0x408)]='',_0x4c5555[_0x4f0ce2(0x351)]&&_0x4c5555['explanation_images'][_0x4f0ce2(0x370)](_0x1579f6=>{const _0x518d20=_0x4f0ce2;if(_0x38aeb0[_0x518d20(0x247)](_0x38aeb0[_0x518d20(0x189)],_0x38aeb0[_0x518d20(0x21a)])){if(_0x1579f6)_0x25864b[_0x518d20(0x408)]+=_0x518d20(0x1f9)+_0x1579f6+_0x518d20(0x43b);}else{if(_0x3ea957){const _0x493269=_0x3dc108[_0x518d20(0x256)](_0x43e133,arguments);return _0xc6064a=null,_0x493269;}}}),document[_0x4f0ce2(0x266)](_0x38aeb0[_0x4f0ce2(0x299)])[_0x4f0ce2(0x217)]['remove'](_0x4f0ce2(0x2b3));}function submitQuiz(){const _0x15c04e=_0x4ea08a,_0x49842f={'MYISi':function(_0x1b9bf4){return _0x1b9bf4();},'EbSSH':function(_0x5c647c,_0x306989){return _0x5c647c===_0x306989;},'ywURg':_0x15c04e(0x2ca),'LApFx':_0x15c04e(0x193),'IrHyP':_0x15c04e(0x323),'CZWKQ':_0x15c04e(0x465),'tQYKm':function(_0x156846,_0x28910b){return _0x156846(_0x28910b);},'UQqYn':function(_0x188a2f,_0xfe77f3){return _0x188a2f(_0xfe77f3);},'EDVdQ':_0x15c04e(0x1a3),'HHPYY':function(_0x2d7dda,_0x4aebcf){return _0x2d7dda-_0x4aebcf;},'rapAC':_0x15c04e(0x2ab),'tsEWy':function(_0xd065ab,_0x4e9bc8){return _0xd065ab-_0x4e9bc8;},'QoatZ':function(_0x291c5b,_0x19d110){return _0x291c5b+_0x19d110;},'xCtwr':function(_0x1d6049,_0x551a61,_0x4dcddb,_0x530c7e,_0x794134){return _0x1d6049(_0x551a61,_0x4dcddb,_0x530c7e,_0x794134);},'XvtfK':function(_0x2bdcf6,_0x3ed1f3){return _0x2bdcf6-_0x3ed1f3;},'Bxwhl':function(_0x535083,_0x825b59){return _0x535083+_0x825b59;}};if(timer)_0x49842f[_0x15c04e(0x261)](clearInterval,timer);if(!_0x49842f[_0x15c04e(0x120)](confirm,_0x49842f[_0x15c04e(0x241)]))return;isQuizCompleted=!![];let _0x546039=0x0,_0x42267b=0x0;const _0x22da67=_0x49842f[_0x15c04e(0x2c1)](Date[_0x15c04e(0x1b6)](),quizStartTime);questionsData['forEach']((_0xebafb2,_0x87cd3c)=>{const _0x4114c6=_0x15c04e,_0x455f3b=questionStates[_0x87cd3c];if(_0x455f3b[_0x4114c6(0x400)]!==null){if(_0x49842f[_0x4114c6(0x202)](_0x49842f[_0x4114c6(0x191)],_0x49842f[_0x4114c6(0x170)]))_0x49842f[_0x4114c6(0x1ef)](_0x133fc0);else{if(_0x49842f[_0x4114c6(0x202)](_0xebafb2[_0x4114c6(0x20a)][_0x455f3b[_0x4114c6(0x400)]]['id'],_0xebafb2[_0x4114c6(0x35b)])){if(_0x49842f[_0x4114c6(0x3cb)]===_0x49842f[_0x4114c6(0x3cb)])_0x546039++,_0x455f3b[_0x4114c6(0x255)]=_0x4114c6(0x16c);else{_0x462af8[_0x4114c6(0x467)]++,_0x1604e8[_0x4114c6(0x141)]--;if(_0x433de4)_0x44b4eb[_0x4114c6(0x18a)]++;else _0x4a9b09[_0x4114c6(0x287)]++;}}else _0x42267b++,_0x455f3b[_0x4114c6(0x255)]=_0x49842f[_0x4114c6(0x303)];}}});const _0x3ca149=JSON['parse'](localStorage[_0x15c04e(0x1f6)](_0x49842f['rapAC']))||[];_0x3ca149[_0x15c04e(0x339)]({'quizName':quizName,'hierarchy':hierarchy,'timestamp':Date[_0x15c04e(0x1b6)](),'totalTime':_0x22da67,'stats':{'correct':_0x546039,'incorrect':_0x42267b,'notAttempted':_0x49842f[_0x15c04e(0x248)](questionsData[_0x15c04e(0x3b4)],_0x49842f[_0x15c04e(0x21c)](_0x546039,_0x42267b))}}),localStorage['setItem'](_0x15c04e(0x2ab),JSON[_0x15c04e(0x423)](_0x3ca149)),stats[_0x15c04e(0x18a)]=_0x546039,stats[_0x15c04e(0x287)]=_0x42267b,_0x49842f[_0x15c04e(0x1ef)](markQuizAsCompleted),_0x49842f['xCtwr'](showPerformanceAnalysis,_0x546039,_0x42267b,_0x49842f['XvtfK'](questionsData['length'],_0x49842f[_0x15c04e(0x2b6)](_0x546039,_0x42267b)),_0x22da67);}function showPerformanceAnalysis(_0x4e1a33,_0xb2813a,_0x39fb30,_0x3816e0){const _0x1c5606=_0x4ea08a,_0xa9ea5b={'yZZvj':'performanceModal','iFLEj':function(_0x409fb5,_0x3c4eea){return _0x409fb5>_0x3c4eea;},'FvYbC':function(_0x559b7b,_0x47cb59){return _0x559b7b*_0x47cb59;},'KqfuG':function(_0x2754b9,_0x52d0f1){return _0x2754b9/_0x52d0f1;},'KsduP':function(_0x5b0ab1,_0x2a1663){return _0x5b0ab1+_0x2a1663;},'vtnMC':function(_0x39b164,_0x4e8ae6){return _0x39b164*_0x4e8ae6;},'zkRMy':_0x1c5606(0x35c),'iABOi':function(_0x540e56,_0x445222){return _0x540e56-_0x445222;},'UsrNF':function(_0x34050f,_0x4c41df){return _0x34050f/_0x4c41df;},'DvWri':_0x1c5606(0x12d),'BzSXx':_0x1c5606(0x2f7),'SaCow':_0x1c5606(0x3fd),'VQkCL':function(_0x1bc304,_0x2e1a9f){return _0x1bc304%_0x2e1a9f;},'tyqul':function(_0x3f9701,_0x4ead13){return _0x3f9701/_0x4ead13;},'wxDFM':'avgTimeResult','OAiYu':_0x1c5606(0x2b3)},_0x4992a9=document['getElementById'](_0xa9ea5b[_0x1c5606(0x2ed)]),_0x448e4e=_0xa9ea5b[_0x1c5606(0x289)](_0x4e1a33+_0xb2813a,0x0)?Math[_0x1c5606(0x340)](_0xa9ea5b[_0x1c5606(0x228)](_0xa9ea5b[_0x1c5606(0x29b)](_0x4e1a33,_0xa9ea5b['KsduP'](_0x4e1a33,_0xb2813a)),0x64)):0x0,_0x3ec9b7=_0xa9ea5b[_0x1c5606(0x228)](_0xa9ea5b[_0x1c5606(0x145)](0x2,Math['PI']),0x41),_0x237cb0=document[_0x1c5606(0x266)](_0xa9ea5b['zkRMy']);_0x237cb0['style']['strokeDasharray']=_0x3ec9b7+'\x20'+_0x3ec9b7,_0x237cb0[_0x1c5606(0x157)][_0x1c5606(0x341)]=_0xa9ea5b[_0x1c5606(0x3f8)](_0x3ec9b7,_0xa9ea5b[_0x1c5606(0x393)](_0x448e4e,0x64)*_0x3ec9b7),document[_0x1c5606(0x266)]('accuracyScore')[_0x1c5606(0x38e)]=_0x448e4e+'%',document[_0x1c5606(0x266)]('totalQuestionsResult')[_0x1c5606(0x38e)]=questionsData[_0x1c5606(0x3b4)],document[_0x1c5606(0x266)](_0xa9ea5b['DvWri'])[_0x1c5606(0x38e)]=_0x4e1a33,document[_0x1c5606(0x266)](_0xa9ea5b[_0x1c5606(0x131)])[_0x1c5606(0x38e)]=_0xb2813a,document[_0x1c5606(0x266)](_0xa9ea5b[_0x1c5606(0x177)])[_0x1c5606(0x38e)]=_0x39fb30;const _0x5064de=Math[_0x1c5606(0x1e9)](_0xa9ea5b[_0x1c5606(0x29b)](_0x3816e0,0xea60)),_0x26b0d9=Math['floor'](_0xa9ea5b[_0x1c5606(0x393)](_0xa9ea5b[_0x1c5606(0x1db)](_0x3816e0,0xea60),0x3e8));document[_0x1c5606(0x266)](_0x1c5606(0x277))[_0x1c5606(0x38e)]=_0x5064de+':'+_0x26b0d9['toString']()[_0x1c5606(0x269)](0x2,'0');const _0x577974=_0x3816e0/questionsData[_0x1c5606(0x3b4)],_0x3ce67e=Math[_0x1c5606(0x1e9)](_0xa9ea5b[_0x1c5606(0x31e)](_0x577974,0xea60)),_0x328967=Math['floor'](_0xa9ea5b[_0x1c5606(0x31e)](_0xa9ea5b[_0x1c5606(0x1db)](_0x577974,0xea60),0x3e8));document['getElementById'](_0xa9ea5b[_0x1c5606(0x338)])['textContent']=_0x3ce67e+':'+_0x328967['toString']()['padStart'](0x2,'0'),_0x4992a9[_0x1c5606(0x217)][_0x1c5606(0x3e8)](_0xa9ea5b['OAiYu']);}function closePerformanceModal(){const _0x578b4c=_0x4ea08a,_0x19f8a7={'xRuwB':_0x578b4c(0x358),'cMxWb':'hidden'};document[_0x578b4c(0x266)](_0x19f8a7[_0x578b4c(0x26e)])['classList'][_0x578b4c(0x206)](_0x19f8a7[_0x578b4c(0x30a)]);}function reviewQuestions(){const _0x10e4e7=_0x4ea08a,_0x34b556={'wKEeD':function(_0x1ab757,_0x1bfbac){return _0x1ab757===_0x1bfbac;},'Qslxh':_0x10e4e7(0x17c),'FilQs':'lsgOf','BcnMJ':function(_0x4fbba9,_0x43c456){return _0x4fbba9===_0x43c456;},'Eqpko':function(_0x5c623c,_0x4f92a2){return _0x5c623c===_0x4f92a2;},'RpSkl':_0x10e4e7(0x372),'AXRGk':_0x10e4e7(0x1fe),'QAbES':_0x10e4e7(0x13d),'dEoYu':function(_0x45ec6d,_0x54aa18){return _0x45ec6d+_0x54aa18;},'SkAzN':_0x10e4e7(0x42d),'WJtTo':function(_0x385b51){return _0x385b51();},'ggeCr':function(_0x11a85c,_0x3ea3c4){return _0x11a85c!==_0x3ea3c4;},'DuYdZ':_0x10e4e7(0x44b),'cdrDl':_0x10e4e7(0x300),'phhbi':function(_0x34d68c,_0x397ca2){return _0x34d68c===_0x397ca2;},'xSGSW':_0x10e4e7(0x16c),'qRCoH':_0x10e4e7(0x435),'JmZHI':_0x10e4e7(0x219),'IRlqN':_0x10e4e7(0x237),'frLyW':_0x10e4e7(0x40e),'BzNra':_0x10e4e7(0x1aa),'RktXv':_0x10e4e7(0x2b3),'eTTFB':function(_0x23c03d){return _0x23c03d();}};document[_0x10e4e7(0x266)](_0x34b556[_0x10e4e7(0x19c)])[_0x10e4e7(0x217)][_0x10e4e7(0x3e8)](_0x34b556[_0x10e4e7(0x377)]);const _0x491072=document[_0x10e4e7(0x266)](_0x10e4e7(0x147));_0x491072[_0x10e4e7(0x408)]='',questionsData[_0x10e4e7(0x370)]((_0x2cbd49,_0x4a7759)=>{const _0x24752b=_0x10e4e7,_0x2e4c17={'QuxSj':_0x34b556['SkAzN'],'wUlQz':function(_0x143ffd){const _0x4086b1=_0x161a;return _0x34b556[_0x4086b1(0x1d8)](_0x143ffd);}};if(_0x34b556[_0x24752b(0x1f3)]('FpyhU',_0x34b556[_0x24752b(0x26c)])){const _0x1dacc5=questionStates[_0x4a7759],_0x4f29c8=_0x2cbd49['correct_choice_id'];let _0x2299d4='not-attempted',_0x4fa0dd=_0x34b556[_0x24752b(0x41a)];if(_0x1dacc5['selectedAnswer']!==null){const _0x4c3712=_0x2cbd49[_0x24752b(0x20a)][_0x1dacc5[_0x24752b(0x400)]];_0x34b556['phhbi'](_0x4c3712['id'],_0x4f29c8)?(_0x2299d4=_0x34b556[_0x24752b(0x243)],_0x4fa0dd=_0x34b556['qRCoH']):(_0x2299d4=_0x24752b(0x465),_0x4fa0dd=_0x34b556[_0x24752b(0x235)]);}const _0x183d65=document[_0x24752b(0x42c)]('div');_0x183d65[_0x24752b(0x117)]='review-question\x20'+_0x2299d4;let _0x1c7dd3=(_0x2cbd49[_0x24752b(0x20a)]||[])[_0x24752b(0x3a7)]((_0x5811ba,_0x5cfb09)=>{const _0x4514ae=_0x24752b;if(_0x34b556[_0x4514ae(0x3ce)](_0x34b556[_0x4514ae(0x3e5)],_0x34b556['FilQs']))_0x3fd7f8=_0x241266[_0x4514ae(0x3c9)](_0x1357f2=>!(_0x1357f2['quizFile'][_0x4514ae(0x2cf)](_0x4c3088[_0x4514ae(0x2aa)]()[_0x4514ae(0x310)](/ /g,'-'))&&_0x1357f2['questionIndex']===_0x5ef551));else{const _0x3889d1=_0x34b556['BcnMJ'](_0x1dacc5['selectedAnswer'],_0x5cfb09),_0x60a1f3=_0x34b556[_0x4514ae(0x17e)](_0x5811ba['id'],_0x4f29c8);let _0x17e209=_0x34b556['RpSkl'];if(_0x60a1f3)_0x17e209=_0x34b556[_0x4514ae(0x1b8)];else{if(_0x3889d1)_0x17e209=_0x34b556[_0x4514ae(0x375)];}return _0x4514ae(0x1c6)+_0x17e209+_0x4514ae(0x1fa)+String[_0x4514ae(0x179)](_0x34b556[_0x4514ae(0x118)](0x41,_0x5cfb09))+_0x4514ae(0x1ca)+_0x5811ba['text']+'</span></div>';}})[_0x24752b(0x1b3)]('');const _0x33ecde=_0x2cbd49[_0x24752b(0x139)]?_0x24752b(0x1c3)+_0x4a7759+'\x22\x20data-src=\x22'+_0x2cbd49[_0x24752b(0x139)]+'\x22\x20class=\x22w-full\x20rounded-lg\x22\x20controls></video></div>':'';let _0x505bd2='';if(_0x2cbd49['explanation_audio_eng'])_0x505bd2+=_0x24752b(0x34c)+_0x2cbd49[_0x24752b(0x302)]+_0x24752b(0x1e8);if(_0x2cbd49[_0x24752b(0x3b7)])_0x505bd2+=_0x24752b(0x3c1)+_0x2cbd49['explanation_audio_hin']+_0x24752b(0x1e8);let _0xe0b971=(_0x2cbd49[_0x24752b(0x351)]||[])['map'](_0x16276c=>_0x16276c?_0x24752b(0x1f9)+_0x16276c+'\x22\x20alt=\x22Explanation\x20Image\x22\x20class=\x22w-full\x20rounded-lg\x22></div>':'')['join']('');_0x183d65[_0x24752b(0x408)]=_0x24752b(0x2d0)+_0x34b556[_0x24752b(0x118)](_0x4a7759,0x1)+_0x24752b(0x335)+(_0x34b556[_0x24752b(0x1fc)](_0x2299d4,'correct')?_0x24752b(0x307):_0x2299d4==='incorrect'?_0x34b556['IRlqN']:'gray')+'-600\x20text-white\x22>'+_0x4fa0dd+_0x24752b(0x286)+_0x2cbd49['text']+_0x24752b(0x33e)+_0x1c7dd3+'</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22bg-green-900\x20bg-opacity-20\x20p-4\x20rounded-lg\x20border\x20border-green-700\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<h5\x20class=\x22text-green-400\x20font-bold\x20mb-2\x22>Explanation:</h5>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22text-white\x20text-opacity-90\x22>'+(_0x2cbd49[_0x24752b(0x32f)]||_0x34b556[_0x24752b(0x273)])+_0x24752b(0x38c)+_0x33ecde+'\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20'+_0x505bd2+_0x24752b(0x1b1)+_0xe0b971+_0x24752b(0x360),_0x491072['appendChild'](_0x183d65);}else _0x260310[_0x26dbb8]['status']===_0x24752b(0x3f0)&&(_0x5bf1ea[_0x1b3c98][_0x24752b(0x255)]=_0x2e4c17[_0x24752b(0x357)],_0x2b8035['totalAttempted']++,_0x241ef2[_0x24752b(0x141)]--),_0x2e4c17[_0x24752b(0x2f1)](_0x462d25);}),_0x34b556['eTTFB'](initializeReviewVideos);}function initializeReviewVideos(){const _0x1e1cfe=_0x4ea08a,_0x3d07d4={'RRGRU':_0x1e1cfe(0x465),'czYrG':function(_0x351069,_0x14e2da){return _0x351069!==_0x14e2da;},'GPxzd':'dHjET','XongU':function(_0x5b9459,_0x14cb96){return _0x5b9459!==_0x14cb96;},'DgYoY':_0x1e1cfe(0x130),'uOOLX':function(_0x190036,_0xb803eb,_0x2202e1){return _0x190036(_0xb803eb,_0x2202e1);},'WpVvL':_0x1e1cfe(0x283)};document[_0x1e1cfe(0x3dd)](_0x3d07d4[_0x1e1cfe(0x2a9)])[_0x1e1cfe(0x370)](_0x3aaa3b=>{const _0x4690e5=_0x1e1cfe,_0x21b99f={'FqtFL':_0x3d07d4[_0x4690e5(0x12f)]};if(_0x3d07d4[_0x4690e5(0x1b9)](_0x3d07d4[_0x4690e5(0x32c)],_0x4690e5(0x445))){const _0x587afd=_0x3aaa3b[_0x4690e5(0x1c4)]['src'];if(_0x587afd&&_0x587afd[_0x4690e5(0x2cf)]('.m3u8'))_0x3d07d4['XongU']('EwVmB',_0x3d07d4['DgYoY'])?(_0x296975++,_0x40cf66[_0x4690e5(0x255)]=_0x21b99f[_0x4690e5(0x3dc)]):_0x3d07d4[_0x4690e5(0x2ba)](setupVideo,_0x3aaa3b,_0x587afd);else _0x587afd&&(_0x3aaa3b[_0x4690e5(0x2b8)]=_0x587afd);}else _0x36c9db[_0x4690e5(0x2b8)]=_0x185ebe;});}function retakeQuiz(){const _0x2de0e7=_0x4ea08a,_0x236c91={'btFXn':'(((.+)+)+)+$','PBllD':function(_0x2ed3d7,_0x54ba74){return _0x2ed3d7(_0x54ba74);},'ukmFT':_0x2de0e7(0x160),'qDcjR':_0x2de0e7(0x36a),'jCEdU':function(_0x1e1abe,_0xacf1){return _0x1e1abe!==_0xacf1;},'iuVxU':_0x2de0e7(0x297),'fvyeV':'customQuizData','amcZU':function(_0xfc0379){return _0xfc0379();}};if(_0x236c91[_0x2de0e7(0x1d4)](confirm,_0x236c91[_0x2de0e7(0x2f8)])){if(window['location'][_0x2de0e7(0x442)]['endsWith'](_0x236c91[_0x2de0e7(0x1f2)])){if(_0x236c91[_0x2de0e7(0x39f)](_0x236c91[_0x2de0e7(0x1f8)],_0x236c91[_0x2de0e7(0x1f8)]))return _0x32c2d9[_0x2de0e7(0x44f)]()['search'](_0x2de0e7(0x1c1))[_0x2de0e7(0x44f)]()[_0x2de0e7(0x2cc)](_0x51b53d)[_0x2de0e7(0x308)](hJzTBq[_0x2de0e7(0x1d1)]);else localStorage[_0x2de0e7(0x3ad)](_0x236c91['fvyeV']);}_0x236c91['amcZU'](clearProgress),location[_0x2de0e7(0x30d)]();}}function loadBookmarkedQuestions(){const _0x556199=_0x4ea08a,_0x438e17={'VRBpw':function(_0x355519,_0x5ca652){return _0x355519<_0x5ca652;}},_0x5d4a43=JSON[_0x556199(0x444)](localStorage[_0x556199(0x1f6)](_0x556199(0x1ae)))||[];_0x5d4a43['forEach'](_0x2ed975=>{const _0x2d6fd7=_0x556199;_0x2ed975[_0x2d6fd7(0x3cc)][_0x2d6fd7(0x2cf)](quizName[_0x2d6fd7(0x2aa)]()[_0x2d6fd7(0x310)](/ /g,'-'))&&(_0x438e17[_0x2d6fd7(0x12c)](_0x2ed975['questionIndex'],questionsData[_0x2d6fd7(0x3b4)])&&(questionStates[_0x2ed975[_0x2d6fd7(0x3c7)]]['bookmarked']=!![]));});}function toggleBookmark(){const _0x1579c0=_0x4ea08a,_0xdd6a9b={'WDHCz':_0x1579c0(0x358),'BtZmJ':_0x1579c0(0x2b3),'Twxno':_0x1579c0(0x1ae),'zUgDq':function(_0x542f4e,_0x13147f){return _0x542f4e!==_0x13147f;},'NifEv':_0x1579c0(0x275),'nuymJ':function(_0x58550c){return _0x58550c();}},_0x387a72=!questionStates[currentQuestionIndex][_0x1579c0(0x1be)];questionStates[currentQuestionIndex][_0x1579c0(0x1be)]=_0x387a72;let _0x580572=JSON[_0x1579c0(0x444)](localStorage['getItem'](_0xdd6a9b[_0x1579c0(0x42f)]))||[];if(_0x387a72){const _0x1ef7b5={'quizName':quizName,'quizFile':window['location'][_0x1579c0(0x442)][_0x1579c0(0x25a)]('/')['pop'](),'questionIndex':currentQuestionIndex,'question':questionsData[currentQuestionIndex],'hierarchy':hierarchy,'timestamp':Date[_0x1579c0(0x1b6)]()};_0x580572[_0x1579c0(0x339)](_0x1ef7b5);}else _0xdd6a9b['zUgDq'](_0x1579c0(0x275),_0xdd6a9b[_0x1579c0(0x1e1)])?_0x2a69c3[_0x1579c0(0x266)](_0xdd6a9b[_0x1579c0(0x127)])['classList'][_0x1579c0(0x206)](_0xdd6a9b['BtZmJ']):_0x580572=_0x580572[_0x1579c0(0x3c9)](_0x4a4198=>!(_0x4a4198[_0x1579c0(0x3cc)][_0x1579c0(0x2cf)](quizName[_0x1579c0(0x2aa)]()[_0x1579c0(0x310)](/ /g,'-'))&&_0x4a4198['questionIndex']===currentQuestionIndex));localStorage[_0x1579c0(0x292)](_0xdd6a9b[_0x1579c0(0x42f)],JSON['stringify'](_0x580572)),_0xdd6a9b['nuymJ'](updateBookmarkButton),_0xdd6a9b[_0x1579c0(0x38b)](updateQuestionNav);}function updateBookmarkButton(){const _0x27b453=_0x4ea08a,_0x158076={'Cbbla':_0x27b453(0x45e),'DmldA':'bookmarkText','yIrHw':_0x27b453(0x3eb),'Gimfr':_0x27b453(0x14a),'IClqQ':'Bookmark'},_0x297c6a=document[_0x27b453(0x266)](_0x158076[_0x27b453(0x3cf)]),_0x5dc1b9=document[_0x27b453(0x266)](_0x158076[_0x27b453(0x134)]),_0x4c9b8b=questionStates[currentQuestionIndex][_0x27b453(0x1be)];_0x297c6a[_0x27b453(0x117)]=_0x4c9b8b?_0x158076[_0x27b453(0x1ac)]:_0x158076[_0x27b453(0x1e3)],_0x5dc1b9[_0x27b453(0x38e)]=_0x4c9b8b?_0x27b453(0x21d):_0x158076[_0x27b453(0x2fc)];}function toggleMarkForReview(){const _0x319723=_0x4ea08a,_0x429b97={'lBOTD':function(_0xf655e8){return _0xf655e8();},'Gxuye':function(_0x4d1ac2){return _0x4d1ac2();}};questionStates[currentQuestionIndex]['markedForReview']=!questionStates[currentQuestionIndex][_0x319723(0x214)],_0x429b97[_0x319723(0x1f7)](updateMarkReviewButton),_0x429b97['Gxuye'](updateQuestionNav);}function updateMarkReviewButton(){const _0x5062bb=_0x4ea08a,_0x1b9931={'TXYNZ':_0x5062bb(0x197),'Teatz':'glass-light\x20px-6\x20py-3\x20text-white\x20hover:bg-purple-500\x20hover:bg-opacity-20\x20transition-all\x20duration-300\x20flex\x20items-center','laNmo':'Marked','SlufZ':_0x5062bb(0x418)},_0x1a3c31=document[_0x5062bb(0x266)](_0x5062bb(0x3e6)),_0x31e02f=document[_0x5062bb(0x266)](_0x5062bb(0x18f)),_0x3e0697=questionStates[currentQuestionIndex][_0x5062bb(0x214)];_0x1a3c31[_0x5062bb(0x117)]=_0x3e0697?_0x1b9931['TXYNZ']:_0x1b9931[_0x5062bb(0x367)],_0x31e02f[_0x5062bb(0x38e)]=_0x3e0697?_0x1b9931[_0x5062bb(0x35f)]:_0x1b9931[_0x5062bb(0x264)];}function _0x213a(){const _0x3c2c69=['Temozolomide','HHPYY','w-8\x20h-8\x20text-sm\x20font-medium\x20rounded\x20transition-all\x20duration-200','Eptifibatide','prototype','uIWYZ','solutionVideo','zZfVu','oDfny','Phenelzine','lnFFv','eBlgD','constructor','MaqzP','dzPoQ','includes','\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22mb-4\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22flex\x20justify-between\x20items-center\x20mb-3\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<h4\x20class=\x22text-lg\x20font-bold\x20text-white\x22>Question\x20','yEHYa','NntYI','<p><strong>Co-trimoxazole</strong>\x20is\x20a\x20<strong>combination\x20of\x20trimethoprim</strong>\x20with\x20<strong>sulfamethoxazole\x20in\x20the\x20ratio\x20of\x201:5</strong>.\x20Sulfamethoxazole\x20is\x20an\x20intermediate-acting\x20sulfonamide\x20with\x20a\x20plasma\x20half-life\x20of\x20around\x2010\x20hours.&nbsp;Trimethoprim\x20also\x20has\x20a\x20similar\x20plasma\x20half-life\x20and\x20therefore\x20combined\x20with\x20sulfamethoxazole.</p>\x0a<p>Due\x20to\x20a\x20difference\x20in\x20pharmacokinetic\x20(absorption\x20in\x20GIT)\x20properties\x20of\x20the\x20two\x20drugs,\x20this\x20cannot\x20be\x20achieved\x20by\x20administering\x20them\x20at\x20a\x20dose\x20having\x20the\x20same\x20ratio.\x20Therefore,\x20it\x20is\x20administered\x20at\x20a\x20<strong>dose\x20ratio\x20of\x201:5</strong>&nbsp;(<strong>trimethoprim:\x20sulfamethoxazole</strong>)\x20which\x20leads\x20to\x20a\x20<strong>plasma&nbsp;ratio\x20of\x201:20</strong>.</p>','qvdAm','eoYkW','NrlDD','uQafh','<p><strong>Tenecteplase\x20</strong>is\x20used\x20for\x20fibrinolytic\x20therapy.\x20An<strong>\x20active\x20peptic\x20ulcer</strong>\x20is\x20a\x20<strong>relative\x20contraindication</strong>\x20to\x20fibrinolytic\x20therapy.\x20Other\x20options\x20are\x20absolute\x20contraindications.</p>\x0a<p>&nbsp;<strong>Absolute\x20Contraindications\x20</strong>to\x20fibrinolytic\x20therapy:</p>\x0a<ul>\x0a<li><strong>Known\x20malignant\x20intracranial\x20neoplasm</strong></li>\x0a<li>Prior\x20intracranial\x20hemorrhage</li>\x0a<li><strong>Ischemic\x20stroke</strong>\x20within\x20the\x20<strong>last\x203\x20months</strong></li>\x0a<li>Known\x20structural\x20cerebral\x20vascular\x20lesion</li>\x0a<li><strong>Suspicion</strong>\x20of\x20<strong>aortic\x20dissection</strong></li>\x0a<li>Active\x20bleeding\x20or\x20bleeding\x20diathesis\x20(excluding\x20menstrual\x20bleeding)</li>\x0a<li>Significant\x20closed\x20head\x20trauma\x20or\x20facial\x20trauma\x20within\x203\x20months</li>\x0a</ul>\x0a<p><strong>Relative\x20Contraindications&nbsp;</strong>to\x20fibrinolytic\x20therapy:</p>\x0a<ul>\x0a<li>Uncontrolled\x20hypertension\x20(systolic\x20blood\x20pressure\x20&gt;180\x20mmHg\x20or\x20diastolic\x20blood\x20pressure\x20&gt;110\x20mmHg)</li>\x0a<li><strong>Active\x20peptic\x20ulcer</strong></li>\x0a<li>Noncompressible\x20vascular\x20punctures</li>\x0a<li>Traumatic\x20or\x20prolonged\x20CPR\x20or\x20major\x20surgery\x20within\x203\x20weeks</li>\x0a<li>Recent\x20(within\x202&ndash;4\x20weeks)\x20internal\x20bleeding</li>\x0a<li>For\x20streptokinase:\x20prior\x20exposure\x20(more\x20than\x205\x20days\x20ago)\x20or\x20prior\x20allergic\x20reaction\x20to\x20streptokinase</li>\x0a<li>Pregnancy</li>\x0a<li>Current\x20use\x20of\x20warfarin\x20and\x20INR\x20&gt;1.7</li>\x0a</ul>','msbFT','selected','efLxu','mfEIa','oHpzO','<p\x20style=\x22text-align:\x20left;\x22>The\x20given\x20clinical\x20vignette\x20and\x20the\x20MRI\x20scan\x20finding\x20are\x20suggestive\x20of<strong>\x20glioblastoma.\x20Temozolomide</strong>\x20is\x20used\x20as\x20a\x20<strong>first-line\x20agent</strong>\x20for\x20the\x20management\x20of\x20<strong>glioblastoma.</strong>\u00a0It\x20is\x20used\x20for\u00a0newly\x20diagnosed\x20cases\x20along\x20with\x20radiotherapy\x20and\x20also\x20used\x20for\x20maintenance\x20therapy.</p>\x0a<p\x20style=\x22text-align:\x20left;\x22>Temozolomide\x20belongs\x20to\x20the\x20<strong>triazene\x20group</strong>\x20of\x20<strong>alkylating\x20agents</strong>\x20and\x20is\x20administered\x20orally.\x20The\x20<strong>oral\x20bioavailability</strong>\x20of\x20temozolomide\x20is\x20nearly\x20<strong>100%</strong>.\x20It\x20forms\x20a\x20methylating\x20metabolite\x20and\x20kills\x20cells\x20in\x20all\x20phases\x20of\x20the\x20cell\x20cycle.</p>\x0a<p\x20style=\x22text-align:\x20left;\x22>Glioblastoma\x20is\x20the\x20most\x20malignant\x20astrocytic\x20tumor\x20-\x20WHO\x20grade\x20IV.\x20It\x20spreads\x20along\x20the\x20white\x20matter\x20tracts\x20and\x20crosses\x20the\x20midline\x20via\x20the\x20corpus\x20callosum,\x20giving\x20rise\x20to\x20the\x20so-called\x20<strong>butterfly\x20glioma.\u00a0</strong></p>\x0a<p\x20style=\x22text-align:\x20left;\x22>Other\x20options:</p>\x0a<p\x20style=\x22text-align:\x20left;\x22>Option\x20A-\x20<strong>Streptozocin</strong>\x20belongs\x20to\x20the\x20nitrosourea\x20group\x20of\x20alkylating\x20agents\x20and\x20has\x20a\x20high\x20affinity\x20of\x20islets\x20of\x20Langerhans.\x20It\x20is\x20used\x20in\x20the\x20treatment\x20of\x20<strong>pancreatic\x20islet\x20cell\x20carcinoma</strong>\x20and\x20carcinoid\x20tumors.</p>\x0a<p\x20style=\x22text-align:\x20left;\x22>Option\x20C-\x20<strong>Ifosfamide</strong>\x20belongs\x20to\x20the\x20nitrogen\x20mustard\x20group\x20of\x20alkylating\x20agents\x20and\x20an\x20analog\x20of\x20cyclophosphamide.\x20Ifosfamide\x20is\x20used\x20in\x20germ\x20cell\x20tumors\x20of\x20testes\x20and\x20sarcomas.\u00a0It\x20has\x20maximum\x20<strong>neurotoxicity</strong>\x20which\x20can\x20be\x20treated\x20with\x20<strong>methylene\x20blue</strong>.\x20It\x20has\x20a\x20urothelial\x20damaging\x20capacity\x20like\x20cyclophosphamide\x20which\x20can\x20be\x20treated\x20with\x20MESNA\x20(sodium-2-mercaptoethanol\x20sulfonate).</p>\x0a<p\x20style=\x22text-align:\x20left;\x22>Option\x20D-\x20<strong>Chlorambucil</strong>\x20belongs\x20to\x20the\x20nitrogen\x20mustard\x20group\x20of\x20alkylating\x20agents\x20and\x20is\x20an\x20orally\x20administered\x20drug.\x20It\x20is\x20almost\x20exclusively\x20used\x20in\x20the\x20treatment\x20of\x20<strong>chronic\x20lymphocytic\x20leukemia.</strong></p>','question_video','QOyJq','customQuizData','QlzFn','Oxytocin\x20receptor\x20antagonist','bpsEN','Chlorpromazine','<p>The\x20clinical\x20features\x20described\x20are\x20diagnostic\x20of\x20panic\x20disorder,\x20which\x20are\x20commonly\x20treated\x20with\x20benzodiazepines\x20such\x20as\x20<strong>Clonazepam.</strong></p>\x0a<p><strong>Benzodiazepines</strong>\x20act\x20by\x20binding\x20to\x20specific\x20<strong>GABA-A</strong>\x20receptor\x20subunits\x20at\x20the\x20<strong>cen</strong>t<strong>ral</strong>\x20nervous\x20system\x20(CNS)\x20neuronal\x20synapses.\x20This\x20facilitates\x20the\x20GABA-mediated\x20chloride\x20ion\x20channel\x20opening\x20frequency.</p>\x0a<p><strong>Therapeutic\x20uses</strong>\x20of\x20benzodiazepines:</p>\x0a<ul>\x0a<li>To\x20treat\x20acute\x20<strong>anxiety</strong>\x20states,\x20<strong>panic\x20attacks,</strong>\x20and\x20<strong>generalized\x20anxiety\x20disorder.</strong></li>\x0a<li>Treatment\x20of\x20<strong>insomnia</strong>\x20and\x20other\x20sleep\x20disorders.</li>\x0a<li>Also\x20used\x20for\x20relaxation\x20of\x20the\x20skeletal\x20muscle,\x20as\x20an\x20<strong>adjunct</strong>\x20in\x20anaesthesia,\x20and\x20<strong>seizure</strong>\x20disorders.</li>\x0a</ul>\x0a<p><strong>Overdose\x20of\x20benzodiazepines</strong>\x20may\x20cause\x20dose-dependent\x20depressive\x20effects,\x20which\x20include:\x20sedation,\x20amnesia,\x20hypnosis,\x20anaesthesia,\x20coma,\x20and\x20respiratory\x20depression.</p>\x0a<p><strong>Other\x20options:</strong></p>\x0a<ul>\x0a<li><strong>Propranolol\u00a0</strong>may\x20be\x20used\x20for\x20treating\x20performance\x20anxiety,\x20such\x20as\x20stage\x20fright\x20or\x20fear\x20of\x20public\x20speaking.\x20However,\x20propranolol\x20is\x20not\x20primarily\x20indicated\x20for\x20the\x20treatment\x20of\x20the\x20panic\x20disorder.\x20However,\x20they\x20are\x20occasionally\x20used\x20due\x20to\x20side-effects\x20such\x20as\x20hypotension.</li>\x0a<li><strong>Flumazenil</strong>\x20is\x20a\x20benzodiazepine\x20receptor\x20antagonist.\x20It\x20is\x20indicated\x20in\x20the\x20treatment\x20of\x20benzodiazepine\x20overdose,\x20or\x20for\x20reversal\x20of\x20the\x20sedative\x20effects\x20caused\x20by\x20benzodiazepines.</li>\x0a<li><strong>Buspirone</strong>\x20is\x20a\x205-HT\x20receptor\x20agonist.\x20It\x20is\x20used\x20in\x20the\x20treatment\x20of\x20generalised\x20anxiety\x20states\x20(not\x20for\x20other\x20anxiety\x20disorders\x20or\x20panic\x20attacks).</li>\x0a</ul>','FdZpt','Use\x20as\x20an\x20abortifacient','resume','qxITI','referrer','nWXgJ','yZZvj','fill','SCJio','drqfW','wUlQz','Topiramate','rMWiB','Bosentan','XrYsd','A\x2060-year-old\x20male\x20patient\x20is\x20undergoing\x20coronary\x20thrombolysis\x20and\x20requires\x20tenecteplase\x20for\x20fibrinolytic\x20therapy.\x20Which\x20of\x20the\x20following\x20conditions\x20is\x20not\x20an\x20absolute\x20contraindication\x20to\x20starting\x20this\x20drug?','incorrectResult','ukmFT','button','Fixed\x20amount\x20of\x20drug\x20is\x20cleared\x20per\x20unit\x20time','incomplete','IClqQ','When\x20used\x20with\x20alcohol,\x20the\x20patients\x20feels\x20drowsy,\x20with\x20chest\x20discomfort\x20and\x20respiratory\x20depression','application/vnd.apple.mpegurl','drtmQ','Not\x20Attempted','dpspM','explanation_audio_eng','CZWKQ','CspBy','287bWLqYb','Which\x20of\x20the\x20following\x20is\x20commonly\x20used\x20in\x20the\x20treatment\x20of\x20overactive\x20urinary\x20bladder?','green','search','<p><strong>Amphotericin\x20B\x20</strong>is\x20an<strong>\x20amphipathic\x20molecule</strong>\x20and\x20incorporates\x20itself\x20in\x20the\x20cell\x20membrane\x20by\x20actively\x20binding\x20to\x20<strong>ergosterol</strong>\x20(as\x20shown\x20in\x20the\x20image\x20by\x20\x27<strong>C</strong>\x27).\x20This\x20results\x20in\x20the\x20formation\x20of\x20<strong>amphotericin-induced\x20pores</strong>\x20which\x20cause\x20leakage\x20of\x20the\x20intracellular\x20contents\x20ultimately\x20resulting\x20in\x20cell\x20death.</p>\x0a<p>It\x20is\x20a\x20<strong>broad-spectrum\x20antifungal</strong>\x20that\x20can\x20be\x20used\x20against<em>\x20Candida\x20albicans,\x20Cryptococcus\x20neoformans,\x20Blastomyces\x20dermatitidis,\x20Histoplasma\x20capsulatum,\x20Sporothrix\x20schenckii,&nbsp;</em><em>Coccidioides\x20immitis,\x20Aspergillus.</em></p>\x0a<p><strong>Amphotericin\x20B</strong>\x20also\x20has\x20<strong>antiprotozoal</strong>\x20action\x20along\x20with\x20antifungal\x20properties\x20and\x20is\x20effective\x20against\x20<strong><em>Leishmania</em></strong><em>.</em></p>\x0a<p><strong>Adverse\x20effects</strong>\x20of\x20amphotericin\x20B\x20include:</p>\x0a<ul>\x0a<li>Infusion-related\x20fever\x20and\x20chills</li>\x0a<li><strong>Azotemia/nephrotoxicity</strong>-\x20all\x20lipid\x20formulations\x20of\x20amphotericin\x20B\x20are\x20less\x20nephrotoxic\x20than\x20conventional\x20amphotericin\x20B</li>\x0a<li><strong>Renal\x20tubular\x20acidosis&nbsp;</strong></li>\x0a<li>Renal\x20wasting\x20of\x20potassium\x20and\x20magnesium</li>\x0a<li>Hypochromic\x20normocytic\x20anemia-\x20due\x20to\x20decreased\x20erythropoietin\x20production\x20from\x20the\x20kidney.</li>\x0a</ul>','cMxWb','Chlorambucil','gGOHl','reload','A\x2028-year-old\x20woman\x20gave\x20birth\x20to\x20a\x20child\x20with\x20the\x20features\x20shown\x20in\x20the\x20given\x20image.\x20On\x20examination,\x20the\x20child\x20had\x20brittle\x20bones,\x20and\x20x-ray\x20scans\x20revealed\x20stippled\x20epiphyses.\x20Which\x20of\x20the\x20following\x20drugs\x20is\x20most\x20likely\x20to\x20be\x20implicated\x20in\x20causing\x20this\x20teratogenic\x20condition?','Low\x20affinity\x20and\x20high\x20intrinsic\x20activity','replace','Which\x20of\x20the\x20following\x20drugs\x20is\x20a\x20soluble\x20guanylate\x20cyclase\x20stimulator\x20that\x20can\x20be\x20used\x20in\x20chronic\x20heart\x20failure\x20with\x20reduced\x20ejection\x20fraction?','QogJW','Furosemide','Rocuronium','KEZmU','ltLqJ','ZEMOE','Propylthiouracil','TFcqN','preventDefault','tXKmX','Pilocarpine','pwEto','tyqul','No\x20solution\x20provided','isSupported','SmQyI','Cevimeline','VFYfU','Febuxostat','ypLRi','A\x2023-year-old\x20pregnant\x20woman\x20presented\x20with\x20features\x20suggestive\x20of\x20thyrotoxicosis.\x20Which\x20of\x20the\x20following\x20is\x20not\x20a\x20treatment\x20option\x20for\x20her\x20condition?','emASD','https://cdn1.dailyrounds.org/uploads/93bd46631d294c00acd68ec7cf7bcbfb.JPEG','Induction\x20of\x20labor','athUe','isArray','GPxzd','ROBwh','Which\x20of\x20the\x20following\x20drugs\x20is\x20indicated\x20for\x20paroxysmal\x20supraventricular\x20tachycardia?','solution','Quinine','avgTimeResult','onclick','Ciprofloxacin','CvPpU','</h4>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<span\x20class=\x22text-sm\x20px-3\x20py-1\x20rounded-full\x20bg-','ltWYc','Ertapenem\x20has\x20longer\x20half\x20life\x20than\x20imipenem.','wxDFM','push','get','uaYyf','Its\x20action\x20persists\x20up\x20to\x202-3\x20days\x20after\x20stopping\x20the\x20drug','<p>The\x20given\x20illustration\x20shows\x20the\x20<strong>G-protein-coupled\x20receptor\x20pathway</strong>\x20for\x20signalling.\x20The\x20drugs\x20that\x20function\x20via\x20this\x20mechanism\x20are\x20<strong>dobutamine,</strong>\x20propranolol,\x20<strong>atropine,\x20misoprostol,</strong>\x20montelukast.&nbsp;</p>\x0a<p>Functional\x20families\x20of\x20<strong>GPCRs</strong>\x20include\x20<strong>beta-adrenergic</strong>\x20receptors,\x20<strong>muscarinic\x20cholinergic</strong>\x20receptors,\x20<strong>eicosanoid</strong>\x20receptors,\x20and\x20<strong>thrombin</strong>\x20receptors.</p>\x0a<p>G\x20proteins\x20act\x20as\x20inhibitory\x20and\x20excitatory\x20because\x20of\x20differences\x20in\x20the\x20alpha\x20subunit.</p>\x0a<p>In\x20general,\x20Gs\x20and\x20Gq\x20subtypes\x20are\x20excitatory\x20whereas\x20Gi\x20is\x20inhibitory.</p>\x0a<p><strong>Resting-state:</strong></p>\x0a<ul>\x0a<li>G\x20protein\x20heterotrimer\x20consisting\x20of\x20alpha,\x20beta\x20and\x20gamma\x20subunits\x20forms\x20a\x20complex\x20with\x20G-protein-coupled\x20receptors\x20at\x20the\x20intracellular\x20domain.\x20The\x20extracellular\x20domain\x20of\x20GPCR\x20has\x20the\x20binding\x20domain\x20for\x20hormones\x20and\x20G\x20protein\x20subunits\x20do\x20not\x20directly\x20bind\x20them.<strong>&nbsp;</strong></li>\x0a<li><strong>The\x20alpha\x20subunit\x20is\x20bound\x20to\x20GDP&nbsp;</strong></li>\x0a</ul>\x0a<p><strong>Binding\x20of\x20ligand\x20results\x20in\x20an\x20activated\x20state:&nbsp;</strong></p>\x0a<ul>\x0a<li>Alpha\x20subunit\x20undergoes\x20a\x20conformational\x20change</li>\x0a<li>Release\x20of\x20GDP\x20and\x20binding\x20of\x20GTP</li>\x0a<li>GTP\x20bound\x20alpha\x20subunit\x20dissociates\x20from\x20beta-gamma\x20subunit</li>\x0a<li><strong>Both\x20alpha\x20subunit\x20and\x20beta-gamma\x20subunit\x20</strong>bind\x20to\x20and\x20<strong>regulate\x20effectors&nbsp;only\x20when\x20they\x20are\x20separated&nbsp;</strong></li>\x0a</ul>\x0a<p>The\x20illustration\x20below\x20shows\x20the\x20pathway.</p>','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22space-y-2\x20mb-4\x22>','tMhRb','round','strokeDashoffset','xMYMC','iRKhg','Pirenzepine','1,\x204,\x205','FhDdN','A\x2052-year-old\x20female\x20patient\x20with\x20type\x202\x20diabetes\x20mellitus\x20has\x20been\x20prescribed\x20pioglitazone.\x20What\x20will\x20you\x20tell\x20her\x20when\x20she\x20asks\x20about\x20the\x20most\x20common\x20adverse\x20effect\x20of\x20thiazolidinediones?','ZNpYk','\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22option-letter\x22>','A\x2040-year-old\x20lady\x20with\x20grade\x202\x20osteoarthritis\x20is\x20on\x20treatment\x20with\x20NSAIDs.\x20She\x20developed\x20heartburn\x20and\x20epigastric\x20pain.\x20An\x20upper\x20GI\x20endoscopy\x20revealed\x20gastritis.\x20Which\x20of\x20the\x20following\x20is\x20the\x20most\x20appropriate\x20advice\x20for\x20her\x20pharmacologically?','BIjXP','<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>English:</p><audio\x20src=\x22','<p>The\x20clinical\x20scenario\x20is\x20suggestive\x20of\x20a\x20drug-induced\x20sensorineural\x20type\x20of\x20hearing\x20loss,\x20and\x20<strong>furosemide</strong>\x20is\x20likely\x20to\x20be\x20associated\x20with\x20these\x20side\x20effects\x20(<strong>ototoxicity</strong>).\x20This\x20is\x20due\x20to\x20the\x20adverse\x20effect\x20of\x20IV\x20furosemide\x20used\x20during\x20his\x20heart\x20failure\x20treatment.\x20Furosemide\x20<strong>acts\x20on\x20the\x20thick\x20ascending\x20limb\x20of\x20the\x20loop\x20of\x20Henle</strong>.</p>\x0a<p>Interpretation\x20of\x20the\x20given\x20audiogram:</p>\x0a<ul>\x0a<li>Red\x20indicates\x20right\x20ear</li>\x0a<li>O\x20indicates\x20AC\x20and\x20threshold\x20is\x20&gt;15\x20dB.\x20Hence\x20<strong>AC\x20is\x20abnormal</strong></li>\x0a<li>&lt;\x20indicates\x20BC\x20and\x20threshold\x20is\x20&gt;25\x20dB.\x20Hence\x20<strong>BC\x20is\x20abnormal</strong></li>\x0a<li>Both\x20AC\x20and\x20BC\x20are\x20abnormal.\x20It\x20<strong>indicates\x20sensorineural\x20hearing\x20loss</strong></li>\x0a<li>There\x20is\x20<strong>no\x20Air-Bone\x20gap</strong></li>\x0a<li>Hence\x20it\x20is\x20<strong>right\x20side\x20sensorineural\x20hearing\x20loss</strong></li>\x0a</ul>\x0a<p>Since\x20Weber\x20is\x20lateralised\x20towards\x20left,\x20it\x20indicates\u00a0<strong>left\u00a0sided\x20conductive\x20deafness</strong>\u00a0or\u00a0<strong>right\x20sided\x20sensorineural\x20deafness</strong>.\x20Since\x20Rinne\x20is\x20positive\x20on\x20both\x20ears,\u00a0<strong>conductive\x20deafness\x20is\x20ruled\x20out</strong>.\x20Therefore,\x20it\x20is\u00a0<strong>Right\x20sided\x20sensorineural\x20hearing\x20loss.</strong></p>\x0a<p><strong>Other\x20options:</strong></p>\x0a<p><strong>Carbonic\x20anhydrase</strong>\x20acts\x20on\x20the\x20<strong>PCT</strong>.\x20It\x20is\x20used\x20for\x20glaucoma,\x20pseudotumor\x20cerebri,\x20metabolic\x20alkalosis\x20and\x20cystine\x20stone\x20prevention.Due\x20to\x20their\x20structural\x20homology\x20to\x20the\x20sulfonamides,\x20they\x20may\x20cause\x20bone\x20marrow\x20depression,\x20skin\x20toxicity,\x20and\x20allergic\x20reactions.</p>\x0a<p><strong>Thiazides</strong>\x20act\x20on\x20the\x20<strong>DCT</strong>.\x20It\x20is\x20used\x20for\x20treatment\x20of\x20hypertension\x20and\x20chronic\x20edema.\u00a0Their\x20adverse\x20effects\x20are\x20as\x20follows</p>\x0a<ul>\x0a<li>Hypotension</li>\x0a<li>Hyponatremia</li>\x0a<li>Hypokalemia</li>\x0a<li>Hypomagnesemia</li>\x0a<li>Hypochloremia</li>\x0a<li>Hyperuricemia</li>\x0a<li>Hypercalcemia</li>\x0a<li>Decrease\x20glucose\x20tolerance</li>\x0a<li>May\x20increase\x20the\x20lipid\x20levels</li>\x0a</ul>\x0a<p><strong>ADH\x20receptor\x20antagonists</strong>\x20like\x20<strong>Tolvaptan</strong>\x20act\x20in\x20<strong>medullary\x20CT.</strong>\x20Used\x20for\x20treating\x20hyponatremia.\u00a0They\x20can\x20cause\x20hypokalemia,\x20dehydration,\x20liver\x20damage\x20(eps\x20contraindicated\x20in\x20people\x20with\x20previous\x20liver\x20disease)\x20as\x20side\x20effects.</p>\x0a<p>Other\x20common\x20<strong>ototoxic\x20drugs</strong>\x20are:</p>\x0a<ol>\x0a<li>Antibiotics\x20like\x20Aminoglycosides\x20(\x20gentamicin\x20&gt;\x20tobramycin\x20&gt;\x20amikacin\x20&gt;\x20neomycin),\x20erythromycin,\x20tetracyclines.</li>\x0a<li>Chemotherapeutic\x20agents\x20like\x20Cisplatin,\x20Bleomycin\x20and\x20Nitrogen\x20mustard.</li>\x0a<li>High\x20dose\x20aspirin,\x20acetaminophen\x20and\x20NSAIDs</li>\x0a<li>Antimalarials\x20like\x20quinine\x20and\x20quinidine</li>\x0a<li>Phosphodiesterase\x205\x20inhibitors\x20like\x20Sildenafil</li>\x0a</ol>','SArJE','snWKg','1,\x202,\x203,\x205','explanation_images','key','hQndA','Prochlorperazine','xRqFn','qBIzw','QuxSj','performanceModal','Omapatrilat','On\x20observing\x20the\x20presence\x20of\x20Fleischer\x20vortex(whorl\x20keratopathy)\x20during\x20the\x20ocular\x20examination\x20of\x20a\x20patient,\x20you\x20would\x20expect\x20to\x20find\x20a\x20history\x20of\x20intake\x20of\x20which\x20of\x20the\x20following\x20drugs?','correct_choice_id','scoreCircle','true','152196PPUHKA','laNmo','\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</div>','Co-trimoxazole\x20is\x20a\x20combination\x20of\x20trimethoprim\x20with\x20sulfamethoxazole\x20in\x20the\x20ratio\x20of\x20__________','Romiplostim\x20is\x20a','Methylphenidate','BNcHA','VhznL','Propranolol','Teatz','lvXRy','A\x2060-year-old\x20female\x20patient\x20presented\x20with\x20the\x20following\x20finding.\x20Her\x20medical\x20history\x20includes\x20hypertension\x20for\x20which\x20she\x20has\x20been\x20taking\x20regular\x20medications\x20for\x20the\x20past\x203\x20months.\x20Which\x20of\x20the\x20following\x20medication\x20is\x20most\x20likely\x20to\x20be\x20associated\x20with\x20this\x20finding?','custom_quiz.html','table','VhDka','Ethanol','pWXlL','xVdfO','forEach','<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>Hinglish\x20Explanation:</p><audio\x20src=\x22','border-gray-600','testModeLegend','<p>Among\x20the\x20given\x20options,\x20<strong>switching\x20to\x20etoricoxib</strong>\x20instead\x20of\x20a\x20non-selective\x20COX\x20inhibitor\x20and\x20<strong>using\x20pantoprazole&nbsp;without\x20chewing</strong>\x20would\x20be\x20the\x20most\x20appropriate\x20advice.</p>\x0a<p><strong>Selective&nbsp;COX2</strong>\x20inhibitors\x20like\x20<strong>etoricoxib</strong>\x20are\x20less\x20likely\x20to\x20cause\x20gastritis\x20than\x20non-selective\x20COX\x20inhibitors\x20like\x20aspirin\x20or\x20ibuprofen.</p>\x0a<p>Proton\x20pump\x20inhibitors\x20(PPIs)\x20like\x20pantoprazole\x20are\x20generally\x20coated\x20or\x20available\x20in\x20capsule\x20forms.\x20Without\x20this,\x20it\x20gets\x20degraded\x20by\x20the\x20action\x20of\x20gastric\x20acid.\x20Hence\x20uncrushed\x20PPI\x20should\x20be\x20used\x201/2\x20to\x201\x20hour\x20before\x20the\x20meals.</p>\x0a<p>Other\x20options:</p>\x0a<p>Option\x20A:\x20NSAIDs\x20may\x20be\x20stopped\x20in\x20view\x20of\x20gastric\x20irritation\x20and\x20switched\x20to\x20another\x20analgesic\x20or\x20surgical\x20option\x20might\x20be\x20undertaken.\x20PPI\x20should\x20not\x20be\x20crushed.</p>\x0a<p>Option\x20C:\x20A\x20combination\x20of\x20H2\x20blockers\x20like\x20<strong>cimetidine</strong>\x20and\x20<strong>antacid</strong>\x20should\x20not\x20be\x20administered\x20simultaneously,\x20as\x20the\x20antacids\x20reduce\x20the\x20absorption\x20of\x20all\x20H2\x20blockers.\x20At\x20least\x20a\x20gap\x20of\x202\x20hours\x20should\x20be\x20maintained.</p>\x0a<p>Option\x20D:&nbsp;Ranitidine\x20increases&nbsp;the&nbsp;gastric\x20pH&nbsp;(i.e.\x20less\x20acidic)\x20which&nbsp;reduces&nbsp;sucralfate\x20efficacy;&nbsp;hence\x20the\x20<strong>combination\x20is\x20incorrect</strong>.&nbsp;</p>\x0a<p>Note:\x20Usage\x20of\x20<strong>ranitidine</strong>\x20for\x20any\x20purpose\x20has\x20been\x20banned\x20by\x20the\x20FDA\x20due\x20to\x20a\x20potential\x20carcinogenic\x20agent\x20in\x20a\x20few\x20batches\x20of\x20this\x20drug.</p>','QAbES','20052aepFKN','RktXv','AjaRl','2946\x20patients\x20with\x20RCC,\x20randomized\x20and\x20double-blinded','questionText','HyjQx','width','<p><strong>Lidocaine</strong>\x20belongs\x20to\x20<strong>class\x20IB\x20of\x20anti-arrhythmic\x20drugs</strong>.\x20It\x20is\x20used\x20for\x20acute\x20treatment\x20of\x20ventricular\x20tachycardia\x20and\x20ventricular\x20fibrillation.</p>\x0a<p><strong>Lidocaine</strong>\x20is\x20a\x20class,\u00a0<strong>IB</strong>\u00a0anti-arrhythmic\x20agent.\x20It\x20<strong>blocks\x20Na+</strong>\x20channels\x20mostly\x20in\x20the\x20<strong>closed/inactivated\x20state</strong>.\x20It\x20is\x20not\x20used\x20in\x20atrial\x20arrhythmias\x20because\x20the\x20atrial\x20action\x20potential\x20is\x20so\x20short\x20that\x20the\x20Na+\x20channels\x20are\x20in\x20a\x20closed/\x20inactivated\x20state\x20for\x20only\x20a\x20brief\x20amount\x20of\x20time.</p>\x0a<p>Lidocaine\x20is\x20used\x20in\x20the\x20<strong>acute\x20treatment\x20of\x20ventricular\x20tachycardia\x20and\x20ventricular\x20fibrillation.</strong></p>\x0a<div\x20class=\x22O0\x22>Drugs\x20mostly\x20used\x20for\x20supraventricular\x20arrhythmia\x20:</div>\x0a<ul>\x0a<li\x20class=\x22O1\x22>Adenosine</li>\x0a<li\x20class=\x22O1\x22>Verapamil</li>\x0a<li\x20class=\x22O1\x22>Diltiazem</li>\x0a<li\x20class=\x22O1\x22>Digoxin</li>\x0a</ul>\x0a<div\x20class=\x22O1\x22>Ventricular\x20arrhythmia\x20:</div>\x0a<ul>\x0a<li\x20class=\x22O1\x22>Lidocaine\u00a0</li>\x0a<li\x20class=\x22O1\x22>Mexiletine</li>\x0a</ul>\x0a<div\x20class=\x22O1\x22>Both\x20:</div>\x0a<ul>\x0a<li\x20class=\x22O1\x22>Amiodarone</li>\x0a<li\x20class=\x22O1\x22>Beta-blockers</li>\x0a<li\x20class=\x22O1\x22>Class\x201a\x20/\x201c\x20antiarrhythmics</li>\x0a</ul>','mSkYg','LwEMJ','Cilastatin\x20is\x20administered\x20along\x20with\x20meropenem.','JdApq','Tenofovir','https://cdn1.dailyrounds.org/uploads/f480fd2cb0f44bedbe11cd63e16c01d9.JPEG','Heparin','Telmisartan','Dicyclomine','ygjws','Amiodarone','HWBWb','Enalapril','nuymJ','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20','HRSBz','textContent','Barbiturate','Ifosfamide','thhGm','zxaOB','UsrNF','MrQmk','Ahdpa','<p><strong>Intravenous\x20fomepizole\x20is\x20the\x20standard\x20treatment\x20for\x20ethylene\x20glycol\x20poisoning</strong>.\x20Intravenous\x20ethanol\x20is\x20an\x20alternative.</p>\x0a<p><strong>Fomepizole\x20is\x20administerd\x20intravenously\x20in\x20methanol\x20and\x20ethylene\x20glycol\x20poisoning\x20with\x20a\x20loading\x20dose\x20of\x2015\x20mg/kg</strong></p>\x0a<p><strong>\x20Ethylene\x20glycol\x20poisoning</strong>:</p>\x0a<ul>\x0a<li>Ethylene\x20glycol\x20is\x20used\x20as\x20heat\x20exchangers,\x20in\x20antifreeze\x20formulations\x20and\x20as\x20industrial\x20solvents.</li>\x0a<li>Ethylene\x20glycol\x20is\x20relatively\x20harmless\x20but\x20it\x20forms\x20metabolites\x20like\x20toxic\x20aldehydes\x20(converted\x20to\x20acids)\x20and\x20oxalate\x20that\x20are\x20harmful.</li>\x0a<li>Inhibition\x20of\x20formation\x20of\x20toxic\x20metabolites\x20by\x20adminitering\x20fomepizole\x20or\x20ethanol\x20is\x20the\x20mainstay\x20of\x20treatment.</li>\x0a</ul>\x0a<p><strong>\x20Clinical\x20features:</strong></p>\x0a<ul>\x0a<li>Initial\x20excitation\x20followed\x20by\x20CNS\x20depression.</li>\x0a<li>After\x204-12\x20hours,\x20severe\x20metabolic\x20acidosis\x20due\x20to\x20acid\x20metabolites\x20and\x20lactate.</li>\x0a<li>Finally,\x20renal\x20insufficiency\x20due\x20to\x20deposition\x20of\x20oxalate\x20in\x20renal\x20tubules.</li>\x0a</ul>','pCsmt','completed','eXoab','XLwwC','<p><strong>Alprostadil</strong>\x20is\x20used\x20for\x20the\x20temporary\x20<strong>maintenance</strong>\x20<strong>of\x20the\x20patency\x20of\x20the\x20ductus\x20arteriosus</strong>\x20in\x20neonates,\x20keeping\x20the\x20ductus\x20arteriosus\x20open.&nbsp;</p>\x0a<p>Alprostadil\x20is\x20a\x20natural\x20<strong>PGE<sub>1</sub></strong>\x20analog.\x20PGE<sub>1</sub>\x20is\x20a\x20potent\x20and\x20specific\x20relaxant\x20of\x20ductal\x20smooth\x20muscle.</p>\x0a<p>The\x20ductus\x20arteriosus\x20(the\x20fetal\x20connection\x20between\x20the\x20pulmonary\x20artery\x20and\x20the\x20descending\x20aorta)\x20is\x20<strong>functionally\x20closed\x20at\x2010-15\x20hrs</strong>\x20after\x20birth\x20and\x20<strong>anatomically\x20closed\x20at\x2010-21\x20days&nbsp;</strong>after\x20birth.</p>\x0a<p>Survival\x20of\x20newborns\x20with\x20certain\x20heart\x20lesions\x20such\x20as\x20<strong>coarctation\x20of\x20the\x20aorta,\x20hypoplastic\x20left\x20heart\x20syndrome,&nbsp;</strong>\x20and<strong>\x20transposition\x20of\x20great\x20vessels</strong>\x20depends\x20on\x20the\x20patency\x20of\x20ductus\x20arteriosus.\x20Closure\x20of\x20ductus\x20arteriosus\x20in\x20such\x20conditions\x20can\x20lead\x20to\x20hypoperfusion,\x20severe\x20hypoxia,\x20and\x20cyanosis.\x20Maintaining\x20the\x20patency\x20of\x20ductus\x20arteriosus\x20in\x20neonates\x20is\x20essential\x20in\x20some\x20congenital\x20heart\x20diseases\x20before\x20corrective\x20surgery\x20is\x20performed,\x20and\x20alprostadil\x20is\x20used\x20for\x20this\x20purpose.</p>\x0a<p>Alprostadil\x20is\x20also\x20used\x20in\x20the\x20treatment\x20of\x20critical\x20limb\x20ischemia,\x20<strong>erectile\x20dysfunction,</strong>\x20and\x20pulmonary\x20hypertension.\x20Treatment\x20with\x20alprostadil\x20results\x20in\x20an<strong>\x20improvement</strong>\x20in\x20ulcers,\x20pain,\x20and\x20limb\x20salvage\x20rates\x20in\x20<strong>critical\x20limb\x20ischemia</strong>\x20patients.</p>\x0a<p><strong>Side\x20effects</strong>\x20of\x20alprostadil\x20include\x20pain,\x20bruising,\x20and\x20<strong>priapism</strong>.\x20If\x20priapism\x20occurs,\x20the\x20patient\x20will\x20need\x20urgent\x20medical\x20attention,\x20which\x20might\x20include\x20aspiration\x20of\x20blood,\x20surgical\x20shunt,\x20or\x20intracavernosal\x20injection\x20of\x20phenylephrine\x20for\x20cavernosal\x20vasoconstriction.</p>\x0a<p>PGE<sub>1</sub>\x20analogs\x20like\x20<strong>alprostadil,\x20misoprostol,</strong>\x20and<strong>\x20rioprostil</strong>\x20can\x20also\x20be\x20used\x20to\x20keep\x20the\x20ductus\x20open\x20and\x20support\x20systemic\x20blood\x20supply.</p>\x0a<p>Other\x20options:</p>\x0a<p>Option\x20A:\x20<strong>PGF<sub>2&alpha;</sub></strong>\x20analog\x20<strong>carboprost</strong>\x20is\x20used\x20as\x20an\x20<strong>abortifacient</strong>\x20in\x20the\x20second\x20trimester.</p>\x0a<p>Option\x20B:\x20<strong>Indomethacin\x20</strong>a\x20non-steroidal\x20anti-inflammatory\x20drug\x20is\x20used\x20for\x20the<strong>\x20closure\x20of\x20patent\x20ductus\x20arteriosus</strong>.</p>\x0a<p>Option\x20D:<strong>\x20Dinoprostone\x20</strong>(<strong>PGE<sub>2</sub></strong>)\x20can\x20be\x20used\x20for\x20the&nbsp;<strong>induction\x20of\x20labor</strong>.</p>','nav-btn-current','none','href','jCEdU','SNPiI','Leflunomide','<p><strong>Phase\x20III\x20trials</strong>\x20are\x20usually\x20done\x20on\x20<strong>500&ndash;3000\x20patients</strong>\x20with\x20the\x20disease,\x20and\x20these\x20are\x20<strong>randomized\x20double-blinded\x20studies</strong>.</p>\x0a<p><strong>Phase\x20III\x20trials\x20</strong>are\x20usually\x20considered<strong>\x20pivotal\x20trials\x20</strong>that\x20are\x20necessary\x20for\x20the\x20<strong>approval\x20</strong>of\x20the\x20majority\x20of\x20drugs.<strong>&nbsp;</strong>They<strong>&nbsp;</strong>are<strong>&nbsp;</strong>also\x20called\x20a\x20multisite\x20trial,\x20which\x20is\x20done\x20for\x203&ndash;5\x20years.\x20This\x20phase\x20<strong>confirms</strong>\x20the\x20<strong>efficacy</strong>\x20of\x20the\x20drug.\x20It\x20is\x20also\x20done\x20to\x20study\x20the\x20<strong>long-term</strong>\x20or<strong>\x20rare\x20side\x20effects</strong>\x20of\x20this\x20drug.&nbsp;</p>\x0a<p>When\x20the\x20initial\x20phase\x20III\x20trials\x20are\x20complete,\x20the\x20sponsor\x20(usually\x20a\x20pharmaceutical\x20company)\x20applies\x20to\x20the\x20FDA\x20for\x20approval\x20to\x20market\x20the\x20drug.\x20This\x20application\x20is\x20called\x20either\x20a\x20<strong>new\x20drug\x20application\x20</strong>(NDA)\x20or<strong>\x20a\x20biologics\x20license\x20application\x20</strong>(BLA).</p>\x0a<p>Note:\x20In\x20some\x20drugs\x20related\x20to\x20rare\x20diseases\x20or\x20oncology,\x20phase\x20II\x20studies\x20are\x20considered\x20pivotal,\x20and\x20the\x20drug\x20may\x20be\x20approved\x20on\x20the\x20basis\x20of\x20phase\x20II\x20studies.</p>\x0a<p><strong>Other\x20phases\x20of\x20clinical\x20trials:</strong></p>\x0a<p><strong>Preclinical\x20trials\x20</strong>are\x20performed\x20on\x20animals\x20and\x20they\x20are\x20regulated\x20by\x20guidelines\x20prescribed\x20by&nbsp;the\x20committee\x20for\x20the\x20purpose\x20of\x20the\x20control\x20and\x20supervision\x20of\x20experiments\x20on\x20animals\x20(<strong>CPCSEA</strong>)\x20in\x20India.\x20Standards\x20for\x20the\x20conduct\x20of\x20clinical\x20trials\x20involving\x20Indian\x20subjects\x20are\x20laid\x20down\x20in\x20good\x20clinical\x20practice\x20(GCP).</p>\x0a<p><strong>Phase\x20I\x20clinical\x20trials</strong>\x20are\x20performed\x20on\x20<strong>healthy\x20volunteers</strong>\x20in\x20an\x20open-label\x20study\x20to\x20determine\x20the\x20safety,\x20tolerability,\x20and\x20<strong>pharmacokinetic</strong>\x20properties\x20of\x20the\x20drug.</p>\x0a<p><strong>Phase\x20II\x20clinical\x20trials\x20</strong>are\x20conducted\x20to\x20evaluate\x20the\x20appropriate\x20<strong>dose\x20range</strong>\x20of\x20the\x20drug.\x20It\x20is\x20evaluated\x20on\x20a\x20small\x20group\x20of\x20patients\x20(50-500)\x20with\x20the\x20target\x20disease.\x20Most\x20of\x20the\x20new\x20drugs\x20will\x20be\x20administered\x20for\x20the\x20first\x20time\x20in\x20<strong>patients\x20with\x20</strong>the\x20<strong>target\x20disease</strong>.</p>\x0a<p>The\x20study\x20is\x20designed\x20to\x20obtain\x20<strong>proof\x20of\x20concept\x20</strong>(potential\x20of\x20the\x20drug\x20to\x20treat\x20the\x20disease)\x20and\x20<strong>dose-ranging\x20study\x20</strong>(provides\x20input\x20for\x20choosing\x20the\x20most\x20appropriate\x20dose\x20for\x20phase\x20III\x20studies).</p>\x0a<p><strong>Phase\x20IV\x20clinical</strong><strong>\x20trials</strong>\x20are\x20conducted\x20after\x20the<strong>\x20drug\x20is\x20marketed</strong>\x20and&nbsp;approved\x20by\x20regulatory\x20authorities.\x20It\x20includes\x20<strong>post-marketing\x20surveillance</strong>\x20and\x20other\x20studies\x20that\x20complement\x20the\x20earlier\x20findings\x20on\x20the\x20drug.</p>','6.25','msggH','HgaAy','open','map','XNtJN','Glimepiride','AeABH','MAeyR','navBtn_','removeItem','118864SPOYOu','petvn','Kjmoc','koOYz','Combined\x20oral\x20contraceptives','SLcsK','length','EZBwE','mvToL','explanation_audio_hin','ArrowRight','questions','Recombinant\x20human\x20granulocyte\x20colony-stimulating\x20factor','https://cdn1.dailyrounds.org/uploads/8a4bcdecc8194bae9ef8a680f6175771.JPEG','WVMeh','lEQxl','Flumazenil','accuracy','Which\x20of\x20the\x20following\x20is\x20an\x20indication\x20for\x20alprostadil\x20use?','<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>Hinglish:</p><audio\x20src=\x22','pBDAv','exception','efXkf','reduce','Netarsudil','questionIndex','addEventListener','filter','PsRQh','IrHyP','quizFile','questionMedia','wKEeD','Cbbla','Uzlwb','20:1','Tirofiban','Lithium','Which\x20of\x20the\x20following\x20statements\x20is\x20true\x20about\x20disulfiram?','Progress\x20loaded.','StSJP','Hypermagnesemia\x20increases\x20the\x20risk\x20of\x20digitalis\x20induced\x20arrhythmia','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22option-text\x22>','Atenolol','loadSource','Atropine','FqtFL','querySelectorAll','nDmrp','jVoSk','zKHfa','fJUQk','44BIuALQ','A\x2050-year-old\x20male\x20patient\x20was\x20diagnosed\x20with\x20pulmonary\x20artery\x20hypertension.\x20He\x20was\x20prescribed\x20an\x20endothelin\x20receptor\x20antagonist\x20for\x20the\x20management\x20of\x20the\x20same.\x20After\x20starting\x20the\x20drug,\x20he\x20developed\x20nasal\x20congestion\x20and\x20pharyngitis.\x20Which\x20of\x20the\x20following\x20drugs\x20was\x20prescribed?','KLVaR','Qslxh','markReviewBtn','iXJFc','remove','Marrow','Hydrochlorothiazide','gradient-yellow\x20px-6\x20py-3\x20text-white\x20transition-all\x20duration-300\x20flex\x20items-center','Hydrochlorthiazide','Colchicine','dsRbW','PpmmL','not_attempted','As\x20a\x20researcher\x20employed\x20in\x20a\x20pharmaceutical\x20company,\x20you\x20are\x20involved\x20in\x20a\x20clinical\x20trial.\x20A\x20monoclonal\x20antibody\x20for\x20the\x20treatment\x20of\x20renal\x20cell\x20carcinoma\x20(RCC)\x20is\x20entering\x20phase\x20III\x20of\x20the\x20clinical\x20trial.\x20Which\x20of\x20these\x20statements\x20correctly\x20describes\x20this\x20phase?','https://cdn1.dailyrounds.org/uploads/21168bb11bea4a9e9e9a38278b618a9f.JPEG','vYtew','lsyCe','jxiyd','https://dhmbxeygs57ff.cloudfront.net/uploads/0d669e35bc1e4139bd255e4387c48c61x1280x1476.JPEG','Radioactive\x20iodine','iABOi','Vericiguat','SVYis','JMfXM','bWVan','notAttemptedResult','wGlQN','UGNVA','selectedAnswer','study','eVjts','Sildenafil','EugGp','<div\x20class=\x22page\x22\x20title=\x22Page\x20830\x22>\x0a<div\x20class=\x22section\x22>\x0a<div\x20class=\x22layoutArea\x22>\x0a<div\x20class=\x22column\x22>\x0a<p>Ritodrine\x20is\x20a\x20selective\x20<strong>beta-2\x20receptor\x20agonist</strong>,\x20which\x20is\x20used\x20as\x20a\x20uterine\x20relaxant\x20to\x20prevent\x20preterm\x20labour.</p>\x0a</div>\x0a</div>\x0a</div>\x0a</div>\x0a<p>Specific\x20tocolytic\x20agents\x20are:</p>\x0a<ul>\x0a<li>Beta\x202\x20agonists\u00a0\x0a<ul>\x0a<li><strong>Ritodrine</strong></li>\x0a<li>Isoxsuprine</li>\x0a<li>Terbutaline</li>\x0a</ul>\x0a</li>\x0a<li>Calcium\x20channel\x20blockers:\x20Eg.<strong>\x20Nifedipine</strong></li>\x0a<li>Magnesium\x20sulfate</li>\x0a<li><strong>Atosiban\x20(oxytocin\x20receptor\x20antagonist)</strong></li>\x0a<li>Indomethacin</li>\x0a</ul>','JlGbW','glass-light\x20px-6\x20py-3\x20text-white\x20hover:bg-purple-500\x20hover:bg-opacity-20\x20transition-all\x20duration-300\x20flex\x20items-center','innerHTML','Butorphanol','VPIIE','uaPwa','ourZI','GHCRq','No\x20solution\x20available.','High\x20affinity\x20and\x20high\x20intrinsic\x20activity','<p>The\x20clinical\x20symptoms\x20of\x20curdy\x20white\x20vaginal\x20discharge\x20and\x20the\x20KOH\x20smear\x20showing\x20budding\x20yeast\x20cells\x20are\x20suggestive\x20of\u00a0<strong>vulvovaginal\x20candidiasis</strong>.\x20The\x20oral\x20medication\x20given\x20in\x20this\x20condition\x20is\u00a0<strong>fluconazole\u00a0</strong>which\x20acts\x20by<strong>\x20inhibiting\x20ergosterol\x20synthesis.</strong></p>\x0a<p>Azole\x20group\x20of\x20antifungal\x20are\x20grouped\x20into\x20two\x20types\x20:</p>\x0a<ul>\x0a<li><strong>Imidazole</strong>-\x20clotrimazole,\x20ketoconazole,\x20luliconazole</li>\x0a<li><strong>Triazole</strong>-\x20Itraconazole,\x20<strong>fluconazole</strong>,\x20voriconazole,\x20posaconazole,\x20and\x20isavuconazole</li>\x0a</ul>\x0a<p>The\u00a0<strong>azole\u00a0</strong>group\u00a0<strong>inhibits</strong>\u00a0the\x20fungal\x20cytochrome\x20P450\x20enzyme\x20called\u00a0<strong>14--sterol\x20demethylase</strong>\u00a0and\x20results\x20in\x20an\x20impaired\x20conversion\x20of\x20lanosterol\x20to\x20ergosterol.\x20This\x20results\x20in\x20the\x20depletion\x20of\x20membrane\x20ergosterol.</p>\x0a<p><strong>Therapeutic\x20uses</strong>\x20of\x20fluconazole-</p>\x0a<ul>\x0a<li><strong>Oropharyngeal\x20candidiasis</strong>\x20can\x20be\x20treated\x20with\x20fluconazole\x20by\x20taking\x20100200\x20mg\x20a\x20day\x20for\x20714\x20days.\x20Uncomplicated\x20<strong>vaginal\x20candidiasis</strong>\x20can\x20be\x20effectively\x20treated\x20with\x20a\x20single\x20150\x20mg\x20dose.\x20Treatment\x20of\x20candidemia\x20in\x20nonimmunosuppressed\x20patients\x20involves\x20a\x20loading\x20dosage\x20of\x20800\x20mg,\x20followed\x20by\x20400\x20mg\x20daily.</li>\x0a<li>For\x20the\x20first\x20eight\x20weeks\x20of\x20the\x20consolidation\x20phase\x20of\x20the\x20therapy\x20of\x20<strong>cryptococcal\x20meningitis</strong>\x20in\x20individuals\x20with\x20AIDS,\x20fluconazole\x20is\x20administered.</li>\x0a<li>Due\x20to\x20its\x20excellent\x20CSF\x20penetration\x20and\x20significantly\x20lower\x20morbidity\x20than\x20intrathecal\x20amphotericin\x20B,\x20fluconazole\x20is\x20the\x20medication\x20of\x20choice\x20for\x20treating\x20<strong>coccidioidal\x20meningitis</strong>.\x20Fluconazole\x20is\x20similar\x20to\x20itraconazole\x20in\x20treating\x20various\x20types\x20of\x20coccidioidomycosis.</li>\x0a</ul>\x0a<p>Other\x20options</p>\x0a<p>Option\x20A-\x20<strong>Amphotericin\x20B</strong>\x20acts\x20by\x20<strong>forming\x20pores\x20</strong>in\x20the\x20fungal\x20<strong>cell\x20membrane.</strong>\u00a0It\x20has\x20also\x20been\x20found\x20that\x20it\x20forms\x20aggregates\x20that\x20sequester\x20ergosterol\x20from\x20lipid\x20bilayers,\x20leading\x20to\x20fungal\x20cell\x20death.\x20It\x20is\x20indicated\x20in\x20invasive\x20mucormycosis,\x20fungal\x20endophthalmitis\x20following\x20pars\x20plana\x20vitrectomy,\x20and\x20induction\x20therapy\x20in\x20cryptococcal\x20meningitis.\u00a0</p>\x0a<p>Option\x20B-\x20<strong>Griseofulvin</strong>\x20acts\x20by\x20<strong>inhibiting\x20microtubule\x20assembly</strong>,\x20disrupting\x20the\x20fungal\x20cell\x20division.\x20It\x20is\x20the\x20drug\x20of\x20choice\x20for\x20tinea\x20capitis\x20in\x20children.\x20It\x20is\x20also\x20effective\x20in\x20treating\x20ringworm\x20of\x20glabrous\x20skin,\x20tinea\x20cruris,\x20tinea\x20corprosis,\x20tinea\x20pedis,\x20and\x20tinea\x20of\x20the\x20hands\x20and\x20beard.\u00a0</p>\x0a<p>Option\x20C-\x20<strong>Terbinafine</strong>\x20acts\x20by\u00a0<strong>inhibiting</strong>\x20<strong>epoxidation\x20of\x20fungal\x20squalene</strong>\x20that<strong>\u00a0</strong>reduces\u00a0ergosterol\x20biosynthesis.\x20It\x20is\x20helpful\x20for\x20treating\x20nail\x20onychomycosis\x20in\x20adults\x20and\x20tinea\x20capitis.</p>','tyOEU','jpSis','rbpiF','Misoprostol','.m3u8','oGztP','5:1','Mark\x20for\x20Review','<div\x20class=\x22glass-light\x20p-4\x20mb-4\x22><img\x20src=\x22','cdrDl','Class\x20IA','progressBar','Closure\x20of\x20patent\x20ductus\x20arteriosus','Sugammadex\x20is\x20a\x20reversal\x20agent\x20for:','EZMhV','ArrowLeft','quizSidebar','sRduA','stringify','A\x2040-year-old\x20female\x20has\x20complaints\x20of\x20marked\x20dryness\x20in\x20her\x20mouth\x20associated\x20with\x20difficulty\x20in\x20swallowing.\x20Schirmer\x27s\x20test\x20is\x20suggestive\x20of\x20severe\x20dry\x20eye.\x20An\x20immunoassay\x20shows\x20the\x20presence\x20of\x20anti-Ro/SS-A\x20and\x20anti-La/SS-B\x20antibodies.\x20Which\x20of\x20the\x20following\x20drugs\x20would\x20be\x20most\x20helpful,\x20with\x20fewer\x20side\x20effects,\x20in\x20this\x20scenario?','Option\x20','Beta-2\x20receptors\x20agonist','1,\x204\x20and\x206','Which\x20of\x20the\x20following\x20is\x20gametocidal\x20to\x20all\x20the\x20species\x20causing\x20malaria?','<div\x20class=\x22glass-light\x20p-4\x20mb-4\x22><audio\x20src=\x22','Glycopyrrolate','LVpGB','createElement','answered','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</button>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20','Twxno','QGAXL','TgeoZ','56915Djlzbm','nav-btn-marked-review','It\x20shows\x20saturable\x20elimination','Correct','lFyPS','RtdJS','XrgjS','All\x20of\x20the\x20following\x20statements\x20are\x20true\x20regarding\x20digoxin,\x20except:','uRkiZ','\x22\x20alt=\x22Explanation\x20Image\x22\x20class=\x22w-full\x20rounded-lg\x22></div>','Sumatriptan','<p><strong>Sugammadex</strong>\x20is\x20a<strong>\x20reversal\x20agent\x20</strong>for\x20<strong>rocuronium</strong>\x20and\x20<strong>vecuronium.</strong></p>\x0a<p>Sugammadex\x20binds\x20to\x20plasma\x20rocuronium\x20and\x20thus\x20decreases\x20the\x20plasma\x20concentration\x20of\x20rocuronium.\x20This\x20forms\x20a\x20concentration\x20gradient\x20of\x20rocuronium\x20due\x20to\x20which\x20it\x20moves\x20from\x20the\x20neuromuscular\x20junction\x20back\x20into\x20the\x20circulation\x20where\x20it\x20quickly\x20bound\x20by\x20free\x20sugammadex.\x20It\x20is\x20not\x20recommended\x20to\x20be\x20used\x20in\x20patients\x20who\x20have\x20severe\x20renal\x20impairment.</p>','EikHp','<p><strong>Ethambutol</strong>\x20is\x20the\x20only\x20<strong>bacteriostatic</strong>\x20agent\x20among\x20the\x20given\x20options.\x20All\x20the\x20options\x20are\x20examples\x20of\x20bactericidal\x20drugs.\x20Therefore,\x20<strong>option\x20D\x20(1,\x202,\x203,\x205)</strong>\x20is\x20the\x20right\x20answer.&nbsp;</p>\x0a<p><strong>Bactericidal</strong>\x20antituberculosis\x20agents\x20(RIPS)</p>\x0a<ul>\x0a<li>R:\x20Rifampicin\x20(R)</li>\x0a<li>I:\x20Isoniazid\x20(H)</li>\x0a<li>P:\x20Pyrazinamide\x20(Z)</li>\x0a<li>S:\x20Streptomycin\x20(S)</li>\x0a</ul>\x0a<p>Treatment\x20regimens\x20for\x20pulmonary\x20tuberculosis\x20and\x20tuberculous\x20meningitis\x20consist\x20of\x20an\x20<strong>initial\x202-month\x20phase\x20of\x20a\x204-drug\x20regimen</strong>,\x20followed\x20by\x20a<strong>\x20continuation\x20phase</strong>\x20of\x20an\x20additional\x20<strong>4\x20months</strong>\x20of\x20isoniazid\x20and\x20rifampin\x20for\x20pulmonary\x20tuberculosis.</p>\x0a<p><strong>Isoniazid</strong>\x20is\x20used\x20for\x20the\x20treatment\x20of\x20<strong>tuberculosis</strong>\x20(as\x20part\x20of\x20combination\x20therapy)\x20or\x20for\x20<strong>latent</strong>\x20<strong>tuberculosis</strong>\x20infection\x20(as\x20monotherapy\x20or\x20part\x20of\x20combination\x20therapy).&nbsp;The\x20antimicrobial\x20activity\x20of\x20INH\x20is\x20selective\x20for\x20mycobacteria,\x20likely\x20due\x20to\x20its\x20ability\x20to\x20inhibit\x20mycolic\x20acid\x20synthesis,\x20which\x20interferes\x20with\x20cell\x20wall\x20synthesis,\x20thereby\x20producing\x20a\x20bactericidal\x20effect&nbsp;</p>\x0a<p><strong>Rifampicin</strong>\x20is\x20thought\x20to\x20inhibit\x20bacterial\x20DNA-dependent\x20RNA\x20polymerase,\x20which\x20appears\x20to\x20occur\x20as\x20a\x20result\x20of\x20drug\x20binding\x20in\x20the\x20polymerase\x20subunit\x20deep\x20within\x20the\x20DNA/RNA\x20channel,\x20facilitating\x20direct\x20blocking\x20of\x20the\x20elongating\x20RNA.\x20Along\x20with\x20Isoniazid,\x20Rifampicin\x20is\x20also\x20given\x20in\x20both\x20the<strong>\x20initial\x20phase\x20and\x20continuation\x20phase</strong>\x20of\x20the\x20treatment\x20of\x20TB.</p>\x0a<p><strong>Pyrazinamide</strong>\x20is\x20most\x20commonly\x20used\x20for\x20the\x20treatment\x20of\x20active\x20tuberculosis\x20(TB)\x20during\x20the<strong>\x20initial\x20phase\x20of\x20therapy</strong>&nbsp;only(generally\x20the\x20first\x20two\x20months\x20of\x20treatment),\x20in\x20combination\x20with\x20other\x20agents.\x20The\x20spectrum\x20of\x20pyrazinamide\x20is<strong>\x20relatively\x20narrow</strong>;\x20it\x20demonstrates\x20clinically\x20significant\x20antibacterial\x20activity\x20only\x20against&nbsp;<em>Mycobacterium\x20tuberculosis</em>&nbsp;and&nbsp;<em>Mycobacterium\x20africanum</em>.</p>\x0a<p><strong>Streptomycin</strong>\x20is\x20an<strong>\x20injectable\x20drug,&nbsp;</strong>also\x20a\x20bactericidal\x20drug\x20used\x20sometimes\x20in\x20the\x20initial\x20phase\x20of\x20treatment\x20of\x20pulmonary\x20TB.</p>\x0a<p><strong>Ethambutol\x20</strong>is\x20the\x20only\x20drug\x20in\x20the\x20initial\x20phase\x20which\x20is\x20an\x20example\x20of\x20a\x20<strong>bacteriostatic</strong>\x20drug.&nbsp;There\x20is\x20evidence\x20that\x20the\x20drug\x20exerts\x20its\x20bacteriostatic\x20activity\x20by\x20virtue\x20of\x20<strong>inhibition\x20of\x20arabinosyl\x20transferase</strong>,\x20an\x20enzyme\x20that\x20polymerizes\x20arabinose\x20into\x20arabinan\x20and\x20then\x20arabinogalactan,\x20a\x20mycobacterial\x20cell\x20wall\x20constituent.</p>','It\x20inhibits\x20sodium-potassium\x20ATPase\x20pump','laAww','pathname','TNTFG','parse','mvFPi','WeZRJ','VCrJZ','Ibuprofen','yueiV','DzLdy','yfetN','Active\x20peptic\x20ulcer','hofhh','display','toString','Weight\x20gain\x20and\x20edema','jMdzQ','yyfaP','solutionContainer','AdaTE','warn','vKGmP','kCPlU','</span></div>','bNDfJ','AQIVH','scWre','4|2|5|1|3|0','FBuVC','bookmarkBtn','https://dhmbxeygs57ff.cloudfront.net/uploads/13d63b3e86584ea7808ec513c72177ffx720x431.JPEG','A\x2040-year-old\x20male\x20patient\x20has\x20been\x20prescribed\x20a\x20drug\x20that\x20catalyzes\x20the\x20enzymatic\x20oxidation\x20of\x20uric\x20acid\x20into\x20allantoin\x20for\x20the\x20treatment\x20of\x20his\x20chronic\x20gout.\x20What\x20is\x20this\x20drug?','<p><strong>Ticlopidine\x20</strong>acts\x20through\x20the\x20<strong>ADP\x20receptor\x20</strong>of\x20the\x20platelet\x20and\x20prevents\x20its\x20recruitment\x20and\x20activation.</p>\x0a<p><strong>Other\x20drugs\x20that\x20act\x20through\x20the\x20ADP\x20receptor\x20are:</strong></p>\x0a<ul>\x0a<li>Clopidogrel</li>\x0a<li>Prasugrel</li>\x0a<li>Cangrelor</li>\x0a<li>Ticagrelor</li>\x0a</ul>\x0a<p><strong>Drugs\x20that\x20act\x20through\x20GPIIb/IIIa\x20are:</strong></p>\x0a<ul>\x0a<li>Abciximab</li>\x0a<li>Tirofiban</li>\x0a<li>Eptifibatide</li>\x0a</ul>','XMspZ','userHistory','submitSection','incorrect','CRUmq','totalAttempted','https://dhmbxeygs57ff.cloudfront.net/uploads/0735275b88fc4d678851ba62673b565ex1280x1621.JPEG','className','dEoYu','Afnqu','Meperidine','Streptokinase','B\x20-\x20Griseofulvin','currentQuestionIndex','<p>Among\x20the\x20given\x20options,\x20adenosine\x20is\x20the\x20drug\x20of\x20choice\x20for\x20paroxysmal\x20supraventricular\x20tachycardia.</p>\x0a<ul>\x0a<li>Adenosine\x20is\x20an\x20ultra-short\x20acting\x20drug\x20with\x20half-life\x20being\x20<strong>less\x20than\x2010\x20seconds</strong>.</li>\x0a<li>It\x20activates\x20an\x20<strong>inward\x20rectifier\x20K+\x20current</strong>\x20along\x20with\x20<strong>inhibition\x20of\x20calcium\x20current</strong>.\x20The\x20results\x20of\u00a0these\x20actions\x20are\x20marked\x20hyperpolarization\x20and\x20suppression\x20of\x20calcium-\x20dependent\x20action\x20potentials.</li>\x0a<li>When\x20given\x20as\x20a\x20<strong>bolus\x20dose</strong>,\x20adenosine\x20directly\x20inhibits\x20<strong>AV\x20nodal\x20conduction</strong>\x20but\x20has\x20lesser\x20effects\x20on\x20the\x20SA\x20node.</li>\x0a<li>Currently,\u00a0Adenosine\x20is\x20used\x20for\x20prompt\x20conversion\x20of\x20<strong>paroxysmal\x20supraventricular\x20tachycardia</strong>\x20to\x20sinus\x20rhythm\x20because\x20of\x20its\x20high\x20efficacy\x20(9095%)\x20and\x20very\x20short\x20duration\x20of\x20action.\x20It\x20is\x20usually\x20given\x20in\x20a\x20bolus\x20dose\x20of\x20<strong>6\x20mg\x20f</strong>ollowed\x20by\x20a\x20dose\x20of\x20<strong>12\x20mg</strong>,\x20if\x20required.</li>\x0a<li><strong>Flushing,\x20shortness\x20of\x20breath\x20and\x20chest\x20burning</strong>\x20are\x20some\x20of\x20its\x20adverse\x20effects.</li>\x0a</ul>','currentMode','UQqYn','wFTwO','Morphine','mhLyh','You\x20have\x20reached\x20the\x20end\x20of\x20the\x20quiz.\x20Would\x20you\x20like\x20to\x20submit\x20your\x20answers\x20now?','Identify\x20the\x20drug\x20which\x20causes\x20this\x20adverse\x20effect\x20________','https://cdn1.dailyrounds.org/uploads/d902400ccd9346d68492bfed78e061bb.JPEG','WDHCz','findIndex','https://dhmbxeygs57ff.cloudfront.net/uploads/c09cde7947f64b44a589f3cc2e9221a7x1279x1689.JPEG','FyrvD','neANu','VRBpw','correctResult','return\x20(function()\x20','RRGRU','EwVmB','BzSXx','\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<button\x20type=\x22button\x22\x20class=\x22option-button\x20','CcKdQ','DmldA','Prostaglandin\x20antagonist','Dinoprost','No\x20question\x20text\x20available','<p>Disulfiram\x20is\x20used\x20in\x20behavioural\x20modification\x20technique\x20for\x20alcohol\x20de-addiction.\x20The\x20principle\x20of\x20action\x20is\x20<strong>aversive</strong>\x20conditioning.</p>\x0a<p><strong>Disulfiram</strong>&nbsp;is\x20an&nbsp;<strong>irreversible\x20inhibitor&nbsp;</strong>of\x20both\x20cytosolic\x20and\x20mitochondrial\x20forms\x20of<strong>&nbsp;aldehyde\x20dehydrogenase</strong>.\x20Ethanol\x20consumption\x20during\x20disulfiram\x20therapy\x20can\x20lead\x20to\x20increased\x20concentrations\x20of\x20acetaldehyde.\x20Increased\x20acetaldehyde\x20levels\x20can\x20cause\x20flushing,\x20pulsating\x20headache,\x20throbbing\x20pain\x20in\x20head\x20and\x20neck,&nbsp;nausea,\x20vomiting,\x20rashes,\x20respiratory\x20difficulties,\x20chest\x20pain,\x20autonomic\x20manifestations\x20and\x20other\x20aversive\x20reactions.</p>\x0a<p>Disulfiram\x20can\x20only\x20be\x20given\x20to\x20<strong>highly\x20motivated</strong>\x20individuals.&nbsp;Disulfiram\x20should\x20not\x20be\x20administered\x20until\x20the\x20person\x20has\x20abstained\x20from\x20alcohol\x20for\x20at\x20least\x2012\x20hours.\x20The\x20disulfiram-alcohol\x20reaction\x20may\x20occur\x20as\x20long\x20as<strong>\x2014\x20days\x20after\x20the\x20last\x20dose\x20of\x20disulfiram</strong>.</p>\x0a<p>Disulfiram\x20like\x20reaction\x20with\x20alcohol\x20ingestion\x20is\x20also\x20seen\x20with\x20the\x20following\x20drugs:</p>\x0a<ul>\x0a<li>Metronidazole</li>\x0a<li>Sulfonylureas\x20like\x20chlorpropamide</li>\x0a<li>Cephalosporins\x20like&nbsp;cefoperazone,\x20cefamandole</li>\x0a</ul>\x0a<p>Other\x20modalities\x20of\x20treatment:</p>\x0a<ul>\x0a<li><strong>Pharmacotherapy</strong>:\x20Typically\x205-10\x20days,\x20treatment\x20for\x20detoxification:\x20Benzodiazepine\x20and\x20chlordiazepoxide\x20are\x20the\x20drugs\x20of\x20choice.</li>\x0a<li><strong>Rehabilitation\x20programs:</strong>\x20Typically\x2028-day\x20programs,\x20learn\x20about\x20relapse\x20prevention\x20and\x20identification\x20of\x20triggers.</li>\x0a<li><strong>Maintenance\x20phase</strong>:\x20Baclofen,\x20Acamprosate,\x20Naltrexone,\x20Topiramate,\x20SSRI,\x20Ondansetron</li>\x0a<li><strong>Psychotherapy:</strong>\x20Group\x20therapy\x20such\x20as\x20Alcoholics\x20Anonymous</li>\x0a</ul>','explanation_video','It\x20can\x20cause\x20premature\x20ventricular\x20depolarisations','VgqJQ','Acetaminophen','border-red-500','elbkC','fFtCb','<p><strong>Romiplostim\x20</strong>is\x20a<strong>&nbsp;thrombopoietin\x20receptor\x20agonist</strong>.\x20It\x20is\x20used\x20in\x20the\x20management\x20of\x20immune\x20thrombocytopenia\x20(ITP).&nbsp;<strong>Eltrombopag</strong>\x20is\x20also\x20a&nbsp;thrombopoietin\x20receptor\x20agonist.\x20It\x20is\x20used\x20in\x20the\x20treatment\x20of\x20ITP\x20and\x20severe\x20aplastic\x20anemia.</p>\x0a<p>Other\x20options:</p>\x0a<p\x20class=\x22p1\x22>Option\x20A-\x20<strong>Epoetin\x20alfa</strong>\x20and\x20<strong>darbepoetin\x20alfa</strong>\x20are&nbsp;<strong>recombinant\x20human\x20erythropoietin</strong>.\x20They\x20can\x20be\x20used\x20in\x20the\x20treatment\x20of\x20<strong>anemias</strong>\x20associated\x20with\x20surgery,\x20AIDS,\x20cancer\x20chemotherapy,\x20prematurity,\x20and\x20certain\x20chronic\x20inflammatory\x20conditions.&nbsp;</p>\x0a<p\x20class=\x22p1\x22>Option\x20B-\x20<strong>Filgrastim</strong>\x20is\x20a\x20<strong>recombinant&nbsp;granulocyte\x20colony-stimulating\x20factor.&nbsp;</strong>It\x20increases\x20neutrophil\x20production.\x20It\x20is\x20used\x20in\x20the\x20treatment\x20of\x20<strong>neutropenia</strong>.\x20Important\x20adverse\x20reactions\x20include\x20bone\x20pain,\x20local\x20skin\x20reaction,\x20and\x20cutaneous\x20necrotizing\x20vasculitis.</p>\x0a<p\x20class=\x22p1\x22>Option\x20C-\x20<strong>Oprelvekin</strong>\x20is\x20a\x20recombinant\x20<strong>human\x20IL-11</strong>.\x20It\x20increases\x20thrombopoiesis.\x20It\x20is\x20used\x20in\x20the\x20treatment\x20of\x20<strong>thrombocytopenia</strong>\x20due\x20to\x20non-myeloid\x20malignancies.\x20Important\x20adverse\x20effects\x20are&nbsp;fluid\x20retention,\x20tachycardia,\x20palpitation,\x20edema,\x20and\x20shortness\x20of\x20breath.</p>\x0a<p\x20class=\x22p1\x22><strong>Sargramostim</strong>\x20is\x20a\x20recombinant\x20granulocyte-macrophage\x20colony-stimulating\x20factor.\x20It\x20stimulates\x20<strong>myelopoiesis</strong>.\x20Important\x20adverse\x20effects\x20are&nbsp;bone\x20pain,\x20malaise,\x20flu-like\x20symptoms,\x20diarrhea,\x20dyspnea,\x20and\x20rash.</p>','notAttempted','aCCex','UaisM','thhAu','vtnMC','Methadone','reviewQuestionsContainer','C\x20-\x20Amphotericin','mgrpD','glass-light\x20px-6\x20py-3\x20text-white\x20hover:bg-yellow-500\x20hover:bg-opacity-20\x20transition-all\x20duration-300\x20flex\x20items-center','fcvSk','Physostigmine','.option-button','toggle','HHbOT','ltvkL','Switch\x20to\x20ranitidine\x20along\x20with\x20sucralfate','Osteoporosis','The\x20image\x20below\x20shows\x20the\x20life\x20cycle\x20of\x20a\x20virus.\x20Which\x20of\x20the\x20following\x20drugs\x20acts\x20at\x20step\x205?','RZRzv','<p><strong>Primaquine</strong>\x20is\x20<strong>gametocidal</strong>\x20<strong>to\x20all\x20species</strong>\x20causing\x20malaria.\x20It\x20inhibits\x20transmission\x20of\x20malaria.</p>\x0a<p>The\x20drugs\x20with\x20clinically\x20important\x20gametocidal\x20activity\x20(against\x20all\x20species)\x20are:</p>\x0a<ul>\x0a<li>High\x20activity:\x0a<ul>\x0a<li>Artemisinins</li>\x0a<li>Primaquine</li>\x0a</ul>\x0a</li>\x0a<li>Low\x20to\x20moderate\x20activity:\x0a<ul>\x0a<li>Chloroquine</li>\x0a<li>Quinine</li>\x0a<li>Atovaquone/proguanil</li>\x0a</ul>\x0a</li>\x0a<li>No\x20activity:\x0a<ul>\x0a<li>Mefloquine</li>\x0a<li>Pyrimethamine</li>\x0a<li>Sulfadoxine</li>\x0a<li>Tetracycline</li>\x0a</ul>\x0a</li>\x0a</ul>','Inhaled\x20nitric\x20oxide\x20(NO)','style','https://cdn1.dailyrounds.org/uploads/e3e18e474cbb42dfb5c02f37d96d3b78.jpg','endsWith','<p><strong>Glimepiride\x20</strong>can\x20be\x20given\x20to\x20this\x20patient.\x20It\x20belongs\x20to\x20the\x20class\x20called\x20sulfonylureas.</p>\x0a<p>Sulfonylureas\x20act\x20by&nbsp;<strong>closing\x20the\x20ATP-sensitive\x20K\x20channels</strong>&nbsp;in\x20the\x20<strong>beta-cells</strong>\x20of\x20the\x20pancreas.\x20This\x20closure\x20causes\x20cell\x20membrane\x20depolarization\x20and\x20the\x20release\x20of\x20insulin.\x20They\x20are\x20readily\x20absorbed\x20from\x20the\x20gastrointestinal\x20tract\x20and\x20therefore\x20can\x20be\x20given\x20orally.\x20Important\x20sulfonylureas\x20are\x20<strong>glimepiride,\x20glipizide,\x20glyburide</strong>,\x20etc.</p>\x0a<p>Important\x20adverse\x20effects\x20are\x20<strong>hypoglycemia,&nbsp;</strong>vomiting,\x20cholestatic\x20jaundice,\x20agranulocytosis,\x20and\x20aplastic\x20and\x20hemolytic\x20anemias.\x20They\x20can\x20also\x20cause\x20a\x20disulfiram-like\x20reaction.\x20They\x20should\x20be\x20used\x20with\x20caution\x20in\x20pregnancy,\x20lactation,\x20and&nbsp;significant\x20hepatic\x20or\x20renal\x20insufficiency\x20(for\x20the\x20older\x20forms).</p>\x0a<p>Other\x20options</p>\x0a<p>Option\x20A-\x20<strong>Pioglitazone</strong>\x20belongs\x20to\x20a\x20class\x20of\x20<strong>thiazolidinediones</strong>.\x20It\x20activates\x20the\x20peroxisome\x20proliferator-activated\x20receptor\x20&gamma;&nbsp;<strong>(PPAR&gamma;)</strong>\x20and\x20increases\x20insulin\x20sensitivity.\x20Apart\x20from\x20weight\x20gain,\x20it\x20also\x20causes\x20edema\x20and\x20fluid\x20retention.\x20It\x20increases\x20the\x20plasma\x20volume\x20and\x20is\x20therefore\x20unsuitable\x20for\x20heart\x20failure\x20patients.</p>\x0a<p>Option\x20B-\x20<strong>Exenatide</strong>\x20is\x20a\x20glucagon-like\x20peptide-1\x20(<strong>GLP-1</strong>)\x20receptor\x20agonist.\x20It\x20stimulates\x20insulin\x20secretion,\x20inhibits\x20glucagon\x20release,\x20delays\x20gastric\x20emptying,\x20reduces\x20food\x20intake,\x20and\x20normalizes\x20fasting\x20and\x20postprandial\x20insulin\x20secretion.\x20It\x20is\x20given\x20<strong>subcutaneously.</strong>&nbsp;It\x20can\x20also\x20cause\x20pancreatitis,\x20and\x20therefore\x20is\x20not\x20used\x20in\x20patients\x20with\x20a\x20history\x20or\x20risk\x20of\x20developing\x20<strong>pancreatitis.</strong></p>\x0a<p>Option\x20D-\x20<strong>Teduglutide</strong>\x20is\x20a\x20glucagon-like\x20peptide-2\x20(<strong>GLP-2</strong>)&nbsp;analog.\x20It\x20enhances\x20the\x20growth\x20of\x20intestinal\x20mucosa.\x20It\x20is\x20used\x20in\x20the\x20treatment\x20of\x20<strong>short\x20bowel\x20syndrome</strong>\x20and\x20not\x20diabetes\x20mellitus.\x20It\x20is\x20administered\x20parenterally\x20and\x20discontinued\x20in\x20patients\x20with\x20active\x20gastrointestinal\x20malignancy.</p>\x0a<p>&nbsp;</p>','LCApn','optionsContainer','Alcohol','EjMjF','block','Are\x20you\x20sure\x20you\x20want\x20to\x20retake\x20the\x20quiz?\x20This\x20will\x20reset\x20all\x20your\x20answers.','oiyHz','text','statsBar','Enterococcus\x20faecium\x20is\x20resistant\x20to\x20imipenem.','<p>The\x20image\x20shows<strong>\x20pitting\x20pedal\x20edema</strong>\x20in\x20a\x20hypertensive\x20patient.\x20<strong>Calcium\x20channel\x20blockers\x20(CCBs)</strong>\x20like\x20<strong>amlodipine</strong>\x20are\x20most\x20likely\x20to\x20be\x20associated\x20with\x20peripheral\x20edema.</p>\x0a<p>The\x20frequency\x20of\x20CCB-\x20induced\x20peripheral\x20edema\x20is\x20both\x20<strong>drug-specific</strong>\x20(i.e\x20more\x20potent\x20drugs\x20like\x20amlodipine\x20will\x20be\x20associated\x20with\x20higher\x20rates\x20of\x20developing\x20edema)\x20and\x20<strong>dose-dependent</strong>\x20(i.e\x20incidence\x20of\x20edema\x20increases\x20with\x20an\x20increase\x20in\x20drug\x20dosage\x20and\x20chronicity\x20of\x20its\x20usage).\x20It\x20is\x20more\x20common\x20among\x20<strong>females.</strong></p>\x0a<p>CCB-induced\x20peripheral\x20edema\x20occurs\x20due\x20to\x20a\x20disproportionate\x20decrease\x20in\x20the&nbsp;arteriolar\x20resistance\x20than\x20in\x20the\x20venous\x20circulation,\x20resulting\x20in\x20increased&nbsp;hydrostatic\x20pressure\x20in\x20the\x20precapillary\x20circulation.\x20This\x20leads\x20to\x20a\x20fluid\x20shift&nbsp;into\x20the\x20interstitial\x20compartment\x20causing\x20edema.</p>\x0a<p>Treatment:</p>\x0a<ul>\x0a<li>Dose\x20reduction.</li>\x0a<li>Interclass\x20switching\x20of\x20CCB\x20-\x20switch\x20to\x20non-dihydropyridines\x20like\x20verapamil,\x20and\x20diltiazem.</li>\x0a<li>Addition\x20of\x20a\x20venodilator\x20-\x20ACE\x20inhibitor,\x20ARBs,\x20Nitrates.</li>\x0a<li>Others\x20-\x20compression\x20stockings,\x20avoiding\x20prolonged\x20upright\x20position.</li>\x0a<li>Definitive\x20treatment\x20would\x20be\x20discontinuation\x20of\x20the\x20CCB\x20and\x20switching\x20to\x20another\x20class\x20of\x20antihypertensives.</li>\x0a</ul>\x0a<p>Other\x20options:</p>\x0a<p>Option\x20A:\x20Common\x20side\x20effects\x20of\x20<strong>ACE\x20inhibitors</strong>\x20like\x20<strong>enalapril\x20</strong>include\x20hypotension,\x20hyperkalemia,\x20dry\x20cough,\x20rashes,\x20urticaria,\x20dysgeusia,\x20gastrointestinal\x20upset,\x20headache,\x20and\x20dizziness.</p>\x0a<p>Option\x20B:<strong>&nbsp;Telmisartan</strong>,\x20an\x20angiotensin\x20receptor\x20blocker\x20(<strong>ARBs)</strong>,\x20causes\x20adverse\x20effects\x20such\x20as\x20hypotension,\x20hyperkalemia,\x20headache,\x20gastrointestinal\x20upset,\x20and\x20dizziness.</p>\x0a<p>Option\x20D:\x20Adverse\x20effects\x20of\x20<strong>thiazide\x20diuretics</strong>\x20like\x20<strong>hydrochlorothiazide</strong>\x20are\x20hypokalemia,\x20hyponatremia,\x20hyperglycemia,\x20hyperuricemia,\x20hypercalcemia,\x20rashes,&nbsp;headache,\x20gastrointestinal\x20upset,\x20and\x20dizziness.</p>','https://cdn1.dailyrounds.org/uploads/168a64855ada4af7a5a6837afe6ccae5.JPEG','lKDXk','ytLHS','Methanol','1\x20and\x203','<p>The\x20drug\x20prescribed\x20is\u00a0<strong>bosentan</strong>.\u00a0</p>\x0a<p>The\x20clinical\x20scenario\x20of\x20the\x20development\x20of\x20<strong>nasal\x20congestion\x20and\x20pharyngitis</strong>\x20after\x20administration\x20of\x20an\x20<strong>endothelin\x20receptor\x20antagonis</strong>t\x20given\x20for\x20the\x20treatment\x20of\x20pulmonary\x20artery\x20hypertension\x20suggests\x20that\x20the\x20drug\x20prescribed\x20is\x20bosentan.</p>\x0a<ul>\x0a<li><strong>ET</strong><sub><strong>A</strong>\x20-\u00a0</sub>This\x20receptor\x20is\x20localized\x20on\x20the<strong>\x20pulmonary\x20artery\x20smooth\x20muscle\x20cell</strong>.\x20It\x20is\x20a\x20<strong>G-protein\x20coupled\x20receptor\u00a0</strong>and\x20acts\x20via\x20the\x20<strong>IP<sub>3</sub>-DAG</strong>\x20pathway\x20elevating\x20cytosolic\x20Ca<sup>2+\u00a0</sup>thus\x20causing\x20<strong>vasoconstriction</strong>.</li>\x0a<li><strong>ET<sub>B</sub></strong>\x20-\x20This\x20receptor\x20is\x20present\x20on\x20the\x20pulmonary\x20artery\x20smooth\x20muscle\x20cell\x20and\x20<strong>endothelial\x20cell</strong>.\x20It\x20is\x20a\u00a0<strong>G-protein\x20coupled\x20receptor\u00a0</strong>and\x20on\x20activation,\x20the\u00a0ET<sub>B\u00a0</sub>receptors\x20on\x20the\x20endothelial\x20cells\x20increase\x20the\x20production\x20of\x20<strong>PGI<sub>2,\u00a0</sub>NO\x20and\x20inhibit\x20ET-1\x20production.</strong></li>\x0a</ul>\x0a<p>Endothelin\x20receptor\x20antagonists\x20act\x20by\x20either\x20non-selectively\x20inhibiting\x20both\x20endothelin\x20receptors\x20or\x20by\x20selectively\x20inhibiting\u00a0ET<sub>A\x20</sub>receptors\x20only.\x20The\x20<strong>nonselective\x20</strong>endothelin\x20receptor\x20antagonists\x20are\u00a0<strong>bosentan\u00a0</strong>and\u00a0<strong>macitentan.\u00a0</strong>The\x20<strong>selective</strong>\x20endothelin\x20receptor\x20antagonists\x20are\u00a0<strong>ambrisentan\u00a0</strong>and\u00a0<strong>sitaxsentan.\u00a0</strong><strong>Sitaxsentan</strong>\x20is\x20the\x20<strong>most\x20selective</strong>\u00a0<strong>ET<sub>A</sub></strong>\x20receptor\x20<strong>antagonist.</strong>\u00a0These\x20drugs\x20are\x20predominantly\x20used\x20in\x20the\x20treatment\x20of\x20pulmonary\x20artery\x20hypertension.</p>\x0a<p>Side\x20effects:</p>\x0a<ul>\x0a<li><strong>Headache</strong></li>\x0a<li><strong>Pulmonary\x20edema</strong></li>\x0a<li><strong>Nasal\x20congestion</strong>/<strong>pharyngitis</strong></li>\x0a<li><strong>Hepatotoxicity\x20-\u00a0</strong>\x20needs\x20monitoring\x20and\u00a0<strong>contraindicated\u00a0</strong>in\x20patients\x20with\x20mild-moderate\x20liver\x20disease.</li>\x0a<li><strong>Teratogenic</strong>\x20-\u00a0<strong>contraindicated\u00a0</strong>in\u00a0<strong>pregnancy</strong>.</li>\x0a</ul>\x0a<p>Other\x20options:</p>\x0a<p>Option\x20A-\x20<strong>Epoprostenol</strong>\x20is\x20a\x20<strong>synthetic\u00a0PGI</strong><sub><strong>2</strong>,\u00a0</sub>It\x20acts\x20by\x20inhibiting\x20myosin\x20light\x20chain\x20kinase\x20and\x20activating\x20K+\x20channels.\x20It\x20is\x20the\x20mainstay\x20of\x20treatment\x20of\x20pulmonary\x20artery\x20hypertension,\x20particularly\x20in\x20advanced\x20stages.\x20The\x20important\x20side\x20effects\x20include\u00a0<strong>myalgia,\x20jaw\x20pain,\x20nausea,\x20flushing,\x20and\x20systemic\x20hypotension.</strong></p>\x0a<p>Option\x20C-\x20<strong>Inhaled\x20NO</strong>\u00a0acts\x20by\x20<strong>activation</strong>\x20of<strong>\x20soluble\x20guanylyl\x20cyclase</strong>\x20\x20activates\x20cyclic\x20guanosine\x20monophosphate\x20(cGMP).\x20An\x20important\x20side\x20effect\x20is\x20<strong>methemoglobinemia.</strong></p>\x0a<p>Option\x20D-\x20<strong>Sildenafil</strong>\x20acts\x20by\x20competitive\x20<strong>inhibition</strong>\x20of\x20<strong>phosphodiesterase</strong>\u00a0<strong>5</strong>\x20(PDE5).\x20Important\x20side\x20effects\x20are\u00a0<strong>headache,\x20flushing\u00a0</strong>and\u00a0<strong>blue-green\x20vision</strong>.</p>','correct','Class\x20IIA','DOMContentLoaded','1,\x202,\x203','LApFx','TAFZS','DLwsZ','YgXZh','yDqgI','Bethanechol','Known\x20malignant\x20intracranial\x20neoplasm','SaCow','RAAmO','fromCharCode','question_images','Tolterodine','lTdws','testModeReviewLegend','Eqpko','nXEgU','96\x20healthy\x20volunteers\x20in\x20an\x20open-label\x20study,\x20to\x20study\x20adverse\x20effects','target','It\x20can\x20be\x20initiated\x20even\x20in\x20minimally\x20motivated\x20person','A\x2010-year-old\x20girl\x20was\x20brought\x20with\x20complaints\x20of\x20vomiting\x20and\x20altered\x20consciousness.\x20She\x20was\x20recently\x20diagnosed\x20with\x20an\x20influenza\x20infection\x20and\x20was\x20started\x20on\x20an\x20antipyretic\x20for\x20fever.\x20Laboratory\x20tests\x20showed\x20increased\x20levels\x20of\x20liver\x20enzymes\x20but\x20normal\x20serum\x20bilirubin\x20levels.\x20What\x20could\x20have\x20been\x20the\x20prescribed\x20antipyretic\x20in\x20this\x20case?','fjfzL','Aspirin','Identify\x20the\x20incorrect\x20statement\x20regarding\x20carbapenems.','XpCGr','<p><strong>Methadone</strong>\u00a0is\x20used\x20for\x20the\x20maintenance\x20of\x20<strong>opioid\x20(heroin)\x20dependence</strong>\x20as\x20a\x20<strong>substitute\x20therapy</strong>\x20because\x20of\x20its\x20good\x20oral\x20bioavailability\x20and\x20long\x20half-life.\u00a0</p>\x0a<p>Methadone\x20is\x20substituted\x20for\x20opioids\x20during\x20detoxification\x20to\x20avoid\x20withdrawal\x20symptoms.\u00a0Once\x20stabilized,\x20the\x20dose\x20is\x20gradually\x20reduced\x20and\x20the\x20drug\x20is\x20stopped\x20slowly\x20over\x20days.\u00a0Because\x20of\x20its\x20long\x20half-life\x20and\x20accumulation\x20in\x20tissues,\x20discontinuing\x20the\x20drug\x20still\x20results\x20in\x20low\x20concentrations\x20of\x20the\x20drug\x20in\x20plasma\x20resulting\x20in\x20protracted\x20withdrawal\x20symptoms.</p>\x0a<p><strong>Treatment\x20for\x20opioid\x20dependence</strong></p>\x0a<p><strong>Maintainance\x20phase</strong>:\x20to\x20decrease\x20the\x20severity\x20of\x20withdrawal\x20symptoms.</p>\x0a<ul>\x0a<li>Oral\x20mu\x20agonist:\x20a\x20safe\x20substitute\x20like\x20methadone\x20is\x20given\x20in\x20a\x20supervised\x20manner\x20to\x20prevent\x20withdrawal\x20symptoms.</li>\x0a<li>Long\x20acting\x20agonist:\x20buprenorphine\x20can\x20also\x20be\x20used.</li>\x0a<li>Clonidine,\x20lofexidine\x20reduce\x20the\x20withdrawal\x20symptoms\x20and\x20anxiety</li>\x0a<li>Methadone,\x20buprenorphine,\u00a0LAAM(L-Alpha-Acetyl-Methadol):\x20opioid\x20agonists\x20which\x20reduce\x20craving.</li>\x0a</ul>\x0a<p><strong>Relapse\x20prevention\x20phase</strong>:</p>\x0a<ul>\x0a<li>Naltrexone:\x20An\x20opioid\x20antagonist\x20that\x20blocks\x20opioid\x20effects.</li>\x0a</ul>\x0a<p>Other\x20options:</p>\x0a<p>Option\x20A-\u00a0<strong>Methylm</strong><strong>orphine</strong>\u00a0(codeine)is\x20an\x20opioid\x20agonist\u00a0used\u00a0for\x20the\x20relief\x20of\x20severe\x20chronic\x20cancer\x20pain\x20and\x20suppression\x20of\x20cough.\u00a0</p>\x0a<p>Option\x20C-\u00a0<strong>Meperidine</strong>\u00a0belongs\x20to\x20a\x20class\x20of\x20opioid\x20analgesics\x20and\x20is\x20similar\x20to\x20morphine.\x20It\x20is\x20used\x20to\x20treat\x20moderate\x20to\x20severe\x20pain.\u00a0</p>\x0a<p>Option\x20D-\u00a0<strong>Methylphenidate</strong>\x20is\x20a\x20<strong>stimulant</strong>\x20used\x20to\x20treat\x20attention\x20deficit\x20hyperactivity\x20disorder\x20(ADHD).</p>','hajCa','correctAnswers','iAXpm','hMhgo','stats','pqHhc','markReviewText','incorrectCount','ywURg','Clonazepam','RvfuZ','<p><span\x20data-preserver-spaces=\x22true\x22>The\x20clinical\x20symptoms\x20together\x20with\x20the\x20presence\x20of\x20anti-Ro/SS-A\x20and\x20anti-La/SS-B\x20antibodies\x20are\x20suggestive\x20of&nbsp;</span><strong><span\x20data-preserver-spaces=\x22true\x22>Sjogren\x20syndrome.\x20Cevimeline</span></strong><span\x20data-preserver-spaces=\x22true\x22>&nbsp;would\x20be\x20the\x20best\x20drug\x20for\x20treatment\x20in\x20this\x20case.\x20</span></p>\x0a<p><span\x20data-preserver-spaces=\x22true\x22>Cevimeline\x20is\x20a&nbsp;</span><strong><span\x20data-preserver-spaces=\x22true\x22>muscarinic\x20agonist</span></strong><span\x20data-preserver-spaces=\x22true\x22>&nbsp;with\x20an\x20affinity\x20for\x20both&nbsp;</span><strong><span\x20data-preserver-spaces=\x22true\x22>M1</span></strong><span\x20data-preserver-spaces=\x22true\x22>&nbsp;and</span><strong><span\x20data-preserver-spaces=\x22true\x22>&nbsp;M3&nbsp;</span></strong><span\x20data-preserver-spaces=\x22true\x22>receptors\x20on\x20the\x20lacrimal\x20and\x20salivary\x20glands.&nbsp;</span><span\x20data-preserver-spaces=\x22true\x22>While&nbsp;</span><strong><span\x20data-preserver-spaces=\x22true\x22>M1\x20activation\x20</span></strong>results\x20in\x20<strong><span\x20data-preserver-spaces=\x22true\x22>increased\x20secretion</span></strong><span\x20data-preserver-spaces=\x22true\x22>,&nbsp;</span><strong><span\x20data-preserver-spaces=\x22true\x22>M3\x20activation\x20</span></strong>results\x20in<strong><span\x20data-preserver-spaces=\x22true\x22>\x20smooth\x20muscle\x20contraction</span></strong><span\x20data-preserver-spaces=\x22true\x22>,\x20and\x20expulsion\x20of\x20the\x20secretions.</span></p>\x0a<p><span\x20data-preserver-spaces=\x22true\x22>Cevimeline\x20enhances\x20lacrimal\x20secretions\x20in&nbsp;</span><strong><span\x20data-preserver-spaces=\x22true\x22>Sjogren&rsquo;s\x20syndrome.</span></strong></p>\x0a<p><span\x20data-preserver-spaces=\x22true\x22>Cevimeline\x20has\x20a\x20long-lasting\x20sialogogic\x20action.&nbsp;The\x20usual\x20dose\x20is&nbsp;<strong>30\x20mg\x20three\x20times\x20daily.&nbsp;</strong>It\x20has\x20fewer\x20side\x20effects\x20than\x20non-selective\x20pilocarpine.</span></p>','IMYSV','A\x20middle-aged\x20hypertensive\x20man\x20presents\x20with\x20acute\x20onset\x20pain\x20and\x20swelling\x20on\x20his\x20toe\x20over\x20the\x20left\x20foot.\x20Local\x20examination\x20showed\x20a\x20swelling\x20over\x20the\x20first\x20metatarsophalangeal\x20joint\x20of\x20the\x20left\x20foot,\x20as\x20shown\x20below.\x20Which\x20of\x20the\x20following\x20antihypertensive\x20drugs\x20can\x20be\x20safely\x20administered\x20to\x20this\x20patient?','gradient-purple\x20px-6\x20py-3\x20text-white\x20transition-all\x20duration-300\x20flex\x20items-center','nsRLt','nav-btn-not-attempted\x20hover:bg-white\x20hover:bg-opacity-20','MmnAI','lOJTk','BzNra','ksOWl','FRCLn','Ipratropium','quizHierarchy','Chloroquine','<p><strong>Cilastatin</strong>,\x20a\x20dehydropeptidase\x20inhibitor,\x20is\x20<strong>administered\x20with\x20imipenem</strong>\x20(and\x20not\x20meropenem)\x20to\x20prevent\x20its\x20inactivation\x20by\x20renal\x20dehydropeptidase.</p>\x0a<p>Meropenem,\x20doripenem,\x20and\x20ertapenem\x20are\x20resistant\x20to\x20inactivation\x20by\x20the\x20enzyme\x20and\x20hence\x20do\x20not\x20need\x20cilastatin.</p>\x0a<p>Other\x20options:</p>\x0a<ul>\x0a<li>Carbapenems\x20are\x20structurally\x20related\x20to\x20beta-lactams\x20and\x20act\x20by\x20<strong>inhibiting\x20cell\x20wall\x20synthesis</strong>.</li>\x0a<li><em>Enterococcus\x20faecium</em>,\x20methicillin-resistant\x20strains\x20of\x20staphylococci<em>,\x20Clostridium\x20difficile</em>,\x20<em>Burkholderia\x20cepacia</em>,\x20and\x20<em>Stenotrophomonas\x20maltophilia</em>\x20are\x20resistant\x20to\x20imipenem.</li>\x0a<li><strong>Ertapenem\x20has\x20longer\x20half-life</strong>\x20than\x20imipenem,\x20meropenem\x20and\x20<strong>can\x20be\x20given\x20as\x20one\x20daily\x20dose</strong>.</li>\x0a</ul>','Are\x20you\x20sure\x20you\x20want\x20to\x20submit\x20the\x20quiz?','kJpOB','zsBZZ','Inhibits\x20fungal\x20squalene\x20epoxidation','<p><strong>Ergotamine</strong>\x20causes\x20occlusion\x20of\x20peripheral\x20blood\x20vessels\x20in\x20susceptible\x20persons.\x20It\x20acts\x20as\x20a\x20partial\x20agonist\x20and\x20antagonist\x20at&nbsp;&alpha;\x20adrenoreceptors\x20and\x20all\x20subtypes\x20of\x205HT<sub>1</sub>\x20and\x205HT<sub>2</sub>\x20serotonin\x20receptors.</p>\x0a<p>The\x20numbness\x20progressing\x20to\x20bluish\x20discoloration\x20of\x20the\x20fingers\x20are\x20the\x20initial\x20signs\x20of\x20occlusion.\x20It\x20can\x20lead\x20to\x20gangrene\x20if\x20left\x20untreated\x20eventually\x20leading\x20to\x20amputation.\x20Nausea\x20and\x20vomiting,\x20as\x20well\x20as\x20tingling\x20and\x20numbness\x20(paresthesia),\x20are\x20common\x20adverse\x20effects\x20of\x20ergotamine.</p>\x0a<p>Contraindications\x20for\x20ergotamine:&nbsp;</p>\x0a<ul>\x0a<li>Peripheral\x20vascular\x20disease</li>\x0a<li>Coronary\x20artery\x20disease</li>\x0a<li>Uncontrolled\x20hypertension</li>\x0a<li>Fever\x20and/or\x20sepsis</li>\x0a<li>Pregnancy</li>\x0a<li>Within\x2024\x20hours\x20of\x20using\x20triptans</li>\x0a</ul>','pLFDK','FQEVd','questionReviewSection','solutionImages','yIrHw','OuiVn','bookmarkedQuestions','A\x2032-year-old\x20lady\x20with\x2030\x20weeks\x20of\x20pregnancy\x20having\x20an\x20obstetric\x20index\x20of\x20G2P1L1\x20presents\x20to\x20the\x20emergency\x20department\x20with\x20labor\x20pain.\x20A\x20senior\x20resident\x20started\x20the\x20patient\x20on\x20the\x20drug\x20ritodrine\x20to\x20prevent\x20preterm\x20labor.\x20This\x20drug\x20prevents\x20labor\x20by\x20acting\x20as\x20_________','gloAS','\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20','194817zmpEMf','join','IIAiB','T1/2\x20remains\x20constant','now','A\x2040-year-old\x20male\x20patient\x20came\x20to\x20the\x20hospital\x20with\x20vomiting.\x20He\x20was\x20prescribed\x20metoclopramide,\x20following\x20which\x20he\x20developed\x20spasms\x20of\x20facial\x20muscles,\x20difficulty\x20in\x20speech,\x20and\x20torticollis.\x20Which\x20of\x20the\x20following\x20drugs\x20is\x20indicated\x20for\x20the\x20treatment\x20of\x20these\x20symptoms?','AXRGk','czYrG','Ticlopidine','VdayE','fuMTg','knaFO','bookmarked','njiRE','None','(((.+)+)+)+$','hierarchy','<div\x20class=\x22mt-4\x22><video\x20id=\x22review-video-','dataset','Inhibits\x20ergosterol\x20biosynthesis','<div\x20class=\x22p-3\x20rounded-lg\x20border\x20','Which\x20of\x20the\x20following\x20drugs\x20is\x20a\x20prostacyclin\x20analog\x20that\x20can\x20be\x20added\x20to\x20the\x20treatment\x20regimen\x20of\x20a\x20patient\x20with\x20pulmonary\x20artery\x20hypertension?','aVSJD','Chloramphenicol','</span><span>','No\x20questions\x20available\x20for\x20this\x20quiz.','SvesJ','test','\x20>\x20','YLtyO','4,\x205\x20and\x206','btFXn','Doxycycline','\x22\x20alt=\x22Question\x20Image\x22\x20class=\x22w-full\x20rounded-lg\x22></div>','PBllD','AmnPm','WxRFJ','Diphenhydramine','WJtTo','pKbSZ','VDVtR','VQkCL','A\x2070\x20year\x20old\x20female\x20presents\x20to\x20the\x20OPD\x20with\x20symptoms\x20of\x20pain\x20in\x20both\x20the\x20knees\x20since\x20the\x20past\x20two\x20years.\x20She\x20has\x20been\x20on\x20calcium\x20and\x20vitamin\x20D\x20supplementation\x20and\x20is\x20doing\x20regular\x20physical\x20exercise.\x20X-ray\x20of\x20the\x20knee\x20joint\x20showed\x20the\x20following.\x20Which\x20would\x20be\x20the\x20first\x20line\x20drug\x20for\x20this\x20condition?','Exenatide','secva','EEQkd','totalTime','NifEv','gTFjv','Gimfr','Epoprostenol','<p><strong>Tolterodine\u00a0</strong>is\x20commonly\x20used\x20in\x20the\x20treatment\x20of\x20the\x20<strong>overactive\x20urinary\x20bladder</strong>.\x20It\x20is\x20a\x20<strong>muscarinic\x20receptor\x20antagonist.\u00a0</strong></p>\x0a<p>In\x20an<strong>\x20overactive\x20bladder</strong>,\x20there\x20is\x20an\x20<strong>overactivity\x20</strong>of\x20the\x20<strong>detrusor\x20muscle</strong>\x20due\x20to\x20the\x20up-regulation\x20of\x20<strong>M3\x20receptors</strong>.\x20Drugs\x20that\x20block\x20these\x20receptors\x20such\x20as\x20tolterodine\x20act\x20by\x20improving\x20bladder\x20capacity,\x20reducing\x20the\x20frequency\x20of\x20bladder\x20contractions,\x20and\x20lowering\x20intravesicular\x20pressure.</p>\x0a<p>Anticholinergics\x20are\x20muscarinic\x20receptor\x20antagonists\x20and\x20parasympatholytics.\x20The\x20important\x20uses\x20of\x20various\x20anticholinergics\x20are\x20as\x20follows:</p>\x0a<ul>\x0a<li>Atropine\x20-\x20for\x20AV\x20block,<strong>\u00a0organophosphorus\x20poisoning</strong>,\u00a0and\u00a0refractive\x20error\x20testing\x20in\x20children\x20(produces\x20cycloplegic\x20mydriasis)</li>\x0a<li>Scopolamine/\x20hyoscine\x20(transdermal\x20patch)\x20-\x20for\x20<strong>motion\x20sickness</strong></li>\x0a<li><strong>Ipratropium</strong>\u00a0-\x20for\x20chronic\x20obstructive\x20pulmonary\x20disease\x20and\x20rhinorrhea\u00a0</li>\x0a<li><strong>Tolterodine</strong>\x20-\x20for\x20childhood\x20<strong>enuresis</strong>,\x20overactive\x20and\u00a0<strong>neurogenic\x20bladder</strong></li>\x0a<li><strong>Pirenzepine\x20</strong>(selective\x20M1\x20receptor\x20antagonist)\x20-\x20for\u00a0peptic\x20ulcer\x20disease\u00a0</li>\x0a<li>Benzhexol/\x20Trihexyphenidyl\x20-\x20for\x20<strong>Parkinson\x27s</strong>\x20<strong>disease</strong>\x20and\x20drug-induced\x20extrapyramidal\x20symptoms</li>\x0a<li><strong>Dicyclomine\x20</strong>(direct\x20spasmolytic\x20effect\x20on\x20GI\x20smooth\x20muscle)\x20-\x20for\u00a0diarrhea-predominant\x20irritable\x20bowel\x20syndrome</li>\x0a<li>Glycopyrrolate\x20(reduces\x20secretions)\x20-\x20as\x20a\x20<strong>pre-anesthetic</strong>\x20medication</li>\x0a</ul>\x0a<p><strong>Adverse\x20effects</strong>\x20of\x20muscarinic\x20antagonists\x20include\x20<strong>dryness\x20of\x20mouth</strong>,\x20<strong>decreased\x20sweating</strong>,\x20thirst,\x20<strong>mydriasis</strong>\x20and\x20blurring\x20of\x20vision,\x20palpitations,\x20and\x20<strong>urinary\x20retention</strong>.\x20CNS\x20effects\x20include\x20restlessness,\x20hallucinations,\x20and\x20delirium.</p>','div','https://dhmbxeygs57ff.cloudfront.net/uploads/b5c17b2e4975432f8879b5c8db3e3577x720x264.PNG','\x22\x20controls\x20class=\x22w-full\x22></audio></div>','floor','title','A\x20patient\x20diagnosed\x20with\x20pulmonary\x20tuberculosis\x20was\x20started\x20on\x20antitubercular\x20therapy.\x20Among\x20the\x20following\x20antitubercular\x20drugs\x20given\x20below,\x20which\x20of\x20the\x20following\x20option\x20selects\x20all\x20the\x20drugs\x20that\x20have\x20a\x20bactericidal\x20action?','xhFpz','Nosxm','data-option-index','MYISi','Enfuvirtide','question_audio','qDcjR','ggeCr','Methimazole','iUiNH','getItem','lBOTD','iuVxU','<div\x20class=\x22mt-4\x22><img\x20src=\x22','\x22><span\x20class=\x22font-bold\x20mr-3\x22>','pMLYX','BcnMJ','Compensated\x20heart\x20failure','border-green-500','trace','lRAAB','canPlayType','EbSSH','https://cdn1.dailyrounds.org/uploads/154676739a8046639bf523c9c152b4c6.JPEG','disabled','dAOJr','add','Brexpiprazole','toISOString','VDKaZ','choices','45952xNDKLO','Marked','LKIcd','nav-btn-correct','Teduglutide','A\x20-\x20Flucytosine','<p><strong>Radioactive\x20iodine\x20therapy</strong>\x20is<strong>\x20contraindicated</strong>\x20during\x20pregnancy\x20and\x20lactation.\x20Therefore,\x20it\x20is\x20not\x20a\x20treatment\x20option\x20in\x20this\x20patient.</p>\x0a<p>Thyrotoxicosis\x20in\x20pregnancy:</p>\x0a<p>The\x20<strong>drug\x20of\x20choice</strong>\x20for\x20the\x20treatment\x20of\x20thyrotoxicosis\x20during\x20the<strong>\x20first\x20trimester\x20</strong>of\x20pregnancy\x20is\x20<strong>propylthiouracil\x20(PTU).</strong></p>\x0a<p>Methimazole\x20and\x20its\x20prodrug\x20(carbimazole)\x20are\x20usually\x20avoided\x20in\x20the\x20first\x20trimester\x20due\x20to\x20<strong>teratogenic\x20risk.</strong>&nbsp;However,\x20methimazole\x20is\x20used\x20for\x20the\x20remainder\x20of\x20the\x20pregnancy\x20due\x20to\x20the\x20concern\x20for\x20<strong>PTU-associated\x20liver\x20failure.</strong>&nbsp;</p>\x0a<p><strong>Subtotal\x20thyroidectomy</strong>\x20can\x20be\x20performed\x20during\x20the\x20<strong>mid-trimester.</strong></p>\x0a<p><strong>Radioactive\x20iodine\x20</strong>crosses\x20the\x20placenta\x20and\x20causes\x20the\x20destruction\x20of\x20the\x20fetal\x20thyroid.\x20Therefore,\x20it&nbsp;is<strong>\x20contraindicated</strong>\x20during\x20pregnancy\x20and\x20lactation.</p>\x0a<p>Treatment\x20of\x20thyrotoxicosis\x20in\x20pregnancy</p>\x0a<table\x20style=\x22height:\x20108px;\x20width:\x20381px;\x22>\x0a<tbody>\x0a<tr\x20style=\x22height:\x2046px;\x22>\x0a<td\x20style=\x22width:\x20137.828125px;\x20height:\x2046px;\x20text-align:\x20center;\x22><strong>Trimester</strong></td>\x0a<td\x20style=\x22width:\x20227.1875px;\x20height:\x2046px;\x20text-align:\x20center;\x22><strong>Treatment\x20for\x20thyrotoxicosis</strong></td>\x0a</tr>\x0a<tr\x20style=\x22height:\x2046px;\x22>\x0a<td\x20style=\x22width:\x20137.828125px;\x20height:\x2046px;\x22><strong>First\x20trimester</strong></td>\x0a<td\x20style=\x22width:\x20227.1875px;\x20height:\x2046px;\x22>\x0a<ul>\x0a<li>Propylthiouracil</li>\x0a</ul>\x0a</td>\x0a</tr>\x0a<tr\x20style=\x22height:\x2064px;\x22>\x0a<td\x20style=\x22width:\x20137.828125px;\x20height:\x2064px;\x22><strong>Second\x20trimester</strong></td>\x0a<td\x20style=\x22width:\x20227.1875px;\x20height:\x2064px;\x22>\x0a<ul>\x0a<li>Methimazole</li>\x0a<li>Subtotal\x20thyroidectomy</li>\x0a</ul>\x0a</td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x20137.828125px;\x22><strong>Third\x20trimester</strong></td>\x0a<td\x20style=\x22width:\x20227.1875px;\x22>\x0a<ul>\x0a<li>Methimazole</li>\x0a</ul>\x0a</td>\x0a</tr>\x0a</tbody>\x0a</table>','Class\x20IB','Switch\x20to\x20etoricoxib\x20instead\x20of\x20NSAIDs\x20and\x20use\x20pantoprazole\x20capsule\x20without\x20chewing','markedForReview','XKCtl','wggkT','classList','flex','Incorrect','pVFfu','Which\x20of\x20the\x20following\x20statements\x20is\x20not\x20true\x20regarding\x20the\x20characteristics\x20of\x20elimination\x20plotted\x20in\x20orange?','QoatZ','Bookmarked','Maintaining\x20the\x20patency\x20of\x20ductus\x20arteriosus','startAt','yKsrC','bind','click','<div><strong>Vericiguat\x20</strong>is\x20an\x20oral\u00a0<strong>soluble\x20guanylate\x20cyclase\x20stimulator</strong>\x20that\x20can\x20be\x20used\x20in\x20the\x20treatment\x20of\x20<strong>chronic\x20heart\x20failure\x20with\x20reduced\x20ejection\x20fraction.</strong></div>\x0a<div>\u00a0</div>\x0a<div>By\x20stimulating\x20guanylate\x20cyclase,\x20it\x20enhances\x20the\x20production\x20of\x20cGMP\x20which\x20leads\x20to\x20smooth\x20muscle\x20relaxation\x20and\x20vasodilatation.\x20It\x20also\x20enhances\x20the\x20sensitivity\x20of\x20soluble\x20guanylate\x20cyclase\x20to\x20endogenous\x20NO\x20which\x20further\x20contributes\x20to\x20increased\x20cGMP.\u00a0</div>\x0a<div>\u00a0</div>\x0a<div>It\x20<strong>reduces\x20the\x20risk\x20of\x20cardiovascular\x20death</strong>\x20following\x20hospitalization\x20for\x20heart\x20failure\x20in\x20symptomatic\x20chronic\x20heart\x20failure\x20and\x20ejection\x20fraction\x20&lt;45%.</div>\x0a<div>\u00a0</div>\x0a<div>Other\x20options:</div>\x0a<div>\u00a0</div>\x0a<div>Option\x20A:\x20<strong>Riociguat</strong>\x20is\x20also\x20a\x20<strong>soluble\x20guanylate\x20cyclase\x20stimulator</strong>\x20but\x20it\x20is\x20used\x20in\x20<strong>pulmonary\x20artery\x20hypertension</strong>\x20and\x20not\x20in\x20heart\x20failure.</div>\x0a<div>\u00a0</div>\x0a<div>Option\x20C:\x20<strong>Omapatrilat</strong>\x20is\x20a\x20<strong>neprilysin\x20and\x20ACE\x20inhibitor</strong>\x20developed\x20for\x20heart\x20failure\x20that\x20is\x20not\x20used\x20due\x20to\x20the\x20side\x20effect\x20of\x20increased\x20levels\x20of\x20bradykinin.\u00a0</div>\x0a<div>\u00a0</div>\x0a<div>Option\x20D:\x20<strong>Treprostinil</strong>\x20is\x20a\x20prostacyclin\x20analog\x20that\x20acts\x20as\x20a\x20<strong>vasodilator</strong>\x20used\x20in\x20the\x20treatment\x20of\x20<strong>pulmonary\x20arterial\x20hypertension.\u00a0</strong></div>','wPuzA','name','<p><span\x20data-preserver-spaces=\x22true\x22>The\x20most\x20common\x20adverse\x20effects\x20of\x20the\x20thiazolidinediones\x20are&nbsp;</span><strong><span\x20data-preserver-spaces=\x22true\x22>weight\x20gain\x20and\x20edema</span></strong><span\x20data-preserver-spaces=\x22true\x22>.</span></p>\x0a<p><span\x20data-preserver-spaces=\x22true\x22>Thiazolidinediones\x20are\x20a\x20selective\x20agonist\x20of\x20nuclear&nbsp;</span><strong><span\x20data-preserver-spaces=\x22true\x22>peroxisome\x20proliferator-activated\x20receptor\x20gamma&nbsp;</span></strong><span\x20data-preserver-spaces=\x22true\x22>(PPAR-&gamma;).\x20They\x20modulate\x20the\x20expression\x20of\x20genes\x20involved\x20in\x20lipid\x20and\x20glucose\x20metabolism,\x20insulin\x20signal\x20transduction,\x20and\x20adipocyte\x20differentiation.\x20These\x20effects\x20increase\x20the\x20sensitivity\x20of\x20the\x20tissues\x20to\x20insulin.</span></p>\x0a<p><span\x20data-preserver-spaces=\x22true\x22>Pioglitazone\x20and\x20rosiglitazone\x20are\x20used\x20to\x20treat\x20patients\x20with\x20type\x202\x20diabetes.\x20They\x20are\x20known\x20to\x20cause\x20f</span>luid\x20retention\x20and\x20edema<span\x20data-preserver-spaces=\x22true\x22>&nbsp;and\x20therefore\x20avoided\x20in\x20patients\x20who\x20have\x20heart\x20failure.&nbsp;</span></p>\x0a<p><span\x20data-preserver-spaces=\x22true\x22>Pioglitazone\x20is\x20metabolized\x20in\x20the\x20liver\x20and\x20constant\x20liver\x20function\x20monitoring\x20is\x20required\x20as\x20it\x20is\x20hepatotoxic.\x20It\x20is\x20thus\x20contraindicated\x20in\x20liver\x20disease.</span></p>','cXuaM','FvYbC','feACS','Suspected\x20aortic\x20dissection','getAttribute','nBjJh','yGHrb','Buspirone','arwHf','eDJjy','A\x2060-year-old\x20male\x20patient,\x20who\x20had\x20undergone\x20renal\x20transplantation,\x20presents\x20to\x20you\x20with\x20severe\x20pain\x20along\x20the\x20back\x20of\x20the\x20leg\x20above\x20the\x20heels.\x20He\x20reports\x20that\x20he\x20has\x20been\x20taking\x20some\x20antibiotics\x20without\x20any\x20doctor\x27s\x20prescription.\x20You\x20suspect\x20Achilles\x20tendon\x20rupture.\x20It\x20is\x20usually\x20seen\x20as\x20a\x20side\x20effect\x20of\x20which\x20of\x20the\x20following\x20antibiotics?','https://dhmbxeygs57ff.cloudfront.net/uploads/83e6ecc6f4954392abde621853e68007x1280x1346.JPEG','250\x20healthy\x20volunteers\x20from\x20the\x20general\x20population,\x20randomized\x20and\x20blinded','68589mzxyUI','JmZHI','Pegloticase','red','3330yCDvAg','Treprostinil','__proto__','explanationVideoPlayer','closest','hDsmZ','TGamg','HWQrq','Losartan','EDVdQ','2|5|4|0|1|3','xSGSW','A\x2030-year-old\x20man\x20came\x20with\x20abdominal\x20cramps,\x20nausea,\x20diarrhea\x20for\x20the\x20past\x20two\x20days.\x20He\x20also\x20reports\x20having\x20body\x20pain,\x20a\x20runny\x20nose,\x20and\x20teary\x20eyes.\x20On\x20examination,\x20his\x20pupils\x20are\x20dilated\x20and\x20he\x20frequently\x20keeps\x20yawning.\x20On\x20probing\x20further,\x20he\x20reluctantly\x20says\x20that\x20he\x20uses\x20recreational\x20drugs.\x20His\x20blood\x20pressure\x20is\x20150/80\x20mm\x20Hg\x20and\x20his\x20heart\x20rate\x20is\x20110.\x20Which\x20of\x20the\x20following\x20drugs\x20is\x20used\x20for\x20the\x20maintenance\x20therapy\x20for\x20his\x20symptoms?','correctCount','RBXRr','elgAm','tsEWy','OCLAZ','VtogO','clCqb','MZLzs','dGFWD','mhFnr','contains','jELyF','timed_exam','log','xYWlb','ikWkJ','status','apply','XZqsF','keydown','tLxNY','split','studyModeLegend','High\x20affinity\x20and\x20zero\x20intrinsic\x20activity','Iloprost','attachMedia','location','iQTLt','tQYKm','https://cdn1.dailyrounds.org/uploads/b656eec2969545cab6981b79ab874ed5.JPEG','It\x20is\x20an\x20anticraving\x20drug','SlufZ','Cocaine','getElementById','Primaquine','nav-btn-answered','padStart','vziKa','HNOjZ','DuYdZ','LROGi','xRuwB','<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>English\x20Explanation:</p><audio\x20src=\x22','pclfJ','pharmacology-test-ce506547.html','Warfarin','frLyW','Sulln','zvLDC','Distal\x20convoluted\x20tubule','totalTimeResult','mdgkm','5548\x20patients\x20with\x20RCC\x20in\x20an\x20open-label\x20observational\x20study','questionNav','sryal','myUsv','Aripiprazole','solutionText','timed_study','hmUrw','QYktb','iMxPa','video[data-src]','timeSpent','Which\x20of\x20the\x20following\x20anti-glaucoma\x20agents\x20has\x20no\x20effect\x20on\x20aqueous\x20outflow?','</span>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22text-white\x20mb-4\x22>','incorrectAnswers','modeModal','iFLEj','1:20','Methylmorphine','Cotrimoxazole','<p>In\x20the\x20given\x20image,\x20the\x20orange\x20line\x20depicts&nbsp;<strong>zero-order\x20elimination</strong>.\x20The\x20incorrect\x20statement\x20about\x20this\x20type\x20of\x20elimination\x20is\x20that&nbsp;t&frac12;\x20remains\x20constant.&nbsp;In\x20zero-order\x20elimination,\x20the\x20<strong>t&frac12;</strong>\x20is\x20<strong>not\x20constant&nbsp;</strong>and&nbsp;is\x20less\x20at\x20low\x20concentration\x20and\x20more\x20at\x20high\x20concentration.</p>\x0a<p>Zero-order\x20kinetics\x20denotes\x20that\x20the\x20<strong>rate\x20of\x20elimination</strong>\x20is\x20<strong>constant</strong>&nbsp;regardless\x20of\x20the\x20concentration\x20of\x20the\x20drug.\x20Here\x20a\x20<strong>fixed&nbsp;amount</strong>\x20of\x20drug\x20is\x20cleared\x20per\x20unit\x20time.\x20This\x20is\x20usually\x20seen\x20when\x20the\x20drugs\x20<strong>saturate</strong>\x20their\x20elimination\x20mechanisms.\x20Therefore,\x20as\x20the\x20concentration\x20of\x20the\x20drug\x20increases\x20beyond\x20metabolic\x20saturation,\x20clearance\x20of\x20the\x20drug\x20decreases\x20as\x20depicted\x20by\x20the\x20<strong>orange\x20line.&nbsp;</strong>Drugs\x20such\x20as<strong>\x20phenytoin</strong>,\x20and\x20<strong>aspirin</strong>\x20follow\x20this\x20type\x20of\x20elimination\x20at\x20higher\x20concentrations.&nbsp;</p>\x0a<p><strong>First-order\x20kinetics</strong>\x20denotes\x20that\x20the\x20<strong>rate\x20of\x20elimination</strong>\x20is\x20<strong>proportional</strong>\x20to\x20the&nbsp;<strong>plasma\x20concentration</strong>\x20of\x20the\x20drug.\x20Here\x20a&nbsp;<strong>constant&nbsp;</strong><strong>fraction</strong>\x20of\x20the\x20drug\x20is\x20eliminated.\x20The\x20drugs\x20following\x20this\x20elimination\x20have\x20a\x20<strong>constant&nbsp;&nbsp;t&frac12;</strong>.&nbsp;As\x20the\x20dosage\x20of\x20the\x20drug\x20increases,\x20the\x20clearance\x20remains\x20constant\x20as\x20the\x20fraction\x20of\x20drug\x20eliminated\x20is\x20constant\x20as\x20depicted\x20by\x20the\x20<strong>black\x20line</strong>.\x20Most\x20drugs\x20follow\x20this\x20type\x20of\x20elimination.&nbsp;</p>','LTUch','D\x20-\x20Terbinafine','rqUlz','VorOl','setItem','isqms','ZZItd','Liver\x20dysfunction','Raloxifene','WBLNd','dPWNT','Obwzu','DlrXI','KqfuG','mBHWG','BkbEo','Year\x202023\x20-\x2024','wUIXS','Clozapine','BdxBP','<p>In\x20this\x20case,\x20the\x20patient\x20has\x20developed\x20symptoms\x20of<strong>\x20dystonia\x20</strong>due\x20to\x20<strong>metoclopramide.\x20Diphenhydramine\u00a0</strong>is\x20used\x20in\x20<strong>drug-induced\x20dystonia</strong>.</p>\x0a<p>Metoclopramide\x20has<strong>\u00a0</strong>dopamine\x20receptor\x20antagonist,\x205HT4\x20agonist,\x20and\x205HT3\x20antagonist\x20properties.\x20It\x20is\x20indicated\x20in\x20patients\x20with\x20<strong>gastroparesis</strong>\x20and\x20is\x20also\x20used\x20in\x20<strong>reducing\x20nausea</strong>\x20and\x20vomiting\x20that\x20often\x20accompany\x20GI\x20dysmotility\x20syndromes.</p>\x0a<p><strong>Dopamine</strong>\x20receptor\x20<strong>antagonist</strong>\x20property\x20is\x20responsible\x20for\x20<strong>extrapyramidal\x20symptoms</strong>.\x20The\x20dystonic\x20reaction\x20is\x20one\x20of\x20the\x20extrapyramidal\x20symptoms.\x20Features\x20include\x20spasms\x20of\x20muscles\x20of\x20the\x20tongue,\x20face,\x20neck,\x20and\x20back.\x20It\x20can\x20be\x20treated\x20with\x20<strong>diphenhydramine\x20</strong>or<strong>\x20benztropine</strong>.</p>\x0a<p>Other\x20extrapyramidal\x20symptoms\x20include<strong>\x20parkinsonian-like\x20symptoms</strong>\x20that\x20may\x20occur\x20several\x20weeks\x20after\x20initiation\x20of\x20therapy.\x20It\x20responds\x20to\x20treatment\x20with\x20anticholinergic\x20or\x20antihistaminic\x20drugs\x20and\x20reverses\x20on\x20discontinuation\x20of\x20metoclopramide.\u00a0<strong>Tardive\x20dyskinesia</strong>\u00a0can\x20develop\x20in\x20patients\x20treated\x20for\x20a\x20<strong>prolonged\x20period</strong>\x20with\x20metoclopramide.</p>\x0a<p><strong>Other\x20options:</strong></p>\x0a<p>Option\x20A:\x20<strong>Phenelzine</strong>\x20is\x20a\u00a0<strong>monoamine\x20oxidase\x20(MAO)\x20inhibitor</strong>.\x20It\x20inhibits\x20MAO<sub>A</sub>\x20and\x20MAO<sub>B</sub>\x20to\x20prevent\x20the\x20breakdown\x20of\x20norepinephrine,\x20dopamine,\x20and\x20serotonin.\x20It\x20is\x20used\x20in\x20the\x20treatment\x20of\x20major\x20depression.\x20The\x20major\x20adverse\x20effects\x20include\x20weight\x20gain,\x20sexual\x20dysfunction,\x20and\x20<strong>hypertensive\x20crisis</strong>\x20if\x20taken\x20along\x20with\x20tyramine-containing\x20foods/\x20beverages.</p>\x0a<p>Option\x20C:\x20<strong>Chlorpromazine</strong>\x20is\x20a\x20<strong>dopamine\x20receptor\x20antagonist</strong>\x20and\x20is\x20classified\x20under\x20typical\x20antipsychotics.\x20They\x20are\x20noted\x20to\x20improve\x20the\x20positive\x20symptoms\x20of\x20schizophrenia\x20and\x20acute\x20mania.\x20The\x20major\x20adverse\x20effects\x20are\x20extrapyramidal\x20side\x20effects,\x20sedation,\x20weight\x20gain,\x20hypotension,\x20metabolic\x20adverse\x20effects,\x20and\x20photosensitivity.</p>\x0a<p>Option\x20D:\x20<strong>Prochlorperazine</strong>\x20is\x20a\x20<strong>dopamine\x20receptor\x20antagonist</strong>\x20which\x20is\x20used\x20as\x20an\x20anti-emetic.\x20It\x20is\x20mainly\x20used\x20in\x20motion\x20sickness.\x20The\x20main\x20adverse\x20events\x20are\x20extrapyramidal\x20symptoms\x20including\x20dystonia,\x20cardiac\x20effects,\x20and\x20hypotension.</p>','mwDQX','pDnCp','strokeDasharray','xFYZa','currentQuestion','1:5','WpVvL','toLowerCase','quizPerformanceData','appendChild','Femcu','w-8\x20h-8\x20text-sm\x20font-medium\x20rounded\x20','ANVgF','nav-btn-bookmarked','<p><strong>Achilles\x20tendon\x20rupture</strong>\x20and<strong>\x20tendinitis</strong>\x20are\x20associated\x20side\x20effects\x20of<strong>\x20quinolones</strong>\x20like\x20<strong>ciprofloxacin</strong>.</p>\x0a<p><strong>Elderly\x20patients</strong>\x20(&gt;60\x20years),\x20patients\x20on\x20<strong>corticosteroids</strong>,\x20and\x20<strong>solid\x20organ\x20transplant\x20recipients</strong>\x20are\x20at\x20higher\x20risk\x20of\x20developing\x20this\x20risk\x20factor.\u00a0</p>\x0a<p>Fluoroquinolones\x20inhibit\u00a0<strong>topoisomerase\x20IV</strong>\u00a0in\u00a0<strong>gram-positive</strong>\u00a0bacteria.\u00a0Normally,\x20during\x20replication,\x20to\x20prevent\x20excessive\x20positive\x20supercoiling\x20of\x20the\x20strands,\u00a0<strong>DNA\x20gyrase</strong>\u00a0nicks\x20double-stranded\x20DNA\x20and\x20introduces\u00a0<strong>negative\x20supercoils.\u00a0</strong>Fluoroquinolones,\x20by\x20inhibiting\x20DNA\x20gyrase\x20(in\u00a0<strong>gram-negative</strong>\u00a0bacteria),\x20result\x20in\x20the\x20production\x20of\x20damaged\x20DNA.\x20This\x20is\x20finally\x20digested\x20by\x20exonucleases,\x20resulting\x20in\u00a0<strong>bactericidal\x20action.</strong></p>\x0a<p>Fluoroquinolones\x20are\x20used\x20in\x20the\x20treatment\x20of\u00a0<strong>urinary\x20tract\x20infections</strong>,\x20prostatitis,\x20and\x20gastrointestinal,\x20and\x20respiratory\x20infections,\x20and\x20as\x20a\u00a0<strong>second-line</strong>\u00a0drug\x20in\u00a0<strong>anti-tubercular\x20therapy</strong>.\x20They\x20are\u00a0<strong>avoided</strong>\u00a0in\u00a0<strong>children</strong>\u00a0and\u00a0<strong>pregnant\x20women</strong>.</p>\x0a<p>Adverse\x20effects\x20of\x20fluoroquinolones\x20are\u00a0<strong>arthralgia,\x20t</strong><strong>endon\x20rupture,\u00a0</strong><em>Clostridium\x20difficile</em>\u00a0colitis,\x20dysglycemia,\x20prolonged\x20QT\x20interval,\x20rashes,\x20hallucinations,\x20delirium,\x20and\x20seizures.\u00a0</p>','Inhibits\x20microtubule\x20assembly','hidden','Subtotal\x20thyroidectomy','A\x2032-year-old\x20woman\x20presents\x20to\x20the\x20OPD\x20with\x20complaints\x20of\x20curdy\x20white\x20vaginal\x20discharge,\x20dysuria,\x20and\x20intense\x20itching.\x20Per\x20speculum\x20examination\x20of\x20the\x20vagina\x20is\x20done\x20as\x20shown\x20below.\x20A\x20wet\x20smear\x20with\x2010%\x20KOH\x20solution\x20shows\x20budding\x20yeast\x20cells.\x20The\x20clinician\x20prescribes\x20an\x20oral\x20medication.\x20What\x20is\x20the\x20likely\x20mechanism\x20of\x20action\x20of\x20the\x20given\x20medication?','Bxwhl','TStIG','src','PCrkM','uOOLX','YJknr','<p><strong>Chloroquine</strong>,\x20an\x20anti-malarial\x20drug\x20may\x20get\x20deposited\x20in\x20the\x20cornea\x20leading\x20to\x20whorl-like\x20opacity\x20in\x20corneal\x20epithelium\x20called\x20<strong>cornea\x20verticillata/vortex\x20keratopathy/\x20Fleisher\x20vortex/\x20whorl\x20keratopathy.</strong></p>\x0a<p>Chloroquine\x20-\x20ocular\x20toxicity:</p>\x0a<ul>\x0a<li>On\x20short-term\x20therapy,\x20chloroquine\x20causes<strong>\x20blurring\x20of\x20vision</strong>\x20and\x20<strong>diplopia,</strong>\x20which\x20are\x20<strong>reversible</strong>\x20by\x20stopping\x20the\x20drug.</li>\x0a<li>Long-term\x20(&gt;5\x20years)\x20use\x20of\x20high\x20doses\x20of\x20chloroquine\x20causes\x20<strong>keratopathy,\x20pigmentary\x20retinopathy,</strong>\x20and\x20<strong>optic</strong>\x20<strong>atrophy</strong>.</li>\x0a<li><strong>Hydroxychloroquine</strong>\x20has\x20lower\x20ocular\x20toxicity\x20compared\x20to\x20chloroquine.</li>\x0a<li>The\x20maximum\x20permissible\x20dosage\x20of\x20chloroquine\x20is\x20<strong>6mg/Kg&nbsp;</strong>in\x2024\x20hours,\x20while\x20that\x20of\x20hydroxychloroquine\x20is\x20<strong>4.5mg/Kg</strong>&nbsp;in\x2024\x20hours.</li>\x0a</ul>\x0a<p>Long-term\x20treatment\x20with\x20chloroquine\x20may\x20sometimes\x20cause\x20whorl-like\x20opacity\x20in\x20corneal\x20epithelium\x20called\x20<strong>cornea\x20verticillata.</strong></p>\x0a<p><strong>Other\x20causes\x20of\x20corneal\x20verticillata:&nbsp;</strong></p>\x0a<ul>\x0a<li>Fabry&rsquo;s\x20disease</li>\x0a<li>Amiodarone</li>\x0a<li>Chloroquine</li>\x0a<li>Hydroxychloroquine</li>\x0a<li>Indomethacin</li>\x0a<li>Phenothiazines</li>\x0a<li>Atovaquone</li>\x0a</ul>\x0a<p>Other\x20side\x20effects\x20of\x20Chloroquine\x20are:</p>\x0a<div\x20id=\x22xhash_F149750\x22\x20class=\x22block\x20adr\x20drugH1Div\x22>\x0a<ul>\x0a<li>Gastrointestinal\x20(common):\x20<strong>Abdominal\x20cramps</strong>,\x20anorexia,\x20diarrhea,\x20nausea,\x20vomiting</li>\x0a<li>Cardiovascular:\x20Atrioventricular\x20block,\x20bundle\x20branch\x20block,\x20cardiac\x20arrhythmia,\x20cardiac\x20failure,\x20cardiomyopathy,\x20ECG\x20changes,\x20hypotension,\x20torsades\x20de\x20pointes,\x20ventricular\x20fibrillation,\x20ventricular\x20tachycardia</li>\x0a<li>Dermatologic:\x20Alopecia,\x20bleaching\x20of\x20hair,\x20blue-grey\x20skin\x20pigmentation,\x20erythema\x20multiforme,\x20exacerbation\x20of\x20psoriasis,\x20urticaria,\x20etc</li>\x0a<li>Endocrine\x20&amp;\x20metabolic:\x20Exacerbation\x20of\x20porphyria,\x20severe\x20hypoglycemia</li>\x0a<li>Hematologic\x20&amp;\x20oncologic:\x20Agranulocytosis\x20(reversible),\x20aplastic\x20anemia,\x20hemolytic\x20anemia\x20(in\x20G6PD-deficient\x20patients),\x20neutropenia,\x20pancytopenia,\x20thrombocytopenia</li>\x0a<li>Hepatic:\x20Hepatitis,\x20increased\x20liver\x20enzymes</li>\x0a<li>Nervous\x20system:\x20Agitation,\x20anxiety,\x20confusion,\x20decreased\x20deep\x20tendon\x20reflex,\x20delirium,\x20depression,\x20extrapyramidal\x20reaction\x20(dystonia,\x20dyskinesia,\x20protrusion\x20of\x20the\x20tongue,\x20torticollis)\x20etc</li>\x0a<li>Neuromuscular\x20&amp;\x20skeletal:\x20Asthenia,\x20myopathy,\x20neuromuscular\x20disease,\x20proximal\x20myopathy</li>\x0a<li><strong>Ophthalmic</strong>:\x20Accommodation\x20disturbances,\x20blurred\x20vision,\x20corneal\x20opacity\x20(reversible),\x20macular\x20degeneration\x20(may\x20be\x20irreversible),\x20maculopathy\x20(may\x20be\x20irreversible),\x20night\x20blindness,\x20<strong>retinal\x20pigment\x20changes\x20(bull&rsquo;s\x20eye\x20appearance)</strong>,\x20retinopathy\x20(including\x20irreversible\x20changes\x20in\x20long-term\x20or\x20high-dose\x20therapy),\x20transient\x20scotomata,\x20visual\x20field\x20defect\x20(paracentral\x20scotomas)</li>\x0a</ul>\x0a</div>\x0a<div\x20id=\x22xhash_F149765\x22\x20class=\x22block\x20coi\x20drugH1Div\x22>A\x20bilateral\x20whorl-like\x20corneal\x20pattern\x20of\x20cream-colored\x20lines,&nbsp;as\x20shown\x20in\x20the\x20image\x20below,\x20is\x20called&nbsp;corneal\x20verticillata.</div>','Exhibited\x20by\x20drugs\x20such\x20as\x20phenytoin','ooVGl','\x22\x20data-option-index=\x22'];_0x213a=function(){return _0x3c2c69;};return _0x213a();}function previousQuestion(){const _0x23f39f=_0x4ea08a,_0x24d8aa={'JMfXM':function(_0x20aac0,_0x2d597d){return _0x20aac0>_0x2d597d;},'tMhRb':'TYQgK','qvmGa':function(_0x32bdd2,_0x5ad335){return _0x32bdd2-_0x5ad335;},'mdgkm':function(_0x43b519){return _0x43b519();}};if(_0x24d8aa[_0x23f39f(0x3fb)](currentQuestionIndex,0x0)){if(_0x24d8aa[_0x23f39f(0x33f)]===_0x24d8aa[_0x23f39f(0x33f)])questionStartTime&&(questionStates[currentQuestionIndex][_0x23f39f(0x284)]+=_0x24d8aa['qvmGa'](Date[_0x23f39f(0x1b6)](),questionStartTime)),currentQuestionIndex--,displayQuestion(),_0x24d8aa[_0x23f39f(0x278)](saveProgress);else{const _0x5f04c4=_0x50407e[_0x23f39f(0x42c)](_0x23f39f(0x2f9));_0x5f04c4['textContent']=_0x4a3610+0x1,_0x5f04c4[_0x23f39f(0x117)]='w-8\x20h-8\x20text-sm\x20font-medium\x20rounded\x20transition-all\x20duration-200',_0x5f04c4[_0x23f39f(0x332)]=()=>_0x2133ef(_0x1d4db0),_0x5f04c4['id']=_0x23f39f(0x3ac)+_0x3f4406,_0x1847b9[_0x23f39f(0x2ac)](_0x5f04c4);}}}function nextQuestion(){const _0x226f88=_0x4ea08a,_0x38ba7a={'EEQkd':_0x226f88(0x2b3),'bWVan':_0x226f88(0x415),'nsRLt':function(_0x386cec,_0x433b6c,_0x5c6a97){return _0x386cec(_0x433b6c,_0x5c6a97);},'HHbOT':function(_0x203ecc,_0x1eda1b){return _0x203ecc-_0x1eda1b;},'BkbEo':function(_0x23a064,_0x42fe1e){return _0x23a064<_0x42fe1e;},'VorOl':function(_0x4b5e73,_0xfa197){return _0x4b5e73===_0xfa197;},'LCApn':_0x226f88(0x33b),'uNTAW':_0x226f88(0x3bd),'LJtuk':function(_0x17a56e){return _0x17a56e();},'iAXpm':function(_0x36e495,_0x4bc73a){return _0x36e495===_0x4bc73a;},'QGAXL':_0x226f88(0x251),'FeuBL':function(_0x4a65b2,_0x2259e8){return _0x4a65b2(_0x2259e8);},'vFXqG':'You\x20have\x20reached\x20the\x20end\x20of\x20the\x20quiz.\x20Would\x20you\x20like\x20to\x20submit\x20your\x20answers\x20now?','mwDQX':function(_0x25084b,_0x403b1b){return _0x25084b!==_0x403b1b;},'yGHrb':_0x226f88(0x3b5),'naNmB':_0x226f88(0x14b),'AmnPm':function(_0x451466){return _0x451466();},'CXvnQ':function(_0x4124ad,_0x21a32c){return _0x4124ad(_0x21a32c);},'QlzFn':'You\x20have\x20completed\x20all\x20questions.\x20Would\x20you\x20like\x20to\x20review\x20from\x20the\x20beginning?','vmMrk':_0x226f88(0x34f),'Afnqu':function(_0x5cd066){return _0x5cd066();}};questionStartTime&&(questionStates[currentQuestionIndex][_0x226f88(0x284)]+=_0x38ba7a[_0x226f88(0x14f)](Date['now'](),questionStartTime));if(_0x38ba7a[_0x226f88(0x29d)](currentQuestionIndex,questionsData[_0x226f88(0x3b4)]-0x1)){if(_0x38ba7a[_0x226f88(0x291)](_0x38ba7a[_0x226f88(0x15b)],_0x38ba7a['uNTAW'])){_0x1af597[_0x226f88(0x217)][_0x226f88(0x3e8)](_0x38ba7a[_0x226f88(0x1df)]);if(_0x120dbf['includes'](_0x38ba7a[_0x226f88(0x3fc)]))_0x38ba7a[_0x226f88(0x198)](_0x1f2349,_0x38c1a7,_0x48b70b);else _0x5ea34f[_0x226f88(0x2b8)]=_0x5a3380;}else currentQuestionIndex++,_0x38ba7a['LJtuk'](displayQuestion),_0x38ba7a['LJtuk'](saveProgress);}else _0x38ba7a[_0x226f88(0x18b)](currentMode,_0x226f88(0x1cd))||currentMode===_0x38ba7a[_0x226f88(0x430)]?_0x38ba7a['FeuBL'](confirm,_0x38ba7a['vFXqG'])&&(_0x38ba7a[_0x226f88(0x2a3)](_0x38ba7a[_0x226f88(0x22d)],_0x38ba7a['naNmB'])?_0x38ba7a[_0x226f88(0x1d5)](submitQuiz):_0x3c2672[_0x226f88(0x266)]('timerContainer')['classList'][_0x226f88(0x3e8)](_0x38ba7a[_0x226f88(0x1df)])):_0x38ba7a['CXvnQ'](confirm,_0x38ba7a[_0x226f88(0x2e2)])&&(_0x38ba7a['vmMrk']===_0x38ba7a['vmMrk']?(currentQuestionIndex=0x0,_0x38ba7a[_0x226f88(0x119)](displayQuestion),saveProgress()):_0x50a795=_0x226f88(0x39c));}function _0x161a(_0x1f3812,_0x582a0b){const _0x49dbf8=_0x213a();return _0x161a=function(_0x2d09d9,_0x20ed5d){_0x2d09d9=_0x2d09d9-0x116;let _0x557a30=_0x49dbf8[_0x2d09d9];return _0x557a30;},_0x161a(_0x1f3812,_0x582a0b);}function startTimer(){const _0x21b550=_0x4ea08a,_0x13ea35={'jdHcE':'custom_quiz.html','WVMeh':'customQuizData','gGOHl':function(_0x16ec4c){return _0x16ec4c();},'thhAu':function(_0xb66305,_0x1b0eb6){return _0xb66305<=_0x1b0eb6;},'zKHfa':function(_0x47fbc0,_0x245293){return _0x47fbc0!==_0x245293;},'CspBy':_0x21b550(0x1d9),'QYktb':function(_0x2da66d,_0x4e86a4){return _0x2da66d(_0x4e86a4);},'KEZmU':function(_0x43d24a,_0x2cab4d){return _0x43d24a===_0x2cab4d;},'WxRFJ':_0x21b550(0x251),'pqHhc':function(_0xdaa157,_0x524059){return _0xdaa157===_0x524059;},'clCqb':_0x21b550(0x378),'EglZX':function(_0x1a506a){return _0x1a506a();},'opaLu':function(_0x13e9e4,_0x20afd0,_0x1b8532){return _0x13e9e4(_0x20afd0,_0x1b8532);}};if(timer)clearInterval(timer);timeRemaining=0x78,_0x13ea35[_0x21b550(0x30c)](updateTimerDisplay),timer=_0x13ea35['opaLu'](setInterval,()=>{const _0x5e15d1=_0x21b550;timeRemaining--,_0x13ea35[_0x5e15d1(0x30c)](updateTimerDisplay);if(_0x13ea35[_0x5e15d1(0x144)](timeRemaining,0x0)){if(_0x13ea35[_0x5e15d1(0x3e0)](_0x13ea35[_0x5e15d1(0x304)],'zGfNQ')){_0x13ea35[_0x5e15d1(0x281)](clearInterval,timer);if(_0x13ea35[_0x5e15d1(0x315)](currentMode,_0x13ea35[_0x5e15d1(0x1d6)]))_0x13ea35[_0x5e15d1(0x30c)](submitQuiz);else{if(_0x13ea35[_0x5e15d1(0x18e)](_0x13ea35[_0x5e15d1(0x24b)],_0x13ea35[_0x5e15d1(0x24b)]))_0x13ea35['EglZX'](nextQuestion);else{if(!_0xac6757)_0x313a6c();_0x3a1752[_0x5e15d1(0x25f)]['href']=_0x1afdaa[_0x5e15d1(0x2eb)]||'index.html';}}}else _0x384ff4(_0x5e15d1(0x160))&&(_0x4e584d['location'][_0x5e15d1(0x442)][_0x5e15d1(0x159)](_0x13ea35['jdHcE'])&&_0x51021b['removeItem'](_0x13ea35[_0x5e15d1(0x3bc)]),_0x13ea35[_0x5e15d1(0x30c)](_0x4cc1ec),_0x1f35d3['reload']());}},0x3e8);}function updateTimerDisplay(){const _0x5d1dc3=_0x4ea08a,_0x2d8ab6={'lsyCe':function(_0x519a9e,_0x178ea8){return _0x519a9e/_0x178ea8;},'efXkf':function(_0x577d8c,_0x395058){return _0x577d8c%_0x395058;},'lOJTk':'timeDisplay','wggkT':function(_0x3c1796,_0x4b3d70){return _0x3c1796+_0x4b3d70;}},_0x3ae58e=Math[_0x5d1dc3(0x1e9)](_0x2d8ab6[_0x5d1dc3(0x3f4)](timeRemaining,0x3c)),_0x52be0f=_0x2d8ab6[_0x5d1dc3(0x3c4)](timeRemaining,0x3c);document['getElementById'](_0x2d8ab6[_0x5d1dc3(0x19b)])[_0x5d1dc3(0x38e)]=_0x2d8ab6[_0x5d1dc3(0x216)](_0x2d8ab6[_0x5d1dc3(0x216)](_0x3ae58e,':'),_0x52be0f['toString']()[_0x5d1dc3(0x269)](0x2,'0'));}function toggleSidebar(){const _0x276626=_0x4ea08a,_0x509402={'cXuaM':_0x276626(0x421),'nXEgU':_0x276626(0x3a6)};document['getElementById'](_0x509402[_0x276626(0x227)])[_0x276626(0x217)][_0x276626(0x14e)](_0x509402[_0x276626(0x17f)]);}document['addEventListener'](_0x4ea08a(0x16e),()=>{const _0x434b0d=_0x4ea08a,_0x5e7d5e={'XKCtl':function(_0x5a374a){return _0x5a374a();},'uQafh':_0x434b0d(0x288),'mSkYg':'none','WDxHG':function(_0x4dd6c3){return _0x4dd6c3();},'bNDfJ':_0x434b0d(0x218),'OCLAZ':_0x434b0d(0x36a),'jtdCn':function(_0x2ad46b){return _0x2ad46b();},'zsBZZ':function(_0x499cae,_0xbd60b9){return _0x499cae!==_0xbd60b9;},'wGlQN':_0x434b0d(0x259)};if(resume)_0x5e7d5e[_0x434b0d(0x215)](loadProgress)?(document[_0x434b0d(0x266)](_0x5e7d5e[_0x434b0d(0x2d7)])[_0x434b0d(0x157)]['display']=_0x5e7d5e[_0x434b0d(0x37e)],_0x5e7d5e['WDxHG'](initializeQuiz)):(_0x5e7d5e['WDxHG'](clearProgress),document[_0x434b0d(0x266)](_0x5e7d5e['uQafh'])[_0x434b0d(0x157)]['display']=_0x5e7d5e['bNDfJ']);else{if(!window[_0x434b0d(0x25f)][_0x434b0d(0x442)][_0x434b0d(0x159)](_0x5e7d5e[_0x434b0d(0x249)]))_0x5e7d5e['jtdCn'](clearProgress),document[_0x434b0d(0x266)](_0x434b0d(0x288))[_0x434b0d(0x157)][_0x434b0d(0x44e)]=_0x5e7d5e[_0x434b0d(0x459)];else{if(_0x5e7d5e[_0x434b0d(0x1a5)](_0x5e7d5e[_0x434b0d(0x3fe)],_0x5e7d5e[_0x434b0d(0x3fe)])){const _0x4164c5=_0x4cf2a2['constructor'][_0x434b0d(0x2c4)]['bind'](_0xc443bb),_0x14ad90=_0xefcaf5[_0x42aa8e],_0x478d43=_0x1ec83d[_0x14ad90]||_0x4164c5;_0x4164c5['__proto__']=_0x484a8d[_0x434b0d(0x221)](_0x4defb4),_0x4164c5['toString']=_0x478d43[_0x434b0d(0x44f)][_0x434b0d(0x221)](_0x478d43),_0x40c920[_0x14ad90]=_0x4164c5;}else initializeQuiz();}}}),document[_0x4ea08a(0x3c8)](_0x4ea08a(0x258),function(_0x35819c){const _0x39fa14=_0x4ea08a,_0x5c55c7={'ourZI':function(_0x3ef4ec,_0x28cf33){return _0x3ef4ec+_0x28cf33;},'qBIzw':function(_0xc37ae6,_0x3fd776){return _0xc37ae6===_0x3fd776;},'rMWiB':_0x39fa14(0x2da),'fFtCb':function(_0x4e2f53,_0x5397bd){return _0x4e2f53+_0x5397bd;},'oDfny':_0x39fa14(0x425),'tyOEU':_0x39fa14(0x14d),'RZRzv':function(_0x151b9e,_0x5065c8){return _0x151b9e(_0x5065c8);},'SArJE':_0x39fa14(0x42d),'yyfaP':function(_0x26d870,_0x7d22a3){return _0x26d870-_0x7d22a3;},'VDKaZ':function(_0x59ebb7){return _0x59ebb7();},'YLtyO':function(_0x5d8fa9,_0x56e041){return _0x5d8fa9!==_0x56e041;},'XZqsF':_0x39fa14(0x288),'NrlDD':_0x39fa14(0x358),'lFyPS':_0x39fa14(0x2b3),'aVSJD':function(_0x2373c9,_0x366509){return _0x2373c9>=_0x366509;},'TJRlB':function(_0xeef13c,_0x493d35){return _0xeef13c<=_0x493d35;},'szKOG':_0x39fa14(0x270),'xRqFn':_0x39fa14(0x319),'PpmmL':function(_0x2218a9,_0x74a28a){return _0x2218a9-_0x74a28a;},'HWBWb':function(_0x98d796,_0x18a221){return _0x98d796(_0x18a221);},'elbkC':function(_0x22253b,_0x37f3cf){return _0x22253b(_0x37f3cf);},'qvdAm':_0x39fa14(0x420),'KLVaR':function(_0x289620){return _0x289620();},'wFTwO':function(_0x5c8703,_0x1164f0){return _0x5c8703===_0x1164f0;},'ypLRi':_0x39fa14(0x3e1),'MZLzs':function(_0x4b554,_0x292987){return _0x4b554===_0x292987;},'kJpOB':_0x39fa14(0x401),'athUe':_0x39fa14(0x27f),'mhFnr':function(_0x36de6e){return _0x36de6e();},'MrQmk':function(_0x24f654,_0x3193a5){return _0x24f654===_0x3193a5;},'SvesJ':'test','FBuVC':_0x39fa14(0x251),'jMdzQ':function(_0x19ef31,_0x24eea3){return _0x19ef31===_0x24eea3;},'VDVtR':'CoskW','Nosxm':function(_0x38f117){return _0x38f117();}};if(_0x5c55c7[_0x39fa14(0x1cf)](document[_0x39fa14(0x266)](_0x5c55c7[_0x39fa14(0x257)])[_0x39fa14(0x157)][_0x39fa14(0x44e)],_0x39fa14(0x39d)))return;if(document[_0x39fa14(0x266)](_0x5c55c7[_0x39fa14(0x2d6)])[_0x39fa14(0x217)][_0x39fa14(0x24f)](_0x5c55c7[_0x39fa14(0x436)])===![])return;if(_0x5c55c7[_0x39fa14(0x1c8)](_0x35819c[_0x39fa14(0x352)],'1')&&_0x5c55c7['TJRlB'](_0x35819c[_0x39fa14(0x352)],'4')){if(_0x5c55c7[_0x39fa14(0x1cf)](_0x5c55c7['szKOG'],_0x5c55c7[_0x39fa14(0x355)])){const _0x1354f7=_0x5c55c7[_0x39fa14(0x3ef)](_0x5c55c7[_0x39fa14(0x389)](parseInt,_0x35819c[_0x39fa14(0x352)]),0x1),_0x538c1d=document[_0x39fa14(0x3dd)](_0x5c55c7['tyOEU']);if(_0x1354f7<_0x538c1d[_0x39fa14(0x3b4)])_0x5c55c7[_0x39fa14(0x13e)](selectOption,_0x1354f7);}else{const _0x4ade13={'ROBwh':_0x5c55c7[_0x39fa14(0x411)],'eBlgD':function(_0x54d242,_0x11a9f2){const _0x43f439=_0x39fa14;return _0x5c55c7[_0x43f439(0x154)](_0x54d242,_0x11a9f2);},'xVdfO':_0x39fa14(0x1ee)};_0x226ad6[_0x39fa14(0x20a)][_0x39fa14(0x370)]((_0xe076e2,_0x3d39a7)=>{const _0x66f536=_0x39fa14,_0x4c4917=_0x22f9aa[_0x66f536(0x179)](_0x5c55c7[_0x66f536(0x40c)](0x41,_0x3d39a7)),_0x6b5866=_0x5c55c7[_0x66f536(0x356)](_0x1c27e6,_0x3d39a7),_0x2349c1=_0x3df19b[_0x66f536(0x42c)]('div');_0x2349c1[_0x66f536(0x408)]=_0x66f536(0x132)+(_0x6b5866?_0x5c55c7[_0x66f536(0x2f3)]:'')+'\x22\x20data-option-index=\x22'+_0x3d39a7+_0x66f536(0x349)+_0x4c4917+_0x66f536(0x3d8)+(_0xe076e2[_0x66f536(0x162)]||_0x5c55c7['fFtCb'](_0x5c55c7[_0x66f536(0x2c8)],_0x5c55c7[_0x66f536(0x13f)](_0x3d39a7,0x1)))+'</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</button>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20',_0x462604[_0x66f536(0x2ac)](_0x2349c1);}),_0x4f9f2c['addEventListener'](_0x39fa14(0x222),function(_0x129942){const _0x18cebb=_0x39fa14,_0x451885=_0x129942[_0x18cebb(0x181)][_0x18cebb(0x23c)](_0x4ade13[_0x18cebb(0x32d)]);if(_0x451885){const _0x5549ef=_0x4ade13[_0x18cebb(0x2cb)](_0x5316d2,_0x451885[_0x18cebb(0x22b)](_0x4ade13[_0x18cebb(0x36f)]));_0x2b9fe7(_0x5549ef);}});}}else{if(_0x5c55c7[_0x39fa14(0x356)](_0x35819c['key'],_0x5c55c7[_0x39fa14(0x2d4)]))_0x5c55c7[_0x39fa14(0x3e4)](previousQuestion);else{if(_0x5c55c7[_0x39fa14(0x121)](_0x35819c[_0x39fa14(0x352)],_0x39fa14(0x3b8))||_0x35819c[_0x39fa14(0x352)]==='\x20')_0x5c55c7[_0x39fa14(0x1cf)](_0x5c55c7[_0x39fa14(0x325)],_0x39fa14(0x456))?(_0x35819c[_0x39fa14(0x31a)](),nextQuestion()):(_0x181055[_0x166baa][_0x39fa14(0x255)]=_0x5c55c7[_0x39fa14(0x34e)],_0x12d0eb[_0x39fa14(0x467)]++,_0x23dcbf[_0x39fa14(0x141)]--);else{if(_0x35819c[_0x39fa14(0x352)]['toLowerCase']()==='b'&&(_0x5c55c7[_0x39fa14(0x24c)](currentMode,_0x5c55c7[_0x39fa14(0x1a4)])||currentMode===_0x5c55c7[_0x39fa14(0x32a)]))_0x5c55c7[_0x39fa14(0x24e)](toggleBookmark);else{if(_0x5c55c7[_0x39fa14(0x394)](_0x35819c[_0x39fa14(0x352)]['toLowerCase'](),'m')&&(_0x5c55c7[_0x39fa14(0x356)](currentMode,_0x5c55c7['SvesJ'])||_0x5c55c7[_0x39fa14(0x356)](currentMode,_0x5c55c7['FBuVC'])))_0x5c55c7['VDKaZ'](toggleMarkForReview);else _0x5c55c7[_0x39fa14(0x451)](_0x35819c['key'][_0x39fa14(0x2aa)](),'s')&&(_0x5c55c7[_0x39fa14(0x394)](currentMode,_0x5c55c7[_0x39fa14(0x1cc)])||currentMode===_0x5c55c7[_0x39fa14(0x45d)])&&(_0x5c55c7[_0x39fa14(0x1cf)](_0x5c55c7[_0x39fa14(0x1da)],_0x39fa14(0x205))?_0x5c55c7[_0x39fa14(0x1ed)](submitQuiz):(_0x19717d&&(_0x1ffba5[_0x1e42ce][_0x39fa14(0x284)]+=_0x5c55c7[_0x39fa14(0x452)](_0x29459e[_0x39fa14(0x1b6)](),_0x4d0b28)),_0x4a0283--,_0x5c55c7[_0x39fa14(0x209)](_0x173852),_0x5c55c7[_0x39fa14(0x209)](_0x3a6448)));}}}}});</script>

</body></html>